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The strong association of H. pylori and gastroduodenal diseases is well accepted, 
whereas the mechanism of pathogenesis remains unclear. H. pylori γ-glutamyl 
transpeptidase (GGT) has been shown to participate in bacterial colonization and cell 
apoptosis induction. However, its role as a virulence factor is as yet undefined.  
 
GGT activity is expressed in all 98 H. pylori isolates studied and remained constant 
irrespective of vacA genotype or other virulence factors examined (cagA, iceA and 
babA2). Interestingly, GGT activity was significantly higher in H. pylori isolated from 
peptic ulcer disease (PUD; n = 54) patients than those from non-ulcer dyspepsia 
(NUD; n = 44) patients (p < 0.001). The results indicate a strong association between 
high H. pylori GGT activity and H. pylori-induced peptic ulcer disease. 
 
It was noted that growth was more profuse for H pylori isolates with higher GGT 
activity than those displaying lower GGT activity. However, in the presence of serine 
borate complex, an inhibitor of GGT, growth of H pylori was retarded in a dose 
dependent manner. In contrast, growth rate was increased in the presence of 
glutathione and glycyl-glycine, a GGT enhancer. The results show the importance of 
GGT activity on the growth of H.  pylori. 
 
DNA sequencing and the translated protein sequence alignment of the ggt gene of 6 
individual isolates showed a high degree of homology (97 - 98%). A fragment 
containing antigenic regions of H. pylori GGT was cloned and expressed in E. coli. 
Using an enzymatic assay and western blot with anti-recombinant GGT antibody as a 
probe on different protein fractions of H. pylori, GGT was shown to localize on the 
membrane of H. pylori. 
Summary  
xiii 
Native GGT protein purified using repeated cation exchange and size exclusion 
chromatography showed one band of 60 KDa on the native gel which, on SDS-PAGE 
separated into two bands of 38 and 22 KDa suggesting that GGT is a heterodimer.  
 
It has been documented that GGT plays a significant role in H. pylori-mediated cell 
apoptosis but the mechanism has not been established. Our results show that in native 
GGT treated AGS (a gastric epithelial cell line) cells, caspase-3 and caspase-9 
activities are elevated and cytosolic cytochrome c is increased. The findings 
demonstrate that GGT-mediated cell apoptosis is mainly dominated through 
mitochondrial-mediated signaling pathway. 
 
In the presence of native GGT, gastric epithelial cells (AGS and KATO III) displayed 
an increase in H2O2 generation, activated NF-κB and IL-8 production. However, 
preincubating these cells with NAC (an antioxidant), ST638 (a tyrosine kinase 
inhibitor) and MG132 (an NF-κB pathway inhibitor) blocked the IL-8 production. The 
results show that GGT-induced IL-8 production is initiated by hydrogen peroxide 
generation and that tyrosine kinase possibly plays a role in signal transmission 
towards the efficient activation of GGT-induced NF-κB activity, resulting in IL-8 
generation. Our findings reveal a novel aspect of the fuction of H. pylori GGT thereby 
providing a new focus in H. pylori-mediated IL-8 generation.  
 
The role that membrane bound GGT plays in affecting growth of H. pylori, its effect 
on hydrogen peroxide and IL-8 production, its contribution in cell apoptosis through 
mitochondrial-mediated signaling pathway and the association of high GGT activity 
Summary  
xiv 
to PUD gives an insight into the enigmatic role of GGT in the pathogenesis of H. 
pylori infection. 
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1.1 Helicobacter  pylori and gastroduodenal diseases                                                            
The discovery of H. pylori in 1983 (Warren and Marshall) and the acceptance of its 
role in gastric pathophysiology (Halter et al., 1992; Blaser, 1995) represent a 
fundamental change in our understanding of gastroduodenal diseases. Over the last 2 
decades, studies on H. pylori can be generally classified into the following categories: 
morphology and biochemical properties of H. pylori (Ottlecz et al., 1993; Enroth et 
al., 1999; Citterio et al., 2004), diagnosis of H. pylori infection (Anderson and 
Gonzalez, 2000; Markristathis et al., 2004), epidemiology of H. pylori infection 
(Mitchell and Megraud, 2002; Perez-Perez et al., 2004), H. pylori and gastroduodenal 
diseases (Hirai et al., 1999; Megraud, 2001), pathogenic and virulence factors of H. 
pylori (McGee and Mobley, 1999; Hofman et al., 2004), treatment and vaccine 
development (Kleanthous  et al., 1998; Ruggiero et al., 2002).  
 
Since the discovery of H. pylori in 1983, it has been recognized as an important 
pathogen that infects at least half of the world’s human population (Parsonnet, 1998; 
Go, 2002). H. pylori has been recognized as the principle cause of type B gastritis and 
peptic ulcer disease (Peterson, 1990; Tytgat et al., 1993). Furthermore, strong 
association between H. pylori infection and gastric cancer has been established 
(Parsonnet et al., 1991; Sipponen et al., 1992). In 1994, H. pylori has been classified 





1.2 Virulence factors of H. pylori                                                         
In human subjects infected with H. pylori, only about 15% develop gastroduodenal 
diseases (Kuipers et al., 1995). The difference in the outcome of infection depends not 
only on the genetic susceptibility of the host and environmental cofactors but also on 
the genetic diversity of the infecting H. pylori strain (Atherton, 1998). 
 
H. pylori possesses a number of virulence factors that are responsible for its survival, 
colonization and gastric pathophysiology. Among them, several virulence factors 
have been reported to be correlated with H. pylori-induced gastroduodenal diseases. 
However, there are vast differences in the association of virulence factors and 
gastroduodenal diseases in patients from the Western and the Asian populations. 
Studies have shown strong association of cagA (Covacci et al., 1993; Jenks et al., 
1998), vacA-s1 (Rudi et al., 1998), iceA1 (van Doorn et al., 1998) and babA2 
(Gerhard et al., 1999) with peptic ulcer disease in Western populations. On the other 
hand, the prevalence of these virulence factors was similar in H. pylori isolates from 
both the peptic ulcer and non-ulcer dyspepsia patients in the Asian countries (Zheng 
et al., 2000; Mizushima et al., 2001). Therefore, studies focusing on new putative 
bacterial virulence determinants are still desirable. 
 
Research over the last 20 years has contributed to a better understanding of the 
physiopathology of H. pylori infection. With the availability of the complete H. pylori 
genome sequence (Tomb et al., 1997; Alm et al., 1999), an increasing number of new 
loci are being reported as virulence factors involved in the pathogenicity of H. pylori. 
One such potential virulence factor is γ-glutamyl transpeptidase (GGT) [EC 2.3.2.2] 
(McGovern et al., 2001). 
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1.3 γ-glutamyl transpeptidase (GGT)                
GGT is found throughout the plant and animal kingdoms. It has been identified as a 
key enzyme in glutathione metabolism and plays a central role in the γ-glutamyl cycle 
involving the degradation and neo-synthesis of glutathione (Meister and Tate, 1976; 
Meister and Anderson, 1983).  
 
1.3.1 GGT in H. pylori 
H. pylori GGT is encoded by a single gene and is translated as a precursor, which is 
processed into two subunits with calculated masses of 38 and 22 kDa respectively. It 
has been reported that GGT is present on the outer membrane of all the H. pylori 
isolates and is highly conserved within H. pylori species. Therefore, it is suggested 
that GGT could be used as an identification marker for H. pylori isolates (Chevalier et 
al., 1999). 
 
1.3.1.1 GGT and H. pylori colonization 
Recently, researchers have made concerted effort to study the function of GGT in H. 
pylori infection. Chevalier et al. (1999) reported that GGT played an essential role in 
the colonization of H. pylori to the gastric mucosal of Swiss specific pathogen-free 
mice. And it was demonstrated that ggt mutants were unable to colonize the gastric 
mucosa of mice when orally administered alone while the parental strain showed the 
contrary result. However, a later report by McGovern et al. (2001) using a different 
animal model (C57BL/6) indicated that GGT is a H. pylori virulence factor rather 
than an essential factor in H. pylori colonization. Thus, the role of GGT in H. pylori 
growth and colonization has not been clearly defined.  
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1.3.1.2 GGT and H. pylori-induced cell apoptosis 
It is well established that cell apoptosis induced by H. pylori infection is closely 
associated with gastroduodenal diseases. And one of the virulence factors, VacA, has 
been reported to be involved in H. pylori-mediated cell apoptosis (Kuck et al., 2001). 
However, only approximately 50% of the H. pylori strains produce functional VacA 
(Cover, 1996). Therefore, it is believed that there must be some other virulence 
factor/s involved in H. pylori induced gastric cell apoptosis. Interestingly, Shibayama 
et al. (2003) reported that GGT plays a significant role in H. pylori-mediated 
apoptosis. However, the mechanism of apoptosis induction by H. pylori GGT has not 
been demonstrated. 
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1.4 Objectives of study                                                                                                           
The aims of this study were to identify the enigmatic role of GGT in H. pylori-
associated gastroduodenal diseases by: 
1. Investigating GGT activity and its effect on the growth of H. pylori in vitro.  
2. Analyzing the relationships between H. pylori GGT activity, virulence factors 
and gastroduodenal disease outcome. 
3. Comparing the DNA sequences of ggt gene and the translated amino acid 
sequences of GGT proteins in different H. pylori strains possessing different 
level of GGT activities. 
4. Determining the subcellular localization of GGT in H. pylori. 
5. Examining the pathway of GGT in mediating the enhanced gastric epithelial 
cell apoptosis. 
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2.1 Historical perspective 
For centuries, the human stomach had been generally considered as an inhospitable 
environment for bacteria because of its acidic pH. In the year 1983, Warren and 
Marshall at the Royal Perth Hospital successfully cultured a spiral microaerophilic 
bacterium from the human gastric mucosa of patients suffering with active chronic 
gastritis and demonstrated an association between the presence of this organism and 
gastric inflammation. Their discovery of the Helicobacter pylori and its role in 
gastritis and peptic ulcer disease succeeded them for the award of the Nobel Prize in 
Physiology or Medicine in 2005. The organism was first named as Campylobacter 
pyloridis and later renamed as C. pylori. Ten years later, the species was placed in a 
new genus Helicobacter based on taxonomical (Goodwin et al., 1993). Then, the 
organism was renamed as Helicobacter pylori. A new era of this gastric microbiology 
started and observations from laboratories across the globe rapidly appeared in 
scientific journals although there was still considerable skepticism about the 
pathogenic capacity of this microbe (Gottke et al., 2000). 
 
2.2 Properties of H. pylori 
2.2.1 Ultrastructure and morphological forms of H. pylori  
H. pylori is a Gram-negative spiral bacterium. The organism is approximately 0.3 - 
0.5µm wide and 2 to 3µm in length, possessing 4 - 6 polar sheathed flagella with a 
membraneous terminal bulb (Geis et al., 1989). 
 
H. pylori exists in two morphological forms, the active vegetative spirals and the 
dormant coccoids. The morphological transformation from spiral to coccoid forms 
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takes place in older cultures (Hua and Ho, 1996) or under adverse conditions such as 
nutrient deprivation, accumulation of waste products and exposure to sub-optimal 
level of antimicrobial agents (Nilius et al., 1993). The coccoid form of H. pylori has 
been suggested by some researchers as degenerative and poses no infectious risk 
(Eaton et al., 1995; Kusters et al., 1997). However, there were reports suggesting that 
the coccoidal form though non-culturable could be potentially viable and is an 
infective agent responsible for the transmission of H. pylori (Nilsson et al., 2002; Ng 
et al., 2003).  
 
2.2.2 Physiological properties 
H. pylori is a fastidious microorganism that requires a rich growth medium for in vitro 
cultivation (Buck and Smith, 1987). Translucent colonies of about 1 mm in diameter 
take 3 to 4 days to form when the bacterium is grown on enriched medium 
supplemented with 5 - 10% blood (Marshall et al., 1984). It is also an oxygen 
sensitive microaerophile as it will grow only in humidified atmosphere with reduced 
oxygen tension, enriched with 5% - 10% carbon dioxide at optimal temperature of 35 
- 37°C and pH of 6.5 - 7.5 (Goodwin et al., 1986). Moisture is also important to H. 
pylori and thus fresh moist plates are required for its isolation (Marshall et al., 1984). 
H. pylori can also be grown in brain heart infusion (BHI) broth, Mueller Hinton broth, 
brucella broth and Columbia broth supplemented with horse serum under 
microaerophilic conditions in an efficient and continuous culture system (Ho and 
Vijayakumari, 1993). 
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 2.2.3 Biochemical Characteristics 
H. pylori produces many different enzymes which serve its metabolic needs and allow 
the bacterium to express its virulence. These enzymes can be classified as the toxic, 
proteolytic, antioxidant and metabolic enzymes (Nilius and Malfertheiner, 1996). 
 
Toxic enzymes like phospholipases and alcohol dehydrogenase, produced by H. 
pylori provide access to the epithelium by altering and weakening the mucosal barrier, 
and may cause direct damage to the epithelial cells (Langton and Cesareo, 1992). 
Catalase and superoxide dismutase are examples of antioxidant enzymes that protect 
the bacteria against the damaging effects of toxic oxygen metabolites (Hazell et al., 
1991; Pesci and Pickett, 1994). H. pylori utilizes metabolic enzymes like 
phosphatases and ATPases which are essential for the generation of energy as well as 
the synthesis and transportation of ions and cell products (Sachs et al., 1990; Mauch 
et al., 1993). 
 
H. pylori urease has multiple effects, providing a protective role to the bacteria by 
generating an alkaline environment that aids its survival in the acidic environment to 
its colonization supportive role (Karita et al., 1995; Moran, 1996). In contrast, it also 
exhibits damaging property on the gastric epithelial surface. As reported by Mobley 
(1996), host tissues can be damaged directly by the urease-mediated generation of 
ammonia and indirectly by urease-induced stimulation of the inflammatory response, 
including recruitment of leukocytes and triggering of the oxidative burst in 
neutrophils.  
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H. pylori strains are usually negative in hippurate hydrolysis, nitrate reduction, indole 
formation, arylsulphatase activity, growth in the presence of 1% to 3.5% NaCl, and 
indoxylacetate hydrolysis (Kung et al., 1989; Owen, 1998). 
 
2.2.4 Genome of H. pylori 
Infection with H. pylori has been linked to numerous severe gastroduodenal diseases 
including peptic ulcer and gastric cancer (Marshall et al., 1988; Forman, 1992; 
Goodwein, 1997; Hirai et al., 1999). Several techniques have been used to measure 
the genetic heterogeneity of H. pylori at several different levels and to determine 
whether there is any correlation with the severity of disease (Alm and Trust, 1999). 
The availability of two completed genome sequences from unrelated strains (J99 and 
26695) has allowed an analysis of the level of diversity from a large-scale yet detailed 
perspective. The complete genome of H. pylori strain 26695 was published by Tomb 
et al. (1997) having 1,667, 867 base pair and 1590 predicted coding sequences. A 
second complete genome for strain J99 was reported by Alm et al. (1999) with 
1,643,831 base pair and 1495 predicted coding sequences.     
 
Although the two genomes are organized differently in a limited number of discrete 
regions, the genome size, gene order and the average length of coding sequences of 
these two H. pylori isolates was found to be highly similar. Functional assignments 
are assigned to approximately only 60% of the gene products in each strain, with one-
half of the remaining gene products of unknown function having homologues in other 
bacteria, while the remainder appears to be H. pylori-specific. Six to seven percent of 
the coding capacity of each genome are genes that are absent from the other strain, 
with almost one-half of these strain-specific genes located in a single hypervariable 
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region called the plasticity zone (Alm et al., 1999). The plasticity zone represents one 
of several regions across each genome that is comprised of lower (G + C)% content 
DNA, some of which has been detected in self-replicating plasmids, suggesting that 
both horizontal transfer from other species and plasmid integration are responsible for 
the strain-specific diversity at this locus (Alm  and Trust, 1999 ).  
 
2.3 H. pylori infections 
Before the discovery of H. pylori, it was generally believed that peptic ulcer disease 
was the result of excess acid secretion in the stomach triggered by stress, smoking, 
diet, and alcohol. With the discovery of H. pylori by Warren and Marshall (1983), the 
interest in the bacteria being the aetiological agent of peptic ulcer disease was 
renewed.  
 
H. pylori causes active chronic gastritis and plays a major role in the pathogenesis of 
peptic ulcer (Marshall et al., 1988) and gastric cancer (Forman, 1992). H. pylori was 
isolated in at least 80% of antral biopsy specimens from patients with gastritis (Blaser, 
1987), in more than 60% of patients with gastric ulcer (Kuipers et al., 1995) and in 
90% of those with duodenal ulcer (Tytgat et al., 1993). 
 
The natural habitat of the bacterium is the gastric mucus layer of humans (Dick, 1990). 
There is a strong correlation between histological gastritis and the presence of H. 
pylori (Jones et al., 1984). Study had shown that H. pylori infection might cause 
duodenal ulceration by simulating the increased release of gastrin and increased acid 
secretion (McColl, 1997). Strong evidence that H. pylori is a causative agent of the 
duodenal ulcer disease is based on the improved rate of healing with H. pylori 
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suppression (Marshall et al., 1988; Graham et al., 1990) and the marked decreased 
recurrence rates and duodenal ulcer rebleeding after eradication of the bacteria (Tytgat, 
1994; Macri et al., 1998).  
 
In the last decade, H. pylori was designated as a Class I carcinogen being a critical 
factor in the development of gastric adenocarcinoma by the International Agency for 
Research on Cancer (IARC, 1994). The evidence that H. pylori eradication therapy 
resulted in histological regression in patients with gastric mucosal associated 
lymphoid tissue (MALT) lymphoma (Huang et al., 1997; Isaacson, 1999) indicated 
that H. pylori infection is also a critically important factor in MALT lymphoma 
(Wotherspoon, 1998; Farinha and Gascoyne, 2005). However, the mechanism on how 
H. pylori causes gastric cancer has yet to be established. 
 
On the other hand, the relationship between H. pylori infection and non-ulcer 
dyspepsia (NUD) is controversial. Dyspepsia is characterized by persistent or 
epigastric pain or discomfort centered in the upper abdomen (Talley et al., 1998). 
Studies had shown that up to 50% of NUD patients have H. pylori (Talley, 1996) but 
the direct causal relationship is yet to be proven (Talley and Hunt, 1997; Perri et al., 
1998). 
 
The correlation between H. pylori infection and gastro-esophageal reflux disease 
(GERD) has been controversial. Although approximately 40% of GERD patients 
harbored H. pylori (O’Connor, 1999), there was no solid evidence that H. pylori 
causes the reflux disease. A study showed that H. pylori might protect against the 
development of GERD and its complication through the decrease of acid secretion 
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associated with atrophic gastritis involving the gastric corpus (Koike et al., 2001). In 
contrast, some researchers suggested that the benefit of eradicating H. pylori infection 
clearly outweighs the risk of GERD (Axon and Forman, 1997; Graham, 1999). 
However, Ho et al. (2004) demonstrated that neither gastric topological distribution 
nor principle virulence genes of H. pylori contributes to clinical outcomes. 
 
2.4 Epidemiology of H. pylori infections 
H. pylori infection is central to the pathogenesis of many gastroduodenal disorders 
including peptic ulcer disease, gastric cancer, and gastric MALT lymphoma (section 
2.3). Of the infected population, essentially majority will have chronic gastritis while 
only a small population will eventually develop clinically significant disease. This 
accounts for about 15 - 20% of individuals who will develop peptic ulcer disease in 
their lifetime and less than 1% will develop gastric cancer (Go, 2002). 
 
H. pylori is a human gastroduodenal pathogen that infects at least half the world’s 
population (Parsonnet, 1998; Go, 2002). The prevalence of H. pylori infection varies 
by the geographical location, ethnic background, socioeconomic conditions and age 
(Malaty et al., 2002). The prevalence rates of H. pylori infection are higher in 
developing countries (about 80%) than in the industrialized world (20 - 50%). H. 
pylori infection is usually acquired by oral ingestion during childhood (Brown, 2000; 
Malaty et al., 2002) and once established can persist for decades or for a life long 
(Kirschner and Blaser, 1995) unless specific antimicrobial treatment is given.  
 
In Singapore, an epidemiological study showed that the seroprevalence of H. pylori 
increased progressively with age from 3% in children below 5 years to 71% in adults 
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above 65 years. Ethnic differences were also observed in terms of the prevalence of 
infection, with more than 30% of Chinese and Indians but only about 14% of Malays 
being seropositive for H. pylori (Committee on Epidemic Diseases, 1996). A low 
socioeconomic status such as the crowded living conditions also correlates with the 
increased risk of H. pylori infection (Torres et al., 2000).  
 
2.5 Pathogenesis of H. pylori  
In patients harboring H. pylori, only about 10 - 20% develops gastroduodenal diseases 
(Kuipers et al., 1995). Evidence has emerged that the outcome of the infection 
depends not only on host factors but also on characteristics of the infecting H. pylori 
strain (Atherton, 1997), of which the virulence factors of H. pylori are the most 
studied (Atherton, 1998). 
 
2.5.1 Virulence and colonization factors 
Virulence factors are bacterial components related to the promotion of diseases and 
are absent from avirulent strains, while colonization factors are those that aid the 
bacteria in adhesion and colonization. Some of the factors discussed in this section 
operate either as the virulence or colonization factor, while others are essential not 
only for colonization but may also contribute to the virulence of the bacteria. 
 
2.5.1.1 Cytotoxin associated antigen  
The cytotoxin-associated gene (cagA) is a marker for a genomic pathogenicity (cag) 
island of about 35 kb whose presence is associated with a more severe clinical 
outcome (Censini et al., 1996; Akopyants et al., 1998). Almost all cagA+ strains 
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produce the CagA protein, which in turn elicits a detectable local and systemic 
antibody response (Cover et al., 1995). 
 
CagA was described as an immunodominant antigen with a molecular weight of 120 - 
140 kDa (Covacci et al., 1993). In recent years, studies have shown that the 
translocation of CagA into the host epithelial cells is accomplished through a 
specialized type IV secretion system that is encoded in the cag pathogenicity island. 
Following the transfer, the tyrosine residues of the CagA are phosphorylated by the 
host cell Src-like protein tyrosine kinase. This leads to the regulation of a series of 
signal transduction cascade, resulting in cytoskeletal rearrangements, the cell 
elongation effect (hummingbird phenotype) and an increased cellular motility 
(Selbach et al., 2002; Stein et al., 2002). 
 
2.5.1.2 Vacuolating Cytotoxin  
Approximately 50% of H. pylori strains induce toxic vacuolization in epithelial cells. 
The cytotoxin protein encoded by vacA gene is responsible for this vacuolization. 
vacA encodes a precursor protein of approximately 140 kDa that is actively secreted 
and cleaved to form a mature 87 kDa polypeptides, that  are aggregated into an 
oligomer, which upon exposure to acids, undergoes conformation changes that render 
the toxin fully active (de Bernard et al., 1995; Lupetti et al., 1996). VacA has been 
shown to alter intracellular vesicular trafficking in eukaryotic cells, leading to the 
formation of large vacuoles (Reyrat et al., 2000). Interestingly, Kuck et al. (2001) also 
described that VacA of H. pylori is a bacterial factor capable of inducing apoptosis in 
gastric epithelial cells.  
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vacA is present in nearly all H. pylori (de Bernard et al., 1995; Zheng et al., 2000) but 
only about half of all H. pylori strains produce functional VacA. The expression of 
VacA is determined by variations in the signal sequence (s1a, s1b, s1c, s2) and mid-
region (m1, m2, m1T, m1Tm2) of the vacA gene. Strains with an s1-type signaling-
sequence allele produce functional VacA toxin, whereas those with an s2-type 
signaling sequence have little cytotoxic activity (Israel and Peek, 2001). 
 
It was reported that there is global variation in the distribution of vacA alleles in 
different ethnic populations. The prevalence of s1c and s1a is high in strains from 
Asia; however, s1b is frequent in Southern Europe, South America, South Africa and 
the United States. Furthermore, it was reported that in North American and Western 
Europe, infection with H. pylori strains containing the s1 vacA allele is associated 
with peptic ulcer disease (PUD) (van Doorn et al., 1999). However, in Japan, South 
Korea, and China, where s1 alleles predominate, vacA genotypes have not been 
associated with more severe clinical outcome (Shimoyama et al., 1998; Yamaoka et 
al., 1999; Zheng et al., 2000). 
 
2.5.1.3 Induced on contact with epithelial cells  
As the name implies, the expression of the IceA is upregulated upon contact with 
epithelium cells (Peek et al., 1998). Sequence analysis revealed the existence of two 
distinct variants of the gene, designated as iceA1 and iceA2 (Peek et al., 1998). The 
allelic sequences of iceA1 and iceA2 are significantly different from each other. 
Interestingly, only iceA1 is induced following contact with epithelial cells. However, 
the true biological function of IceA is still unclear (Figueiredo et al., 2000). 
 
Survey of Literature 
16 
2.5.1.4 Lipopolysaccharide 
Outer membrane-derived lipopolysaccharides (LPSs) of most Gram-negative bacteria 
are powerful stimulators of the host immune response. However, the LPS from H. 
pylori is known to have 1000-fold less ability to stimulate IL-8 production than LPS 
from E. coli (Muotiala et al., 1992; Moran, 1999; 2001).  
 
Recently, it has been shown that the LPS of about 85% of all H. pylori strains is 
composed of Lewis x (Lex) and/or y (Ley) blood group antigens (Chan et al., 1995; 
Aspinall et al., 1996). Lex and Ley are also expressed on human cell surfaces and have 
been found on gastric mucosal epithelial cells and gastric mucin (Sakamoto et al., 
1989). Therefore, bacterial expression of Le antigens mimics that of the gastric 
mucosa, thereby aiding initial colonization and adhesion of H. pylori to the gastric 
epithelium (Moran, 1999). 
 
2.5.1.5 Blood group antigen-binding adhesin  
H. pylori can adhere tightly to human gastric epithelial cells. It is generally assumed 
that this adherence is relevant to the colonization and the persistence of infection by H. 
pylori. Like other pathogenic bacteria, H. pylori binds to host cell receptors by means 
of adhesins. It has been reported by Karlsson (1998) that the adherence of H. pylori 
appears to be a complex where there are more than ten different binding specificities 
for glycoproteins, carbohydrates and phospholipids. However, the corresponding 
receptors are still unknown eventhough many adhesins have been reported to be 
involved in H. pylori adherence and colonization to gastric epithelial cells (Boren et 
al., 1993; Peck et al., 1999; Mahdavi et al., 2002; Odenbreit et al., 2002).  
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One of these is BabA2 (antigen-binding adhesin) which is encoded by babA2 gene. It 
was reported that BabA mediated adherence of H. pylori to host Lewis B (Leb) blood 
group antigens found on the gastric epithelial cells (Boren et al., 1993; Falk et al., 
1993). BabA-mediated adherence of H. pylori to gastric epithelium plays a critical 
role in the efficient delivery of bacterial virulence factors that damages host tissue 
either directly or through inflammatory or autoimmune reactions that may eventually 
lead to gastroduodenal diseases (Ilver et al., 1998; Rad et al., 2002).  
 
2.5.1.6 Sialic acid-binding adhesin  
The sialic acid-binding adhesin is a 70 kDa protein that belongs to the large Hop 
family of H. pylori outer membrane protein, including BabA. sabA is found to be 
present in most of H. pylori isolates. The SabA binds sialyl-Lewis x antigen in the 
membrane glycolipids, which may protrude less from the cell surface (Mahdavi et al., 
2002), while H. pylori BabA binds the Lewis b antigen on glycoproteins (Falk et al., 
1993). Thus, H. pylori adherence during chronic infection might involve two separate 
receptor-ligand interactions – one is mediated by Leb, and the other, more intimate, 
weaker, the sLex-mediated adherence (Mahdavi et al., 2002). 
 
2.5.1.7 Urease  
Urease is one of the most abundant proteins produced by H. pylori, representing ~ 5% 
of the total bacterial cell protein (Mobley et al., 1991). It has been recognized as one 
of the virulence factors identified in H. pylori (Dunn et al., 1990; Evans et al., 1991). 
The genetic organization of urease comprised the structural (ureAB) and accessory 
(ureEFGHI) genes. The ureA and ureB genes encoded the two structural subunits of 
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the urease enzyme, while ureE, ureF, ureG and ureH encode accessory proteins 
necessary for assembly and Ni2+ insertion required to form active urease (Labigne et 
al., 1991, Cussac et al., 1992). In contrast to urease of other bacteria, H. pylori urease 
is found both within the cytoplasm and on the cell surface (Phadnis et al., 1996; Dunn 
et al., 1997). The majority of this enzyme is cytoplasmic, although a fraction is 
present on the bacterial surface after prolonged in vitro growth (Hawtin et al., 1990).  
 
It was proposed that the DNA region immediately upstream of the ureAB that encodes 
the ureC and ureD, may be the target of a transcription activator essential for the full 
expression of the ureAB genes in H. pylori. The ureC gene is present in every H. 
pylori isolate and the gene product of ureC, phosphoglucosamine mutase, is highly 
conserved (Kansau et al., 1996; de Reuse et al., 1997), and is thus a poteintial 
candidate for anti-H. pylori drugs. 
 
It has been documented that in the presence of physiological urea, urease permits H. 
pylori to maintain a constant internal and periplasmic pH through catalyzing the 
hydrolysis of urea. And this prevents a collapse of the transmembrane potential 
difference and the subsequent death of the bacteria (Meyer-Rosberg et al., 1996). 
Isogenic urease-negative mutants of H. pylori are incapable of colonizing the gastric 
mucosa indicating that urease is essential for the H. pylori colonization (Tsuda et al., 
1994). 
 
In addition to the survival benefit of expressing urease, there is evidence that 
ammonium hydroxide, generated by urea hydrolysis, contributes significantly to 
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histological damage, indicating urease can cause direct toxicity to the host (Smoot et 
al., 1990). 
 
2.5.1.8 Flagella  
H. pylori is a highly motile bacterium, owing to a tuft of four to six polar sheathed 
flagella. Motility makes possible the rapid transit of H. pylori through the acidic 
lumen and penetration into the viscous epithelial mucus layer, which protects the 
bacteria against acid contact. 
 
The flagellar filaments of H. pylori comprise two different subunit components, the 
flagellins FlaA and FlaB (Kostrzynska et al., 1991). The expression of both flagellin 
genes is required for full motility (Josehans et al., 1995) and colonization efficiency 
of H. pylori (Ottemann and Lowenthal, 2002). 
 
2.5.2 Association of virulence factors and gastroduodenal diseases 
In general, there are vast differences in the association of virulence factors and 
gastroduodenal diseases in patients from the Western and Asian populations. Studies 
showed strong association of cagA (Covacci et al., 1993; Weel et al., 1996; Jenks et 
al., 1998), vacA-s1 (Rudi et al., 1998), iceA1 (van Doorn et al., 1998), and babA2 
(Gerhard et al., 1999) with peptic ulcer disease in Western populations. In contrast, 
the prevalence of these virulence factors was similar in H. pylori isolates from both 
the peptic ulcer and non-ulcer dyspepsia patients in the Asian countries (Pan et al., 
1997; Zheng et al., 2000; Mizushima et al., 2001).   
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2.6 Possible mechanisms in H. pylori pathogenesis    
H. pylori is linked to the appearance of several gastric diseases and probably 
associated with the progression of gastric cancer. Understanding the pathogenesis of 
H. pylori infection has been a major investigative target. Several possible mechanisms 
have been reported that infection with H. pylori has led to epithelial damage via 
cellular injury, inflammation and apoptosis (Tahara, 1998; Zarrilli et al., 1999; 
Nedrud et al., 2002). 
 
2.6.1 H. pylori-induced oxidative stress in gastroduodenal diseases 
Although H. pylori has been shown to be an important pathogen of gastric and 
duodenal inflammation, the pathogenic mechanisms are not well defined. One of the 
potential toxic factors involving H. pylori-induced gastric injury is oxygen radicals 
(Morris and Nicholson, 1987).  
 
2.6.1.1 Reactive oxygen species (ROS) and cellular damage 
ROS, including hydrogen peroxide, hypochlorite ion, hydroxyl radical and superoxide 
anion can cause oxidative damage to various cellular components in the host, 
including structural and regulatory proteins, carbohydrates, lipids, DNA and RNA. It 
has been well established that the DNA damage induced by oxygen free radicals 
could have very harmful consequences, leading to gene modifications that are 
potentially mutagenic and/or carcinogenic (Olinski et al., 2003). ROS, including lipid 
peroxides, may also cause tissue injury by increasing the synthesis of cyclo-
oxygenasse (Chakaborti et al., 1989) and lipoxygenase (Yamamoto et al., 1997) 
pathway products of arachidonic acid. Arachidonic acid will in turn stimulate the 
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release of platelet activating factor that plays important roles in inflammatory 
responses (Heller et al., 1998; McManus and Pinckard, 2000). In addition, ROS can 
activate the NF-κB transcription factor, which causes increased expression of genes 
coding for a range of pro-inflammatory mediators, including interleukin-6, 
interleukin-8, and tumor necrosis factor α (Schreck et al., 1991). The increased 
expression of these pro-inflammatory mediators will consequently lead to the host 
inflammatory response-related mucosa damage. Moreover, ROS has also been known 
to induce injury to gastric mucosa, thereby potentially predisposing the tissue to ulcer 
formation (Davies et al., 1992). 
 
2.6.1.2 H. pylori induced ROS and gastroduodenal diseases 
Excessive ROS production is thought to contribute to a variety of diseases of the 
gastrointestinal (GI) tract, as shown in animal and human studies (Gotz et al., 1997).  
 
Enhanced ROS level in H. pylori+ patients (Davies et al., 1992; 1994) as well as 
increased oxidative DNA damage in H. pylori infected mucosa have been reported 
(Baik et al., 1996). The production of ROS induced by H. pylori has also been 
documented in an in vitro study (Hyeyoung et al., 2000). In 2000, Obst et al. and Beil 
et al. reported that incubation of gastric cells (AGS and HM02) with H. pylori or H. 
pylori extract induced the synthesis of ROS, diminished the levels of reduced 
glutathione (GSH), and induced DNA fragmentation in gastric cells. These results 
indicated that both H. pylori whole cells and H. pylori extract can directly induce the 
synthesis of ROS. However, the exact mechanism and the possible virulence factor/s 
of H. pylori in ROS generation have not been clearly defined.  
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It is established that ROS generated by H. pylori play an important role in the 
pathogenesis of gastroduodenal mucosal inflammation, peptic ulcer disease and 
probably even gastric cancer (van der Vliet and Bast, 1992; Gotz, et al., 1997; Zhang 
et al., 1997). However, the virulence factor/s involved in ROS generation has not 
been well defined. 
 
2.6.1.3 Antioxidant  
Antioxidants can scavenge ROS before they cause damage to the various biological 
molecules, or prevent oxidative damage from spreading. One of the ways is by 
interrupting the radical chain reaction of lipid peroxidation. The antioxidant defense 
systems in the human body are extensive and consist of multiple layers, which protect 
at different sites and against different types of ROS (Cheng et al., 2001). 
 
An important part of the antioxidant defense system inside cells is the antioxidant 
enzymes, such as superoxide dismutases and catalase. In addition to the antioxidant 
enzymes, there are several small-molecule antioxidants that play important roles in 
antioxidant defense systems. These small-molecule antioxidants include vitamin E, 
ascorbic acid and glutathione (Cheng et al., 2001).  
 
Among these antioxidants, GSH is one of the major endogenous defense components 
against oxidative stress (Meister et al., 1983). It directly quenches reactive hydroxyl 
free radicals, other oxygen-centered free radicals and radicals that centered on DNA 
and other biomolecules (Kidd, 1997). GSH is the essential co-factor for many 
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enzymes which require thiol-reducing equivalents, and helps keep redox-sensitive 
active sites on enzymes in the necessary reduced state (Weber, 1999). Higher-order 
thiol cell systems – the metallothioneins, thioredoxins, and other redox regulator 
proteins are ultimately regulated by GSH levels and the GSH/oxidized GSH (GSSG) 
redox ratio. GSH/GSSG balance is crucial to homeostasis, stabilizing the cellular 
biomolecular spectrum, and facilitating cellular performance and survival. Moreover, 
GSH availability down-regulates the pro-inflammatory potential of leukotrienes and 
other eicosanoids (Hiraishi et al., 1991; Weber, 1999). 
 
2.6.1.4 H. pylori infection decreases the GSH level in gastric mucosa 
As stated in section 2.6.1.2, an excess ROS production was demonstrated in mucosal 
biopsy specimens taken from H. pylori+ patients with duodenal ulcer and gastritis. In 
H. pylori+ patients, GSH values are significantly lower than in patients who are H. 
pylori negative (Beil et al., 2000; Shirin et al., 2001).  
 
GSH has been reported to be involved in the direct repair of oxidative DNA lesions 
(Lenton et al., 1999). Thus, increased ROS generation and decreased GSH level in 
gastric mucosa caused by H. pylori infection may favour the development of gastritis 
and peptic ulcer disease (Beil et al., 2000; Shirin et al., 2001). One may raise the 
question that the high ROS and diminished GSH levels in the gastric mucosa, lead to 
gastric carcinogenesis? 
 
Survey of Literature 
24 
2.6.2 Role of cytokines in pathogenesis of H. pylori-induced mucosal damage 
During H. pylori infection, both bacterial virulence factors and the host’s 
inflammatory response will contribute to mucosal damage. Direct bacterial damage 
may result from the bacterial production of urease, vacuolating cytotoxin and other 
virulence factors. The bacterium also may indirectly induce mucosal damage as a 
consequence of the persistent inflammatory response, neutrophil activation, and 
changes in host physiological responses associated with infection (Ernst et al., 1997).  
 
Gastrointestinal epithelial cells, which form the major interface between the host and 
enteric pathogens, initiate acute mucosal inflammation and interact with other 
mucosal cell populations via a complex cytokine network. Gastrointestinal epithelial 
cells secrete chemokines (Sharma et al., 1995) which regulate innate defense 
mechanisms activating neutrophils and macrophages. Epithelial cells also possess 
receptors for numerous cytokines (Colgan et al., 1994; Reinecker et al., 1996). 
Therefore, cytokines released from activated mucosal cell populations will, in turn, 
modify both epithelial phenotype and barrier function (Madara et al., 1989; Mullin 
and Snock, 1990).  
 
Numerous proinflammatory and immunoregulatory cytokines are increased in the 
gastric mucosa during H. pylori infection, including interleukin-1β (IL-1 β), IL-2, IL-
6, IL-8 and TNF-α (Crabtree, 1996). Specific interest has focused on the chemokines, 
a superfamily of small related proteins identified as key molecules in the recruitment 
and activation of immune cells, such as IL-8 having specific target activity for 
neutrophils (Baggiolini et al., 1994).  
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2.6.2.1 H. pylori infection and IL-8 generation 
IL-8 and related peptides of the chemokine family secreted by gastric epithelial cells 
are likely to be important host mediators of the inflammatory response inducing 
neutrophil migration to the sites of infection. It has been documented that epithelial 
IL-8 can be up-regulated by TNF-α and IL-1 and by H. pylori (Huang et al., 1995; 
Harris et al., 1996). In addition to its chemotactic potential, IL-8 is capable of 
activating polymorphonuclear leukocyte degranulation, the respiratory burst, and the 
5-lipoxygenase pathway (Baggiolini et al., 1989). Thus, IL-8 may be an important 
component of the inflammatory cascade. 
 
The importance of IL-8 in the host response to H. pylori infection has been confirmed 
by a study using cDNA microarray assays, which showed that co-culturing gastric 
epithelial cells with H. pylori significantly upregulated mRNA expression in 8 of 
2304 genes tested. Among these 8 upregulated genes, IL-8 showed the greatest 
increase of 11.8-fold (Maeda et al., 2001). These data suggest that IL-8 induction in H. 
pylori-infected gastric epithelial cells is universal and specific, and may be an 
important factor which is responsible for the neutrophil activation and infiltration, and 
consequently, for the inflammation-associated mucosal injury and carcinogenesis. 
 
Indeed, gastric mucosal levels of IL-8 correlate with histological severity in patients 
with H. pylori-induced gastritis (Ando et al., 1996). Recently, Shimizu et al. (2000) 
reported that the mucosal tissues obtained from H. pylori+ peptic ulcer patients 
showed significantly higher levels of IL-8 and increased numbers of inflammatory 
cells as compared to that in H. pylori negative peptic ulcer patients or H. pylori 
negative controls. When the values were compared between the mucosal tissues from 
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the normal gastric antrum and those from the ulcer site, the latter group of tissues 
showed significantly higher levels of IL-8 and increased numbers of neutrophils and 
macrophages than the former group regardless of its healing process in patients with 
H. pylori-positive peptic ulcer (Shimizu et al., 2000). These results demonstrate IL-8 
is important in ulcerogenesis with respect to H. pylori-associated peptic ulcer disease. 
 
2.6.2.2 Regulation of IL-8 gene expression 
It has been documented that expression of IL-8 is regulated initially at the level of 
gene transcription (Mukaida et al., 1990; Chaudhary and Avioli, 1996) although post-
transcriptional control has also been reported (Villarate and Remick, 1996). In fact, 
the human IL-8 gene contains several binding sites within its promoter region. A 
nuclear factor (NF)-kB binding motif is located at nucleotides (nt) 280 to 270, and a 
NF-IL-6 site lies immediately adjacent to this motif (nt 294 to 281). In addition to 
these loci, a binding site for c-fos and c-jun, which together comprise the transcription 
factor AP-1, is present at nt 2126 to 2120 (Lakshminarayanan et al., 1998; Roebuck et 
al., 1999). 
 
2.6.2.2.1 Role of NF-κB  
NF-κB is a transcription factor sequestered in the cytoplasm, whose activation and 
regulation are tightly controlled by a class of inhibitory proteins termed IκBs (I-κBα, 
I-κBβ, and I-κBε). Through non-covalent association, I-κB proteins mask the nuclear 
localization signals of NF-κB, thereby preventing movement of NF-κB to the nucleus. 
On stimulation with ROS or some signaling molecules such as tumor necrosis factor 
(TNF)-α, I-κBα and I-κBβ will be phosphorylated by Ser/Thr protein kinases. 
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Phosphorylation of I-κBα and I-κBβ leads to the ubiquitination and 26S proteaosome-
mediated degradation of phospho-IκBα, thereby liberating NF-κB to enter the nucleus 
(Mercurio et al., 1997; Kim et al., 2000). Once translocated to the nucleus, NF-κB can 
mediate transcriptional activities without the requirement of de novo synthesis 
(Baeuerle, 1991; Baeuerle and Baltimore, 1996). 
 
The activated NF-κB then plays a key role in the induction of pro-inflammatory gene 
expression, leading to the synthesis of cytokines, adhesion molecules, chemokines, 
growth factors and enzymes (Roebuck et al., 1999). It is well established that NF-κB 
is an inducible transcription factor and its binding site is found in the promoter region 
of the IL-8 gene, thereby controlling the expression of IL-8 at the transcriptional level.  
 
2.6.2.2.2 Role of mitogen-activated protein kinases (MAPKs) pathway  
In addition to NF-κB, mitogen-activated protein kinases (MAPKs) have been 
implicated as mediators of IL-8 expression. MAPKs cascades are signal transduction 
networks that target transcription factors and thus participate in diverse array of 
cellular functions including cytokine production (Garrington et al., 1999).  
 
The MAPKs comprise an important group of serine and threonine signalling kinases 
that transduce a variety of extracellular stimuli through a cascade of protein 
phosphorylations that lead to the activation of transcription factors (Ip and Davis, 
1998; Kyriakis and Avruch, 2001). Three MAPK pathways contribute to IL-8 gene 
expression: the extracellular-regulated protein kinases (ERKs), the c-Jun NH2-
terminal protein kinases (JNKs) and p38 MAPK cascades (Hsu et al., 2000; Pestka et 
al., 2005). 
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2.6.2.2.3 Role of transcription factor AP-1  
AP-1 is an inducible transcription factor of the bZip family and is critical for the 
expression of many genes involved in the inflammatory response, including cytokines 
and adhesion molecules. AP-1 is composed of either Jun-Fos heterodimers or Jun-Jun 
homodimers (Smeal et al., 1989). AP-1 binding sites can also interact with 
transcription factors of the CREB/ATF family by forming heterodimers with Jun and 
Fos proteins (Roebuck et al., 1993; Rabbi et al., 1997). Formation of cross-family 
dimers may further increase the number of transcription factors available for IL-8 
gene regulation. Although not essential in most cell types, the distal AP-1 binding site 
has been shown to contribute to IL-8 promoter activity and is critical in several 
epithelial cell lines (Nakamura et al., 1991). In addition, AP-1 can physically interact 
with NF-κB (Stein et al., 1993) and synergistically activate IL-8 gene expression. 
(Nakamura et al., 1991; Harada et al., 1994) 
 
AP-1 activity is controlled at both the transcriptional and post-transcriptional levels. 
The expression of c-fos, which is nearly absent in quiescent cells, is controlled at the 
level of transcription. All three MAPKs, ERK1/2, SAPK/JNK, and p38, can 
phosphorylate the transcription factor Elk-1, a member of the complex family (Zinck 
et al., 1995; Rinegaud et al., 1996). Elk-1 binds the serum response element motif in 
the c-fos promoter, thereby inducing c-fos transcription (Hipskind et al., 1991). In 
contrast, c-jun is regulated both transcriptionally and post-transcriptionally. A few c-
Jun homodimers pre-exist in resting cells. In addition, c-jun transcription is 
upregulated by activated MAPKs (Lamph et al., 1988). Subsequently, c-Jun can 
increase its own transcription by binding to the TRE motif in its promoter (Talley et 
al., 1991). Novel c-Fos synthesis leads to the formation of Jun/Fos heterodimers, 
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which have a 10-fold higher DNA binding affinity than Jun/Jun homodimers, 
resulting in increased AP-1 activity (Han and Prywes, 1995; Karin et al., 1997). Post-
transcriptionally, c-Jun activity is potentiated through phosphorylation of two serine 
residues in the transcriptional activator domain by SAPK/JNK (Derijard et al., 1994; 
Karin, 1995). 
 
2.6.2.3 H. pylori activates NF-κB, AP-1 and MAPK 
Several studies have demonstrated that contact between H. pylori and gastric 
epithelial cells results in brisk activation of NF-κB, which followed by increased IL-8 
expression. In vivo studies also showed that activated NF-κB is present within gastric 
epithelial cells of infected, but not uninfected patients (Crabtree et al., 1994; Keates et 
al., 1997). 
 
In 1999, Keates et al. reported that MAPKs also play a critical role in IL-8 production 
via documenting that H. pylori activate MAPK signaling pathway and consequently 
lead to enhancing IL-8 promoter binding activity of AP-1. And this suggestion has 
been further confirmed by Seo et al. (2004) who reported that MAPK cascade may act 
as the upstream signaling for the activation of AP-1 and NF-κB, which induces 
chemokine expression in H. pylori-infected AGS cells. 
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Recently, the function of AP-1 in H. pylori-induced IL-8 production has been 
documented by Sang et al. (2003). Using an in vitro study, they demonstrated that 
activated AP-1 complex (a c-Jun/c-Fos heterodimer) was detected in H. pylori-
infected AGS cell, indicating that H. pylori induced the expression of mRNA and 
protein for IL-8 via AP-1. 
 
2.6.2.4 Virulence factors and H. pylori - induced IL-8 production 
It has been documented that CagA was associated with IL-8 production from gastric 
epithelial cells in vitro and in vivo. The infection with cagA+ H. pylori strains was 
associated with higher grades of gastric inflammation, correlating with increased risk 
of peptic ulceration (Crabtree and Lindley, 1994; Peek et al., 1995). However, there 
are also reports to the contrary as indicated by Crabtree et al. (1995) and Nozawa et al. 
(2002) that there was no significant difference between IL-8 production induced by 
the cagA positive wild-type strain and the cagA negative isogenic mutant strain of H. 
pylori. Therefore, the relationship between cagA and IL-8 production is still unclear. 
 
Although VacA has been recognized as an important virulence factor involved in the 
pathogenesis of H. pylori infection, there was no correlation between IL-8 production 
and the presence of vacA gene in the H. pylori strains (Rieder et al., 1997). In addition, 
the isogenic cytotoxin-negative mutant H. pylori strain had the same IL-8-stimultory 
ability as the parent strain (Huang et al., 1995; de Jonge et al., 2001). Similarly, there 
was no decrease in IL-8 induction by a mutant lacking the urease subunits (Sharma et 
al., 1995).  
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More recently, Viala et al. (2004) documented that an intracellular protein, Nod1, 
being a major pathogen-regonition molecule involved in IL-8 secretion from gastric 
epithelial cells sensing of H. pylori bacteria. They reported that Nod1 responses to 
peptidoglycan delivered by bacterial type IV secretion system, encoded by H. pylori 
cag pathogenicity island. However, the virulence factor/s in the IL-8 production are 
still not been well defined.  
 
2.6.3 H. pylori infection and cell apoptosis  
Apoptosis, or programmed cell death, is an essential physiological process that is 
required for the normal development and maintenance of tissue homeostasis (Vaux et 
al., 1999). When misregulated, apoptosis can contribute to various diseases including 
cancer, autoimmune and neurodegenerative diseases (Martin and Elkon, 2004).  
 
A large variety of stimuli, both physiological and stress stimuli, have been shown to 
induce apoptosis. Physiological stimuli include surface receptors such as tumor 
necrosis factor (TNF) or CD95; examples of stress stimuli are ionizing and ultraviolet 
radiation, ROS, increased calcium concentration, heat shock, viral and bacterial 
infections, etc. While many physiological stimuli trigger death via surface receptors, 
the initiation of stress-induced apoptosis is much less defined, but seems to involve 
mitochondria at a very early stage of the intracellular signaling cascade (Rowan and 
Fisher, 1997). 
 
It has been established that central components of the apoptotic death machinery 
which have been conserved throughout evolution include the Bcl-2, Apaf-1 (apoptotic 
protease-activating factor 1) and caspase family members. Caspases (cysteinyl 
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aspartate-specific proteases) are synthesized as dormant proenzymes that, upon 
proteolytic activation, acquire the ability to cleave key intracellular substrates, 
resulting in the morphological and biochemical changes associated with apoptosis 
(Budihardjo et al., 1999). Recently, it was found that, in apoptosis triggered by many 
stimuli, mitochondria play a pivotal role in coordinating caspase activation through 
the release of cytochrome c (Desagher and Martinou, 2000; Wang, 2001).  
 
2.6.3.1 The intrinsic and extrinsic apoptotic pathways 
The apoptotic pathway can be divided into extrinsic and intrinsic arms. The intrinsic 
arm of the apoptotic program arises from the mitochondria (Ravagnan et al., 2002). 
Mitochondria have the ability to promote apoptosis through release of mitochondrial 
components, such as cytochrome c. Following release from mitochondria, cytochrome 
c, together with apoptosis protease-activating factor-1 (Apaf-1), deoxyadenosine 
triphosphate (dATP), and procaspase-9, assembles into a heptameric wheel-like 
caspase-activating complex (Figure 1), which has been termed the apoptosome (Liu et 
al., 1996). Procaspase-9 molecules recruited to the apoptosome are thought to auto-
activate via proximity-induced autoprocessing (Acehan et al., 2002). Upon activation 
within the apoptosome, caspase-9 can then propagate the death signal by activating 
downstream caspases, including caspase-3, caspase-7, etc (Figure 2). 




Figure 1. The cytochrome c-induced caspase activation pathway 
(Adapted from Wang, 2001) 
Apoptotic stimuli exert their effects on mitochondria to cause the release of 
cytochrome c. Cytochrome c in turn binds to Apaf-1, a cytosolic protein that normally 
exists as an inactive monomer. The binding of cytochrome c induces a conformational 
change in Apaf-1, allowing it to bind the nucleotide dATP or ATP. The nucleotide 
binding to the Apaf-1–cytochrome c complex triggers its oligomerization to form the 
apoptosome, which recruits procaspase-9. The binding of procaspase-9 to the 
apoptosome forms the caspase-9 holoenzyme that cleaves and activates the 
downstream caspases, such as caspase-3. 
 
 
The extrinsic arm is initiated by the binding of death factors to their surface receptors 
that will transmit apoptosis signals inside the cell (Figure 2). They play an important 
role in apoptosis and can activate a caspase cascade within seconds after the ligand 
binding. Induction of apoptosis via this mechanism is therefore very rapid. It was 
found that certain members of the TNF receptor superfamily are involved in 
transducing death signals and share a distinct domain within their cytoplasmic tails, 
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which has been termed the death domain (Ashkenazi and Dixit, 1998). Upon 
engagement of these receptors with their extracellular ligands such as TNF, Fas 
ligand/CD95L and TNF-related apoptosis-inducing ligand (TRAIL), oligomerization 
and /or a conformational change in the receptor occur. Within seconds of receptor 
engagement, an intracellular death-inducing signaling complex (DISC) is formed 
through recruitment of adapter molecules, such as FADD (Fas-associated death 
domain protein), that also contain death domain motifs (Muzio et al., 1996). FADD 
also contains a DED (death effector domain) and recruits the DED-containing caspase, 
caspase-8, into the DISC through homotypic interactions between the DED motifs 
present in both proteins.  
 
Upon activation of caspase-8 within the DISC, the death signal is propagated by two 
alternative mechanisms, depending on the cell type (Scaffidi et al., 1998) (Figure 2). 
In certain cell types (type I cells), stimulation of death receptors results in a robust 
activation of caspase-8, followed by direct activation of effector caspases downstream. 
In contrast, other cell types (type II cells) fail to activate sufficient caspase-8 within 
the DISC (for reasons that are currently unknown) to permit direct activation of the 
caspase cascade. Instead, death receptor-mediated activation of caspase-8 in type II 
cells results in the proteolysis of Bid (a member of Bcl-2 protein family). Truncated 
Bid (tBid) translocates to mitochondria where it promotes the Bax/Bak-dependent 
release of cytochrome c, thereby triggering apoptosome assembly (Li et al., 1998; 
Luo et al., 1998). Therefore, a level of cross-talk exists between the death receptor 
and mitochondrial apoptosome pathways of apoptosis. 
 
 




Figure 2. Two major apoptosis pathways 




2.6.3.2 Apoptosis in gastric epithelium induced by H. pylori infection 
Apoptosis is an essential part of the cycle of cellular turnover in many tissues, 
including the gastrointestinal tract. H. pylori infection induces apoptosis in gastric 
epithelial cells (Moss et al. 1996; Moss, 1998), which has been suggested to play a 
significant role in the development of pathological outcomes by disturbing the 
balance between the rate of new cell production and the rate of cell loss by apoptosis 
(Correa and Miller, 1998). The induction of an increased rate of apoptosis by H. 
pylori could induce a secondary hyperproliferative response in an attempt by the 
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mucosa to maintain cell mass (Shirin and Moss, 1998). In lesions in which both 
apoptosis and proliferation are continuously augmented, alterations and mutations of 
apoptosis regulating genes could occur more frequently, thus leading to an increased 
risk of developing gastric cancer. Therefore, it is hypothesized that H. pylori-induced 
apoptosis also plays a key role in gastric carcinogenesis (Correa and Miller, 1998; 
Shirin and Moss, 1998; Xia and Talley, 2001). 
 
In addition to the gastric carcinogenesis associated with H. pylori-induced apoptosis, 
it has been reported that H. pylori infection is associated with increased epithelial 
apoptosis in the gastric mucosa of peptic ulcer patients. In contrast, apoptosis 
decreases to the levels found in normal controls after eradication of H. pylori (Moss et 
al., 1996; Honghton et al., 1999; Kohda et al., 1999). Kohda and colleagues (1999) 
also showed that the increase of cell apoptosis in the antral mucosa correlated closely 
with the stage of ulceration.  
 
Several studies have shown that H. pylori-induced apoptosis is strongly associated 
with the development of peptic ulceration and gastric carcinoma. In vitro studies 
using gastric cancer cell lines have shown that incubation of the gastric epithelial cells 
with either live or dead H. pylori or sonicate of H. pylori cells leads to an induction of 
apoptosis (Wagner et al., 1997). Recently, there has been continuing interest in 
identifying H. pylori virulence factors that may influence the proliferation or death of 
gastric epithelial cells. To date, several virulence factors have been reported to have 
apoptosis-inducing activity. 
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2.6.3.3 Virulence factors in H. pylori-mediated cell apoptosis 
2.6.3.3.1 CagA and H. pylori-mediated cell apoptosis 
The relationship between CagA and H. pylori-induced cell apoptosis has been 
investigated. It has been documented that cag pathogenicity island was associated 
with increased apoptosis (Le'Negrate et al., 2001; Maeda et al., 2002). However, the 
H. pylori cagA+ strains induced increased gastric cell proliferation, which was not 
accompanied by a parallel increase in apoptosis. In addition, the apoptotic indices in 
cagA+ H. pylori infected patients were similar to those in the uninfected patients (Peek 
et al., 1997; Rokkas et al., 1999; Moss et al., 2001). These results suggest that CagA 
may not participate in the H. pylori-mediated cell apoptosis.  
 
2.6.3.3.2 VacA and H. pylori-mediated cell apoptosis 
The vacuolating cytotoxin, VacA, is one of the most important virulence factors of H. 
pylori. Several groups have reported that VacA induces epithelial cell apoptosis 
(Kuck et al., 2001; Cho et al., 2003; Patrice et al., 2003). In 2001, Kuck et al. 
reported that VacA of H. pylori induced apoptosis in the human gastric epithelial cell 
line AGS via increasing the expression of Fas L receptor on the AGS cells. It has also 
been documented that VacA cellular intoxication resulted in the induction of 
apoptosis by a mitochondria-dependent mechanism. VacA has been shown to induce 
cytochrome c release (Galmiche et al., 2000) and a collapse in mitochondrial 
transmembrane potential (Kimura et al., 1999), suggesting that modulation of 
mitochondrial membrane permeability occurs in cells intoxicated with VacA.  
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2.6.3.3.3 Lipopolysaccharide and H. pylori-mediated cell apoptosis 
It has been suggested that high dose of purified H. pylori lipopolysaccharide-induced 
gastric mucosal responses cause a marked increase in epithelial cell apoptosis 
(Wagner, et al., 1997; Kawahara, et al. 2001). The obtained apoptotic index correlated 
with the severity of induced gastropathy and the dose of lipopolysaccharide 
(Piotrowski et al., 1996; 1997). However, the course of ensuing events involved in the 
H. pylori lipopolysaccharide induction of gastric epithelial cell apoptosis is not readily 
apparent. 
 
2.6.3.3.4 Urease and H. pylori-mediated cell apoptosis 
In 2000, Fan et al. reported that H. pylori urease bound to gastric epithelial cells 
expressing various class II MHC alleles, and subsequently induced their apoptosis. In 
addition, the Fab from anti-class II MHC blocked the induction of apoptosis by urease 
in a concentration-dependent manner. These results indicate that urease may play a 
role in the H. pylori-induced cell apoptosis. However, the conclusion was not evident. 
 
2.6.3.3.5 γ-glutamyl transpeptidase (GGT) and H. pylori-mediated cell apoptosis 
Using an in vitro study, Shibayama et al. (2003) showed that H. pylori GGT exhibited 
apoptosis-inducing activity on AGS cells. In addition, the apoptosis-inducing activity 
of the isogenic mutant ggt-deficient strain was significantly lower compared with that 
of the parent strain. The results demonstrated that GGT plays a significant role in H. 
pylori-mediated apoptosis. However, the mechanism of GGT in apoptosis induction 
has not been established. 
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2.7 γ-glutamyl transpeptidase 
γ-glutamyl transpeptidase (EC 2.3.2.2) is found throughout the plant and animal 
kingdoms. It has been identified as a key enzyme in glutathione metabolism and plays 
a central role in the γ-glutamyl cycle involving the synthesis and degradation of GSH 
(Meister et al., 1976; 1983). GGT is a membrane-bound and heavily glycosylated 
protein. In vitro translation studies and pulse-chase labeling experiments have 
revealed that GGT is translated as a single chain precursor form, which is then 
glycosylated. The glycosylated precursor is subsequently processed into two subunits 
by the processing protease(s) (Capraro and Hughey, 1983; Finidori et al., 1984).  
 
2.7.1 Catalytic activity of GGT 
GGT cleaves γ-glutamyl amide bonds. A general formula for the reaction (Hanigan, 
1998) is shown in Figure 3. Glutathione and glutathione conjugates are the most 
abundant physiologic substrates for the enzyme. The enzyme can hydrolyze the γ-
glutamyl bond, a reaction favoured under physiologic conditions (McIntyre and 
Curthoys, 1979). In addition, Hanes and Hird (1950) discovered the ability of GGT to 
transfer the γ-glutamyl group of glutathione to an acceptor amino acid, a process they 
termed ‘transpeptidation’. Increased pH and high concentrations of acceptor 
molecules, which include free amino acids and peptide acceptors, shift the kinetics to 
favour the transpeptidation reaction (Curthoys and Hughey, 1979). As described 
below, hydrolysis of glutathione and glutathione-conjugates are the primary reactions 
catalyzed by the enzyme in vivo. However, GGT can use a wide variety of γ-glutamyl 
compounds as substrates (Magnan et al., 1982). The only specificity in the structure 
of the substrate is that it contains a free glutamic acid linked via the carboxy side 
chain to an amide group. 





Figure 3. Catalytic action of GGT 
“R” represents any chemical group. 





2.7.2 Physiological function of GGT 
Glutathione cannot be taken up by most cells. It first must be hydrolyzed into its 
constituent amino acids, which can then be taken up by the amino acid transport 
proteins in the cell membrane (Figure 4). The γ-glutamyl-group renders glutathione 
resistant to proteases. GGT is the only enzyme that can cleave intact glutathione. The 
enzyme initiates the breakdown of glutathione by cleaving the γ-glutamyl group 
releasing cysteinyl-glycine. The dipeptide can then be hydrolyzed into cysteine and 
glycine by dipeptidases on the cell surface (McIntyre and Curthoys, 1982). It has been 
shown directly, by transfection studies, that expression of GGT enables cells to 
recover the amino acids from extracellular glutathione (Hanigan and Ricketts, 1993). 
 
GGT 




Figure 4. Hydrolysis of extracellular glutathione by GGT 
GGT cleaves the gamma-glutamyl bond of glutathione releasing glutamate and 
cysteinylglycine. Cysteinylglycine is hydrolyzed by dipeptidases on the surface of the 
cell. The amino acids can then be taken up into the cell where they enter many 
pathways including the synthesis of intracellular glutathione. 
 
 
Based on the capability to catalyze the transfer of a γ-glutamyl moiety, it was 
proposed that the γ-glutamyl cycle includes glutathione synthesis, the formation of γ-
glutamyl amino acids outside cells, and the regeneration of amino acids inside cells 
(Griffith and Meister, 1979). A series of reactions by this cycle accompanies the 
uptake of amino acids by cells. Of six enzymes constituting the reaction cycle, only γ-
glutamyl transpeptidase functions outside cells, while the other members function 
exclusively inside the cells. Thus, γ-glutamyl transpeptidase is thought to be of critical 
importance in this cycle in terms of amino acid transport. 
 
2.7.3 ggt gene 
The structure of the ggt gene differs among species. In rat and mouse, ggt is a single 
copy gene which can be transcribed from multiple promoters (Brouillet et al., 1994; 
Dipeptidases 
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Shi et al., 1995). Each promoter gives rise to one or more distinct GGT mRNAs that 
can be distinguished with probes to unique sequences upstream of the coding region 
(Darbouy et al., 1991). The mRNAs are expressed in a developmentally regulated and 
tissue specific pattern. In human, GGT is a multigene family. At least four different 
genes or pseudogenes are present in the human genome (Figlewicz et al., 1993). The 
5% untranslated region of the GGT mRNAs isolated from human tissues appears to 
have a regulatory role in the tissue specific modulation of GGT expression (Diederich 
et al., 1995). 
 
2.7.4 Cellular expression of GGT 
GGT is strongly expressed by renal tubular cells, pancreas, vascular endothelium, and 
peripheral blood macrophages (Tate and Meister, 1981). GGT activity has been 
detected on both T and B cells (Novogrodsky et al., 1976; Nichols et al., 1998). It was 
reported that the CD4 (+) T cell subset with the capacity to migrate across human 
endothelial cell monolayer expresses high GGT levels. And the expression of GGT on 
T cells can be up-regulated following activation (Karp et al., 1999). 
 
2.7.5 GGT and tumor  
GGT has become the focus of increased interest in cancer research with the 
observation that GGT is induced in many animal tumors that are used as models of 
chemical carcinogenesis. Carcinogen-induced rat hepatocellular carcinomas, mouse 
skin tumors and hamster squamous cell carcinomas have highly induced levels of 
GGT activity. Induction of GGT is an early event in the formation of these tumors and 
therefore expression of GGT was used as a marker to identify preneoplastic cells in 
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these systems (Hendrich and Pitot, 1987; Zhang and Mock, 1987; Tennenbaum et al., 
1993). Studies in animals have demonstrated that GGT expression increased the 
growth rate of rapidly dividing tumor cells (Hanigan, 1995). 
 
GGT is expressed in many normal human tissues, and tumors derived from these 
tissues often retain their GGT-positive phenotype (de Camargo et al., 1988). It has 
been shown that GGT expression is altered during the development of tumors 
(Hanigan et al., 1999). Analysis of GGT expression in human breast tumors has 
shown that some mammary epithelial cells lose their GGT-positive phenotype as they 
progress to a malignant phenotype (Durham et al., 1997). In contrast, GGT is induced 
in many lung and ovarian tumors and in some squamous cell carcinomas (Hanigan et 
al., 1994).  
 
2.7.6 Inhibitors of GGT 
It is known that L isomer of serine, in the presence of borate, effectively inhibit GGT 
(Tate and Meister, 1978). Serine mimics the substructure around an α-carbon of a γ-
glutamyl moiety of a donor substrate and thus appears to occupy the subsite for the 
portion of the substrate so that the amino acid alone weakly inhibits the enzyme in a 
competitive manner against the donor. In the presence of borate, the hydroxyl groups 
of the active site of the enzyme and the serine would be bridged by the borate (Tate 
and Meister, 1978). The resultant tetrahedral borate complex strongly inhibits the 
enzyme and is thought to serve as a transition state analogous at the catalytic center of 
the enzyme. 
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In addition to the serine borate complex (SBC), acivicin was frequently used in 
studies aimed at demonstrating the physiological role of GGT (Anderson and Meister, 
1986). Acivicin is a competitive nonreversible inhibitor that binds this enzyme sites 
closely to the site where γ-glutamylation occurs (Stole et al., 1994; Smith et al., 1995). 
However, as acivicin is a glutamine antagonist, it also inhibits many other glutamine-
dependent enzymes involved in purine and pyrimidine biosynthesis (Lyons et al., 
1990). Several studies have shown that acivicin induced apoptosis in various cell lines 
such as human lymphoblastoid cells (Graber and Losa, 1995) and V79 cell lines 
(Aberkane et al., 2001). 
 
Apart from SBC and acivicin, 6-diazo-5-oxo-L-norleucine (DON) has also been used 
as a GGT inhibitor. However, DON is a glutamine analogue that binds and inhibits a 
variety of glutamine-dependent amidotransferases and may interfere with the 
biosynthesis of nucleic acids, providing another mechanism of cytotoxicity (Lyons et 
al., 1990). 
 
2.7.7 GGT in H. pylori 
Constitutive expression of GGT activity in all H. pylori strains, and very high degree 
of conservation of GGT within H. pylori species has been reported (Chevalier et al., 
1999). H. pylori GGT was found to have a similar feature, although its maturation 
process is not clear. H. pylori GGT exhibits a typical signal sequence at its N-terminal 
end (26 amino acids with the cleavage site occurring between Ala-26 and Ala-27). 
The position of the second cleavage site locates between amino acid 379 and 380, 
which results in the processing of the pro-GGT into a large and a small subunit. These 
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two subunits are associated in a non-covalent manner to form an active enzyme 
(Shibayama et al., 2003).  
 
After secretion and maturation, H. pylori GGT is likely to be associated to membrane 
by an ionic bond, which is consistent with a previous observation that direct contact 
of bacteria with the host cell is required for apoptosis induction (Chen et al., 1997; 
Shibayama et al., 2001). 
 
In 1999, Chevalier et al. reported that deletion of a 700 bp fragment within the GGT-
encoding gene of a mouse-adapted H. pylori strain (SS1) resulted in mutants that were 
negative in GGT activity. This isogenic mutant was unable to colonize the gastric 
mucosa of mice when orally administered alone or together (co-infection) with the 
parental strain. They suggested that H. pylori GGT has an essential role for the 
establishment of the infection in the mouse model. However, McGovern et al. (2000) 
using another mouse model demonstrated that GGT was not essential for the H. pylori 
colonization, indicating that the role of GGT in the bacterial colonization has not been 
defined clearly. And the effect of GGT on H. pylori growth in vitro has not been 
established. 
 
Although McGovern et al. (2001) reported that GGT is a virulence factor of H. pylori, 
no evidence was given in the report as to the actual mechanism of the virulence of 
GGT in their study. In addition, the relationship between GGT activity and the 
gastroduodenal diseases outcome, and the role of GGT in the pathogenesis of H. 
pylori is still unknown. 
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The finding that GGT plays a significant role in H. pylori-mediated apoptosis 
(Shibayama et al., 2003) reveals that GGT could be one of the most important virulent 
elements of H. pylori causing severe gastroduodenal diseases including peptic ulcer 
diseases and gastric cancer. But, there is no information available on the mechanism 
of apoptosis induction by H. pylori GGT.  
 
2.8 Assays of apoptosis 
2.8.1 Analysis of cell morphology 
Apoptosis was originally recognized based on typical changes in cell morphology as 
revealed by light or electron microscopy (Wyllie, 1992; Majno and Joris, 1995). In 
most cell types the morphological features of cells dying by apoptosis are very 
characteristic and thereby their identification based on morphological criteria is 
simple.  The most commonly used morphological criteria for identification of 
apoptotic cells are reduced cell size, plasma membrane undulations, chromatin 
condensation, and presence of apoptotic bodies (van Cruchten and van Den Broeck, 
2002).  
 
The major advantage of morphological assays is that identification of apoptotic cells 
is based on the classical criteria of apoptosis. The disadvantage of these assays is that 
the methodology is cumbersome and selection of the cells to be analyzed is not 
random but subjective and possibly biased. 
 
Survey of Literature 
47 
2.8.2 Analysis of DNA fragmentation 
It has been established that activation of endonuclease(s) which cleaves DNA into 
discrete fragments, initially into 300 - 50 kb and subsequently into 180 bp-sections 
(Oberhammer et al., 1993) is considered to be a hallmark of apoptosis. This event, 
therefore, provides a marker for identification of apoptotic cells and measurement of 
the extent of apoptosis. There are several different approaches to detect DNA 
degradation. The most commonly used method is agarose gel electrophoresis for 
detection of 180 bp or 300 - 50 kb DNA fragments (Compton, 1992). It should be 
pointed out, however, some cell types do not display the pattern of DNA 
fragmentation (Brown et al., 1993; Oberhammer et al., 1993). And in many cell types 
the DNA degradation results in 300 to 50 kb DNA fragments and does not progress to 
the inter-nucleosomal section (Akagi et al., 1995). Therefore, the large DNA 
fragments can only be detected by field-inversion gel electrophoresis (FIGE).  
 
2.8.3 Analysis of cell organelles 
Functional assays of cell organelles provide information about the mechanism of cell 
death; therefore, those assays have been used to analyze cell apoptosis. An early 
apoptotic event involves a decrease in mitochondrial transmembrane potential 
(Golstein, 1997; Nagata, 1997). Several different fluorochromes are used as probes of 
mitochondrial transmembrane potential. For example, the charged cationic green 
fluorochromes rhodamine 123 (Rh123) has been used to assay the functional state of 
mitochondria (Darzynkiewicz et al., 1982). Cell incubation with Rh123 results in 
labeling of live cells, while dead cells, having uncharged mitochondria, showing 
minimal Rh123 uptake. Cell incubation with both Rh123 and propidium-iodide (PI) 
labels live cells green (Rh123) and dead cells red (Darzynkiewicz et al., 1982).  
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Other organelles whose function changes during cell death, and which can be 
analyzed by flow cytometry, are lysosomes. These organelles can be probed by 
lysosomal-trophic probes. The most frequently used probe is acridine orange (AO). 
Incubation of cells in the presence of 1 - 2 µg/ml of the metachromatic fluorochromes 
AO resulted in the uptake of this dye by lysosomes of live cells which fluoresced red 
(Darzynkiewicz et al., 1992). The uptake is the result of an active proton pump in 
lysosomes: the high proton concentration (low pH) causes AO, which can enter the 
lysosomes in the uncharged form to become protonated and thus entrapped in the 
organelle. Late apoptotic and necrotic cells, at that low AO concentration, exhibit 
weak green and minimal red fluorescence. This assay is useful for cells that have 
numerous active lysosomes, such as monocytes and macrophages. 
 
It should be stressed that during the early stages of apoptosis both the plasma 
membrane is preserved and most organelles and cellular functions remain relatively 
unchanged as compared to live cells. The assays based on functional assays of the cell 
organelles, like the dye exclusion tests, are not able to identify cells that die by 
apoptosis, especially for detection of those cells in the early apoptotic status (Arends 
et al., 1990). 
 
2.8.4 Assays detecting changes in the plasma membrane 
One of the features distinguishing dead from live cells is the loss of transport function 
and often even the loss of the structural integrity of the plasma membrane. A plethora 
of assays of cell viability have been developed based on changes in properties of the 
plasma membrane. This is because the intact membrane of live cells excludes charged 
dyes such as trypan blue or propidium-iodide (PI), short incubation with these dyes 
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results in selective labeling of dead cells, while live cells show minimal dye uptake 
(Ormerod et al., 1992; Darzynkiewicz, 1994). 
 
Another assay of membrane integrity employs the nonfluorescent esterase substrate, 
fluorescein diacetate (FDA) (Ormerod et al., 1992). This substrate, after being taken 
up by live cells, is hydrolyzed by intracellular esterases, which are present in all types 
of cells. The product of the hydrolysis, fluorescein, is charged and thereby becomes 
entrapped in the cell. It is also highly fluorescent, emitting green fluorescence. 
Incubation of cells in the presence of both PI and FDA, thus, labels live cells green 
(fluorescein) and dead cells red (PI).  
 
It should be pointed that because during the early stages of apoptosis, the integrity of 
plasma membrane is still preserved, the early apoptotic cells are undistinguishable 
from live cells by the tests that utilize exclusion of PI or FDA hydrolysis (Ormerod et 
al., 1992). 
 
Plasma membrane phospholipids are asymmetrically distributed between inner and 
outer leaflets of the plasma membrane. Specifically, phosphatidylcholine and 
sphingomyelin are exposed on the external surface of the lipid bilayer while 
phosphatidylserine is located on the inner surface (Fadok et al., 1992). It has been 
shown recently that loss of phospholipid asymmetry leading to the exposure of 
phosphatidylserine on the outside of the plasma membrane is an early event of 
apoptosis (Fadok et al., 1992; Koopman et al., 1994). The anticoagulant annexin V 
preferentially binds to negatively charged phospholipids such as phosphatidylserine. 
By conjugating fluorescein to annexin V, it has been possible to use such a marker to 
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identify apoptotic cells by flow cytometry. During apoptosis the cells become reactive 
with annexin V after the onset of chromatin condensation but prior to the loss of the 
plasma membrane ability to exclude PI. Therefore, by staining cells with a 
combination of fluoresceinated annexin V and PI, it is possible to detect non-
apoptotic live cells (annexin V and PI negative), early apoptotic cells (annexin V 
positive, PI negative) and late apoptotic or necrotic cells (PI positive) by fluorescence 
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3.1 Patients and H. pylori strains 
A total of 98 H. pylori clinical strains isolated from the biopsies obtained from the 
anterior and posterior gastric wall of the gastric antrum within 2 cm of the pylorus 
with informed consent were included in this study. In addition, two standard strains 
SS1 and NCTC 11637 were also included in this study. The patient population 
comprised 49 males and 49 females with a mean age of 48.45 ± 17.31 years (20 - 82). 
Among these, the majority were Chinese (78/98, 79.6%) and remaining consisted of 
the Malays (6/98, 6.1%), Indians (10/98, 10.2%) and other races (4/98, 4.1%).  The 
patients were classified into two main groups based on clinical history and endoscopic 
examination: peptic ulcer disease (PUD) group (n = 54) which included isolates 
obtained from patients with duodenal ulcer (n = 33) or gastric ulcer (n = 21), while the 
non-ulcer dyspepsia (NUD) group (n = 44), which included isolates from patients 
with gastritis. NUD was defined as patients with neither a history of ulcer disease nor 
endoscopic evidence of ulcer disease. 
 
3.2 Growth of H. pylori on solid medium 
The bacteria were subcultured onto chocolate blood agar (CBA) plates or brain-heart 
infusion (BHI) broth containing 10% horse serum and 0.4% yeast extract at 37°C in a 
humidified incubator (Forma Scientific) supplied with 5% CO2.  
 
3.3 Genomic DNA extraction from H. pylori 
Genomic DNA from H. pylori was extracted according to the method as described by 
Hua et al. (1998). A CBA plate culture of H. pylori was harvested and transferred into 
an eppendorf tube containing 1.5 ml of Tris-EDTA (TE) buffer (100 mM Tris-HCl 
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and 1mM EDTA). The bacterial suspension was centrifuged at 8,000 × g for 5 
minutes at room temperature and washed once with TE buffer. The pellet was then 
suspended in 800 µl TE buffer. The bacterial suspension was treated with 100 µl of 10 
mg/ml lysozyme (Amersham Biosciences) at 37oC for 30 minutes and then lysed with 
100 µl of 10% sodium dodecyl sulphate (SDS) (Sigma) for another 30 minutes at 
37oC. Following the addition of 5 µl of 10 mg/ml proteinase K (Boehringer 
Mannheim), the mixture was further incubated at 56oC for 1 hour.  
 
The DNA was extracted twice with an equal volume of buffer equilibrated phenol 
(Sigma) and once with an equal volume of chloroform (Merck). DNA was then 
precipitated overnight with two volumes of absolute ethanol (Merck) and 1/10 volume 
of 3 M sodium acetate (Merck) at -20oC. The DNA precipitate was then washed twice 
with 70% ethanol. The pellet was vacuum-dried using speedvac (Savant concentrator) 
and resuspended in 200 µl sterile distilled water. 
 
3.3.1 Spectrophotometric analysis of DNA 
A Shimazu UV-1601 spectrophotometer was used to measure the concentration of 
DNA sample. DNA samples were diluted 1:200 (v/v) in distilled water and assayed 
for absorbance at wavelength of 260 nm, read against 200 µl distilled water as control. 
As a guideline, an absorbance of 1.0 at OD260 nm is defined as equivalent to a 
concentration of 50 µg/ml double stranded DNA (Sambrook et al., 1989). 
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3.3.2 Agarose gel electrophoresis 
Electrophoresis was performed using gels consisting of 0.8 - 1.5% agarose in 0.5 × 
TAE buffer (Appendix 4) containing 0.1 µg/ml ethidium bromide. Each DNA sample 
was mixed with gel loading buffer (Appendix 4) before loading into the gel. The gels 
were run submerged in 0.5 × TAE buffer at 100 V constant voltages for 60 minutes. 
DNA bands were visualized using ultraviolet transilluminator (Vilber Lourmat) and 
images captured using gel documentation system (Kodak EDAS 290). Molecular 
weight markers used were 1 kb DNA ladder (Gibco BRL or NEB) and the GeneRuler 
100 bp DNA ladder Plus (Fermentas). 
 
3.4 “Virulence genes” of H. pylori 
3.4.1 Detection of “virulence genes” by PCR 
DNA of each H. pylori strain was isolated by chloroform-phenol extraction as 
described in section 3.3, and DNA concentration was measured 
spectrophotometrically at 260 nm. A 50µl of the reaction mixture containing 1 U Taq 
DNA polymerase, 5µl of 10 × Taq polymerase buffer, 0.2 mM of each 
deoxynucleotide, 20 pmol each of forward and reverse  primers and 50ng of target 
DNA was prepared. The PCR reaction was carried out in an amplification thermal 
cycler (Perkin-Elmer) programmed according to the protocol as described by Zheng et 
al. (2000). The PCR reactions for cagA, vacA, iceA and babA2 genes are listed in 
Table 1. Briefly, the procedures involved 30 cycles of denauration, annealing and 
extension; with an initial denaturation of 94oC for 5 minutes and a final extension of 
72oC for 5 minutes. The PCR primers for amplification of these genes and expected 
fragment sizes are listed in Table 2. The PCR products were analyzed by running in 
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1% agarose gel electrophoresis for 1 hour at 100 V in 0.5 × TAE buffer. DNA bands 
were visualized using ultraviolet transilluminator (Vilber Lourmat) and images 




Table 1. PCR amplification conditions for H. pylori cagA, vacA, iceA and babA2 
genes 
 
Gene Denaturation Annealing Extension 
cagA 94oC, 1 min 50oC, 1 min 72oC, 1 min 
vacA 94oC, 1 min 50oC, 1 min 72oC, 1 min 
iceA 94oC, 1 min 50oC, 45 sec 72oC, 45 sec 
babA2 94oC, 1 min 52oC, 1 min 72oC, 1 min 
 




Table 2. PCR primers for H. pylori cagA, vacA, iceA and babA2 genes 
Region Primer Nucleotide sequence (5’-3’) 
Size of PCR 
product (bp) 
Reference 
cagA-F AATACACCAACGCCTCCAAG cagA 
cagA-R TTGTTGCCGCTTTTGCTCTC 
400 Lage  et al., 
1995 
vacA-F GCTTCTCTTACCACCAATGC vacA 
vacA-R TGTCAGGGTTGTTCACCATG 
1160 Xiang  et al., 
1995 
iceA1-F GTGTTTTTAACCAAAGTATC iceA1 
iceA1-R CTATAGCCAGTCTCTTTGCA 
246 van Doorn et 
al., 1998 
iceA2-F GTTGGGTATATCACAATTTAT iceA2 
iceA2-R TTGCCCTATTTTCTAGTAGGT 
229 or 334 van Doorn et 
al., 1998 
babA-F AATCCAAAAAGGAGAAAAAGTATGAAA babA2 
babA-R TGTTAGTGATTTCGGTGTAGGACA 
831 Mizushima  et 
al., 2001 
 
3.4.2 Clonal study 
VacA negative strains have been detected in our lab (Ho et al., 2004) as well as other 
H. pylori research groups (Wagner et al., 1997; Jones et al., 1999). In order to analyze 
the predominant vacA genotype in Singapore population, a subset of 15 isolates (9 
from PUD and 6 from NUD) were randomly chosen from 77 vacA positive H. pylori 
isolates. For each isolate, 5 colonies were randomly selected from subculture.  In all, a 
total of 75 clones from 15 isolates were used in this subset study. Subsequently, the 
genomic DNA of each of these 75 clones was extracted and kept for vacA genotyping.  
Simultaneously, each of the 75 clones was harvested from its 3-day old culture and 
used for GGT activity analysis. 
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3.4.3 Genotyping of vacA gene 
Typing of vacA for signal sequence region alleles (s1a, s1b, s1c and s2) and middle 
region alleles (m1, m2, m1T and m1Tm2) was carried out using the primers and 
methods as described by Atherton et al. (1995) and Wang et al. (1998). These 8 pairs 
of primers and the expected PCR fragment lengths are listed in Table 3. 
 
 
Table 3. PCR primers for genotyping of H. pylori vacA alleles 
Region Primer Nucleotide sequence (5’ 3’) 







































199 Atherton et al., 
1995 
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3.5 GGT and H. pylori growth 
3.5.1 γ-glutamyl transpeptidase activity assay 
GGT activity was assayed according to the method as described by Chevalier et al. 
(1999) using γ-glutamyl-ρ-nitroanilide (Sigma) as donor substrate for the GGT 
hydrolytic activity and glycyl-glycine (Sigma) as glutamate acceptor for the 
transpeptidation reaction. The assay was carried out by incubating 5×107 H. pylori 
cells  (whole cells) of a 3-day-old culture at 37°C for 30 minutes in 1 ml of 100mM 
Tris-HCl (pH 8.0), in the presence of 1 mM γ-glutamyl-ρ-nitroanilide and 20 mM 
glycyl-glycine. The production of free ρ-nitroanilide released in the incubation 
medium was determined by spectrophotometry at 405 nm. One unit of GGT activity 
was defined as the quantity of enzyme that releases 1µmol ρ-nitroaniline per min per 
mg of protein at 37°C. The GGT activity of each H. pylori strain was carried out in 
quadruplicate. 
 
3.5.2 Growth of different H. pylori strains  
Three-day-old culture of two clinical strains each with high GGT activity (strains 
1018 and 712) and low GGT activity (strains 1082 and 888) at a bacterial population 
of  5×107 were grown in BHI broth at 37°C in a humidified incubator (Forma 
Scientific) supplied with 5% CO2 over a period of 3 weeks without shaking. The 
bacterial populations of the various strains were enumerated by viable bacterial count 
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3.5.3 Inhibitory effect of serine borate complex on H.  pylori GGT activity 
A bacterial population of 5×107 of a 3-day-old H. pylori SS1 culture was incubated in 
BHI broth containing various concentrations (2 - 10 mM) of SBC (Sigma) at 37oC for 
30 minutes. GGT activity of H. pylori cells was then measured by GGT assay as 
described in section 3.5.1.  
 
3.5.4 Stimulatory effect of GSH and glycyl-glycine on H.  pylori GGT activity 
A bacterial population of 5×107 of a 3-day-old H. pylori SS1 culture was incubated in 
BHI broth containing 1 mM glycyl-glycine supplemented with various concentrations 
(0.01 - 1 mM) of GSH (Sigma) at 37oC for 30 minutes. GGT activity of H. pylori was 
then measured by GGT assay as described in section 3.5.1. 
 
3.5.5 Growth inhibition and stimulation studies 
H. pylori SS1 was suspended in fresh BHI broth at a final cell concentration of 
approximately 5×105 CFU per ml. For growth inhibition study, appropriate volumes 
of filter-sterilized (pore size, 0.2 µm; Sartorius) SBC stock solution (100 mM) were 
added to sterile BHI broth to provide final concentrations of SBC in BHI in the range 
of 2-10 mM. For growth stimulation study, filter-sterilized glycyl-glycine (Sigma) and 
GSH (Sigma) were added to BHI broth at a final concentration of 1 mM and 0.1 mM, 
respectively. Growth inhibition and stimulation curves were constructed based on 
viable bacterial count at different time intervals. The experiments were also carried 
out using H. pylori SS1. 
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3.6 Sequencing of ggt gene of H. pylori 
Based on ggt gene sequence of H. pylori NCTC 11637 (Busiello et al., 2004), primers 
were designed as shown in Table 4.  
 
 







Sequence (5’    3’) 
F1 1-23 23 ATGAGACGGAGTTTTTTGAAAAC
R1 1683-1704 21 TTAAAATTCTTTCCTTGGATC 
F2 511-531 20 GCGATTTCACAAAGACAAGC 
R2 1167-1186 19 TAACGCTGACTGCATTCCC 
F3 1111-1129 18 ATGGGGCAGTTGCATGAG 
R3 600-621 21 CTCTTGATAATCAAGATGCCC 
M13 F  18 GGTTTTCCCAGTCACGAC 
M13 R  20 AGCGGATAACAATTTCACAC 
* Primers were designed according to published ggt gene sequence of NCTC 11637 
(Busiello et al., 2004). 
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3.6.1 Cloning strategy for sequencing 
The PCR amplified ggt gene fragment (primers F1 & R1) was inserted into pGEM-T 
Easy vector (Promega) as shown in Figure 6. The construct, pGEM-ggt was transformed 
into E. coli Top 10 as it gave high transformation efficiencies and plasmid yield. The 





Figure 6. Construction of pGEM-ggt for ggt gene sequencing   
PCR amplified ggt gene fragment was cloned into pGEM-T easy vector (Promega) by 
TA cloning strategy 
 
 
3.6.2 Amplification of ggt gene  
Genomic DNA templates from SS1 and 4 clinical isolates (825, 840, 712 and 998) 
were used for PCR reaction. Briefly, 50µl of the reaction mixture containing 1.0 U 
Taq DNA polymerase, 5µl of 10 × Taq polymerase buffer, 0.2  mM of each 
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was prepared. The polymerase chain reaction (PCR) was carried out in a thermal 
cycler ((Perkin-Elmer). Hot start was performed to minimize the possibility of 
mispriming. This was accomplished by manually adding Taq polymerase after strand 
denaturation. Briefly, PCR reaction tubes without Taq polymerase were heated to 
94°C for 5 minutes and subsequently Taq polymerase was added. The reaction 
mixture was subjected to 30 cycles of reaction with denaturation at 94°C for 1 minute, 
annealing at 62°C for 1 minute and extension at 72°C for 2 minutes followed by 1 
cycle of final extension at 72°C for 10 minutes. PCR products were analyzed by gel 
electrophoresis and subsequently stored at -20°C until use. 
 
3.6.3 Purification of ggt PCR product 
PCR product of ggt was run in 1% agarose gel at 100 V for 1 hour. The PCR product 
fragment was cut from agarose gel and purified by QIAquick gel extraction kit 
(Qiagen) according to the manufacturer’s instructions. The concentration of DNA of 
PCR product was measured as described in section 3.3.1. 
 
3.6.4 TA cloning 
TA cloning was employed in the cloning of PCR product of the gene of interest, ggt. 
The cloning vector used was pGEM- T Easy vector (Figure 6). Ligation was carried 
out in accordance to the manufacturer’s instruction. Briefly, 100 ng ggt gene PCR 
product was ligated to 50 ng of pGEM- T easy vector with 3 units of T4 DNA ligase 
(Promega) in a total volume of 10 µl at 4oC overnight. 
 
                                                                                                     Materials and Methods 
62 
3.6.5 Preparation of competent cells 
The E. coli strain Top 10 (Invitrogen) and E. coli strain BL21 (DE3) (Novagen) were 
used for the preparation of competent cells. The E. coli cells from a frozen stock 
culture were grown on LB agar plate overnight at 37oC. A single colony was 
inoculated into a 5 ml LB broth and incubated overnight at 37oC with shaking at 200 
rpm. Following incubation, an aliquot of 100 µl of the overnight culture was 
inoculated into 10 ml fresh LB broth and incubated for 2 - 4 hours at 37oC until the 
optical density at 600 nm was found to be around 0.4. The culture was chilled on ice 
for 20 minutes and then centrifuged at 5,000 × g for 5 minutes at 4oC. The pellet was 
resuspended in 2.5 ml of cold 100 mM CaCl2 and incubated for 10 minutes on ice. The 
suspension was centrifuged and resuspended in 500 µl cold 100 mM CaCl2. The cells 
were used immediately or aliquoted into 100 µl amount supplemented with 10% 
glycerol and stored at -80oC until use. 
 
3.6.6 Transformation of E. coli 
Ten µl of the above ligation mixture (section 3.6.4) was added to 100 µl competent 
cells in a cold eppendorf tube followed by incubation for 30 minutes on ice before 
subjecting it to heat shock at 42oC for 1.5 minutes. To the mixture, 400 µl LB broth 
was added and incubated at 37oC for 60 minutes with gentle shaking (90 rpm). 
Aliquots of 100 µl were spread onto selective LB agar plate supplemented with 50 
µg/ml ampicillin, 50 µg/ml isopropylthio-β-D-galactoside (X-gal) and 25 µg/ml 5-
bromo-4-chloro-3-indolyl- β-D-galactoside (IPTG). Plates were incubated overnight 
at 37oC. Insertional inactivation of the lacZ gene in the pGEM- T Easy vector resulted 
in recombinants appearing as white colonies. 
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3.6.7 Plasmid DNA extraction 
Single white colony from selective plate was picked and inoculated into 10 ml LB 
broth with 50 µg/ml ampicillin and incubated overnight at 37°C with vigorous 
shaking of 200 rpm. One ml of the culture was harvested by centrifugation and 
plasmid was extracted by alkali lysis method as described by Sambrook et al. (1989). 
The harvested cells were resuspended in 100µl of ice-cold Solution I (Appendix 6) 
and vortexed vigorously. Aliquot of 200µl of freshly prepared solution II (Appendix 6) 
was then added and gently mixed, followed by the addition of 150µl of Solution III 
(Appendix 6) and vortexed gently in an inverted position for 10 seconds. The tubes 
were stored on ice for 3 - 5 minutes before centrifuging at 12,000 × g for 5 minutes. 
The supernatant was transferred to a fresh eppendorf tube and equal volume of phenol 
chloroform was added. The phenol chloroform DNA mixture was centrifuged at 
12,000 × g for 5 minutes at 4°C. The resultant supernatant was transferred to a fresh 
tube and the plasmid DNA was precipitated with 2 volumes of ice cold absolute 
ethanol and 1/10 volume of 3 M sodium acetate at -20°C for 2 hours. The mixture was 
centrifuged at 12,000 × g for 10 minutes at 4°C and supernatant aspirated. The pellet 
was rinsed twice with 1 ml of 70% ethanol and air dried for 15 minutes. Finally the 
pellet was resuspended in 25µl of TE (pH 8.0) containing DNase-free RNase 
(20µg/ml) and was stored at - 20°C until use. 
 
3.6.8 DNA sequencing 
DNA sequencing was performed using the ABIPRISM Big-dye Terminator 
sequencing kit (Applied Biosystems). The primers used were the M13 forward and 
reverse sequencing primers which were specific to the sites flanking the insertion 
region (Table 4). In addition, three pairs of primers (F1 & R3, F2 & R2 and F3 &R1) 
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as shown in Table 4 and Figure 7 were also used for gene sequencing. The sequencing 
reaction included 25 cycles of 96°C for 10 seconds, 50°C for 5 seconds and 60°C for 
4 minutes. Ethanol precipitation was carried out to remove the excess terminators and 
primers. Sequencing was then performed on the ABI PRISM 377 DNA sequencer 
(Applied Biosystems).  
 
           F1                                   F2                                           F3 
ggt gene 
                                                             R3                                          R2                                          R1 
Figure 7. Location and direction of the primers in H. pylori ggt gene sequencing 
 
Upon translating the DNA sequences into amino acid sequences, the AA sequence 
alignment of the GGT from different H. pylori strains was carried out using 
CLUSTAL W program. 
 
3.7 Cloning and expression of recombinant GGT (rGGT) 
3.7.1 Cloning strategy  
Antigenicity of GGT was analyzed by Princeton BioMolecules Corporation using 
antigenicity prediction software (Welling et al., 1985). As shown in Figure 8, the 
antigenic regions of GGT are 32th - 47th, 97th - 112th, 145th - 158th, 175th - 205th, and 338th 
-351th AA. Therefore, H. pylori SS1 ggt fragment (85th - 362th AA) is considered as the 
enriched antigenic region and was amplified by PCR and inserted into expression vector 
pRSET-A (Novagen) (Figure 9). This construct, pRSET-GGT, was transformed into E. 
coli Top 10. The plasmid was then extracted and transformed into expression host E. coli 
                                                                                                     Materials and Methods 
65 
strain BL21 (DE3) (Novagen) as it contains a chromosomal copy of gene T7 polymerase 
to facilitate production of rGGT protein upon IPTG induction. The pRSET-A vector was 




Figure 8. Antigenicity prediction of H. pylori SS1 GGT 
 , antigenic region. 
The antigenic regions of GGT are: 32th - 47th, 97th -112th, 145th -158th, 175th - 205th 
and 338th -351th AA 







Figure 9. Construction of pRSET-GGT for expression of recombinant GGT 
protein 
 
A ggt gene fragment containing most of the antigenic epitopes of H. pylori SS1 GGT 
was PCR amplified, restriction enzymes digested and cloned into an expression vector 
pRSET-A (Novagen) 
BamH I Hind III 
rggt 831bp 
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3.7.2 PCR amplification of rggt 
The primers were designed according to the ggt gene sequence of H. pylori SS1 (this 
study). The forward primer used was 5′ -
CCGCGGATCCATGGGTTTTGCGGTTATCCATT- 3′, while the reverse primer 
used was 5′ - CCGCAAGCTTTTATGGCTGGATAGTGTCAA - 3′. BamH I and 
Hind III restriction sites (as underlined in the primers) were introduced in the 5′ end 
of the two primers, respectively for insertion into the expression vector pRSET-A 
(Figure 9). The amplification conditions were set for denaturation at 94°C for 5 
minutes followed by 25 cycles of 94°C for 30 seconds, 52°C for 30 seconds, 72°C for 
1 minute and with additional extension at 72°C for 10 minutes. 
 
3.7.3 Restriction enzyme digestion 
Restriction enzyme digestion of the PCR fragment and pRSET-A vector was carried 
out using Hind III and BamH I simultaneously at 37°C for 2 hours. Buffer compatible 
to both of these enzymes was used for this double digestion. The products from the 
restriction enzyme reactions were subsequently analyzed by agarose gel 
electrophoresis and the desired DNA bands were extracted and purified as described 
in section 3.6.3. 
 
3.7.4 Ligation of rggt into expression vector pRSET-A 
The molar ratio of the insert DNA (rggt) to the vector DNA pRSET-A was 3:1 to 
maximize ligation efficiency. Briefly, 100 ng rggt PCR product was ligated to 80 ng 
of pRSET-A vector digested by the same restriction enzymes (BamH I and Hind III) 
with 3 units of T4 DNA ligase in a total volume of 10 µl at 16oC for 4 hours.  
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3.7.5 Transformation and selection of positive clones 
After ligation, the mixture was transformed into competent E. coli Top 10 cells. 
Screening was done by identification of ampicillin resistant clones instead of α-
complementation. Prospective transformants were subcultured in LB ampicillin broth 
and the plasmid was isolated as described in section 3.6.7. Restriction enzyme digest 
for the identification of positive pRSET-GGT was carried out as described in section 
3.7.3. Transformation of the positively identified plasmid into competent expression 
host E. coli BL21 (DE3) was carried out by the method described in 3.6.6. 
 
3.7.6 Expression of the target gene 
A single colony of pRSET-GGT transformed E. coli BL21 (DE3) was inoculated into 
50 ml of LB ampicillin broth and incubated with vigorous shaking at 200 rpm at 37°C 
until the OD reached 0.6. Subsequently, IPTG was added to a final concentration of 
0.2 - 1 mM for the induction of rGGT expression. Aliquots of 0.5 ml were collected at 
time intervals of 3 - 6 hours after induction. The cells were collected by centrifugation 
and the supernatant was discarded. The pellet was thoroughly resuspended in 50 µl of 
2× loading buffer (Appendix 9) by vortexing vigorously. Samples were then boiled 
and centrifuged at 10,000 × g for 5 minutes. Aliquot of 10µl of the supernatant from 
each sample was then analyzed by SDS-PAGE. The pRSET-A transformed E. coli 
BL21 (DE3) was used as a negative control. 
 
3.7.7 Localization of target protein 
During induction, an additional 1 ml of the culture at each time point was also 
collected for the localization of the target protein. Cells were collected by 
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centrifugation (5,000 × g for 10 min at 4°C) and resuspended in 0.5 ml of 10 mM Tris 
buffer (pH 7.5) containing 5µg/ml protease inhibitors (Sigma). This cell suspension 
was sonicated on ice 3 times for 10 seconds each with 30 seconds rest. After 
centrifugation at 10,000 × g for 30 minutes, the supernatant designated as the soluble 
fraction and the pellet as the insoluble fraction. The pellet was resuspended in SDS 
loading buffer, and the protein concentrations in the soluble and insoluble fraction 
were measured by Modified BioRad Protein assay (section 3.10.5). Fractions of 50 µg 
of each were then loaded into different lanes of SDS-PAGE accordingly, and then 
electrophoresed as described in section 3.8. The gel was stained by comassie blue and 
visualized as described in section 3.8.4.  
 
3.7.8 Purification by His-Tag affinity column 
3.7.8.1 Preparation of cell extract 
Since the target protein was mainly localized as inclusion bodies, purification was 
done under denaturing condition. The cells from 200 ml of culture were harvested by 
centrifugation at 5,000 × g for 5 minutes. Cells were then resuspended in 40 ml of 
binding buffer (Appendix 7) that does not contain urea and sonicated 10 times for 10 
seconds each with 30 seconds rest. The sonicate was centrifuged at 10,000 × g for 30 
minutes at 4°C to collect the inclusion bodies. The pellet was then resuspended in 20 
ml of binding buffer without urea and centrifuged at 10,000 × g for 15 minutes. 
Subsequently, the resultant pellet was resuspended in 10 ml of binding buffer 
containing 6 M urea. This suspension was left on ice for 1 - 2 hours to completely 
dissolve the protein. The remaining insoluble material was then removed by 
centrifugation at 10,000 × g for 20 minutes at 4°C. The supernatant obtained after 
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centrifugation was then filtered through a 0.2µm filter (Sartorius) before loading it on 
the His tag affinity column (Amersham Pharmacia Biotech). 
 
3.7.8.2 Column chromatography 
Since purification of the target protein was done under denaturing condition, all 
buffers loaded on the column contained 6M urea. His tag affinity column was first 
washed with distilled water and then charged with charging buffer (Appendix 7). The 
column was subsequently equilibrated with binding buffer (Appendix 7). The sample 
was then loaded on the column and washed with binding buffer to remove all those 
unbounded proteins. Following this, the column was washed again with 6 volumes of 
wash buffer (Appendix 7). The bound protein was then eluted using 6 column volume 
of elute buffer (Appendix 7).  
 
3.7.8.3 Refolding the rGGT protein 
The eluted protein was diluted to the concentration of 50 µg/ml, and then step-wisely 
dialyzed against PBS buffer containing decreasing concentration of 4 M urea at 4°C 
for 10 - 12 hours each. Finally, the protein solution was dialyzed against PBS buffer 
containing 0.5 M L-Arginine at 4°C for 24 hours with several buffer changes to refold 
the protein. Concentration of the protein was carried out using 30% PEG 35000 
(Merck) in 20 mM Tris-HCl buffer. After refolding, the soluble rGGT was used for 
raising antibody in rabbits. 
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3.8 Polyacrylamide gel electrophoresis 
3.8.1 Native PAGE  
The electrophoretic technique of the discontinuous Native PAGE system was carried 
out as described by Ornstein (1964). After adding the loading buffer (Appendix 8), 
the purified native H. pylori GGT was electrophoresed in a 4% stacking gel and 12% 
separating gel at 200v for 5 hours at 4°C.  
 
3.8.2 SDS-PAGE 
The electrophoretic technique of the discontinuous SDS-PAGE system was carried 
out as described by Laemmli (1970). Loading buffer (Appendix 9) was added to 
different protein samples and heated at 100°C for 5 minutes to denature the proteins. 
Samples were then electrophoresed in a 4% stacking gel (Appendix 9) and 12% 
separating gel (Appendix 9) at 100v for 2 hours. Unstained precision protein marker 
(BioRad) was used as the molecular weight marker. 
 
3.8.3 Silver staining  
The silver staining method employed was a modified protocol of Shevchenko et al. 
(1996b).  After the electrophoretic run, the PAGE gel was fixed in the fixing solution 
[50% methanol (Merck) and 5% acetic acid (Merck)] for at least 30 minutes at room 
temperature. The gel was then rinsed in distilled water for 1 hour with 3 changes. The 
gel was sensitized with 0.02% sodium thiosulfate (Sigma) at room temperature for 2 
minutes. Distilled water was then used to rinse the gel for 1 minute with 2 changes. 
The gel was then soaked in chilled 0.1% silver nitrate at room temperature for 20 
minutes in the dark. The gel was again rinsed in distilled water for 1 minute with 2 
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changes. Development of the gel was carried out with the developing solution [2% 
sodium carbonate (Merck) and 0.04% of 37% formaldehyde (Merck)], until the 
desired intensity was reached. The colour development was stopped by the addition of 
5% acetic acid. The gel was scanned in a densitometer (GS710, BioRad) and stored in 
1% acetic acid. 
 
3.8.4 Coomassie blue staining and destaining 
After the electrophoretic run, the PAGE gel was stained in the staining solution [0.2% 
Coomassie Blue R250 (Sigma), 40% methanol and 10% acetic acid] overnight with 
gentle shaking on the belly dancer (Stovall). The gel was then immersed in the 
destaining solution (40% methanol and 10% acetic acid) with several changes until a 
clear gel background with sharp protein bands was obtained. The gel was scanned in a 
densitometer (GS710, BioRad) and stored in 1% acetic acid. 
 
3.9 Raising antibody against rGGT 
An antibody against rGGT was raised as described by Coligan et al (1991). The 
procedure has been approved by the Animal Experimental Ethic Committee, National 
University of Singapore. After refolding, the purified rGGT was injected into New 
Zealand white rabbits intramuscularly with two different dosages, 150 µg for the first 
immunization and 200 µg for booster. After 3 boosters, the rabbits were sacrificed, 
and the serum was separated from the whole blood obtained.  
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3.9.1 Purification of anti-rGGT antibody 
Protein A Sepharose CL-4B (Amersham Pharmacia Biotech) affinity column was 
used to purify IgG from antiserum (Coligan et al., 1991). The serum was diluted with 
50 mM Tris-Cl buffer (pH 7.0) and loaded into the equilibrated column. The specific 
IgG was eluted with 0.1 M glycine-Cl buffer pH 3.0 and neutralized with 1 M Tris-Cl 
pH 9.0 (50–100 µl/ml fraction) right after elution. Antibody titer was assayed by 
indirect ELISA method using 10 ng H. pylori total cell lysate as antigen. 
 
3.10 H. pylori protein extraction 
3.10.1 Modified acid-glycine extraction 
A 3-day-old H. pylori culture grown in BHI broth supplemented with 0.4% yeast 
extract and 10% horse serum was harvested and lysed using 0.2 M acid glycine (pH 
2.2) according to the method described by Ho and Jiang (1995). Supernatant collected 
was dialyzed against PBS at 4°C overnight with 3 times buffer change. The dialysate 
was centrifuged at 3,000 × g for 10 min at 4°C, to remove any remaining precipitate. 
The protein concentration was determined using the Modified BioRad protein assay 
(section 3.10.5). The sample was stored at -20°C until use. 
 
3.10.2 Outer membrane protein (OMP) extraction 
OMP was isolated according to the method as described by Ascencio et al. (1998). In 
brief, harvested 3-day-old culture was broken by sonication (30 seconds × 3 with 30 
seconds rest each). Unbroken cells were removed by centrifugation at 5,000 × g for 30 
minutes at 4°C. The supernatant was further centrifuged at 20,000 × g for 90 minutes 
at 4°C and the pellet was suspended in 150 µl of distilled water. Samples were treated 
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with eight volumes of 2% sodium N-lauroylsarcosine for 1 hour at room temperature. 
The insoluble OMP was pelleted twice by centrifugation at 20,000 × g for 60 minutes 
at 4°C and washed twice with 2 ml deionized water to remove the excess detergent. 
Finally, the pellet was resuspended in 50µl of distilled water, and stored at -20°C until 
use. 
 
3.10.3 Cytoplasmic protein (CP) extraction 
A cytoplasmic fraction of H. pylori cells was extracted according to the method as 
described by Chmiela et al. (1996). Briefly, the 3-day-old H. pylori culture was 
harvested and the cell pellet was resuspended in an appropriate volume of PBS buffer 
(~ 109 cells/ml), followed by sonication (30 seconds × 3 with 30 seconds rest each). 
The cell suspension was centrifuged at 20,000 × g for 90 minutes at 4°C. The 
supernatant was collected and sterilized by filtration through a 0.2µm filter (Sartorius). 
The protein extracts were kept at -20°C until use.  
 
3.10.4 Whole bacterial cell lysis 
The H. pylori cells were lysed according to the method as described by Berkelman 
and Stenstedt (1998). In brief, the 3-day-old cultures were washed three times with 
ice-cold PBS and resuspended in lysis buffer containing 9 M Urea, 4% CHAPS, 40 
mM Tris-Cl pH 8.8, protease inhibitor cocktail (Roche), and freshly prepared 50 mM 
DTT for 109 cells in each volume of 300 - 400 µl. The cell suspension was left on ice 
for 1 hour and was vortexed occasionally. DNase (20 U) and RNase (20 U) were 
added into the cell suspension and left on ice for 10 more minutes before centrifuging 
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at 10,000 × g for 10 minutes at 4°C. The resultant supernatant was transferred into a 
new eppendorf tube and stored at -20°C until use.  
 
3.10.5 Modified BioRad Protein Assay 
Modified BioRad protein assay was used to determine the amount of protein in 
samples. A standard curve was created using different known concentrations of 
bovine serum albumin (BSA). Determination of protein content in sample was done 
by adding 10 µl of each sample in 1 ml of BioRad dye solution (previously diluted 1:5 
times with distilled water and filtered through Whatman paper number 1), followed 
by vortexing and incubation at room temperature for 15 minutes. The optical density 
(OD) was measured at 595 nm in a spectrophotometer (Spectronic Genesys 5). 
Concentration of protein in different samples was extrapolated against the standard 
curve of BSA. 
 
3.11 Subcellular localization of GGT in H. pylori 
The subcellular localization of GGT was carried out by western blot as well as GGT 
activity analysis. H. pylori cells of 3-day old culture were harvested from CBA plates. 
The cells were washed with PBS buffer for 3 times, and protein extraction was carried 
out as described in section 3.10 to obtain AGE, OMP, CP and whole cell lysate. The 
protein concentration was measured by modified BioRad protein assay (section 
3.10.5). Aliquot of 15 µg protein for each respective fraction was subjected to SDS-
PAGE and Western blot using the rGGT antibody as a probe. Simultaneously, 50 ng 
of purified rGGT was used as positive control. The GGT activities in different 
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subcellular fractions were determined using an enzymatic method as described in 
section 3.5.1.  
 
3.12 Purification of native GGT from H. pylori 
3.12.1 Culture of H. pylori  
H. pylori strain SS1 was grown for 3 days at 37°C on CBA plates in a humidified 
incubator (Forma Scientific) supplied with 5% CO2. The bacteria cells grown on 60 
CBA plates were harvested, washed twice with 20 ml of phosphate-buffered saline 
(PBS) and resuspended in 20 ml of 50 mM phosphate buffer, pH 7.5. Cells were 
disrupted by sonication (30 seconds × 10 with 30 seconds rest each), and the cellular 
debris along with unbroken cells were removed by centrifugation at 5,000 × g for 15 
minutes at 4°C. The supernatant was centrifuged at 20,000 × g for 90 minutes at 4°C 
and the clear supernatant was collected, membrane filtered (0.2 µm, Sartorius) and 
used for native GGT purification. 
 
3.12.2 First Ion Exchange Chromatography (IEX) purification  
Test-tube method was used for determining the starting buffer pH so that substances 
of interest, H. pylori native GGT protein, to be bound to the exchanger are charged. A 
series of 6 test-tubes were set up. Fifty micrograms of SP Sepharose (Amersham 
Pharmacia Biotech) was added into each tube and equilibrated to a different pH by 
washing 10 times with 5 ml of 50 mM phosphate buffer (with a pH range of 6 - 8.5). 
Following which, a known constant amount of sonicated H. pylori cell sample was 
added to each tube and the protein-resin mixture was gently mixed for 5 - 10 minutes. 
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After the resin was completely settled, GGT in the supernatant was examined using 
the GGT assay as stated in section 3.5.1. 
 
The sample obtained as described in section 3.12.1 was loaded in an SP Sepharose HP 
column which has been pre-equilibrated with 50 mM phosphate buffer, pH 7.5. 
Sample was eluted with a linear gradient of 50 - 500 mM NaCl in 50 mM phosphate 
buffer, pH 7.5 with flow rate of 2 ml/min. The fractions containing the GGT activity 
were collected for the next purification step. 
 
3.12.3 Gel Filtration purification 
Sephadex G200 column (Fluka) was equilibrated with 50 mM phosphate buffer, pH 
7.5. The sample obtained from the first IEX was loaded onto the column and eluted 
with 50 mM phosphate buffer, pH 7.5 with the flow rate of 0.3 - 0.5 ml/min. The 
fractions containing the GGT activity were collected for the second IEX purification 
step. 
 
3.12.4 Second IEX purification 
After modifying the pH, sample obtained from gel filtration was loaded in a 
RESOURCE S column (Amersham Pharmacia Biotech) which has been pre-
equilibrated with 50 mM phosphate buffer, pH 7.75. The sample was eluted with a 
linear gradient of 50 - 250 mM NaCl in 50 mM phosphate buffer, pH 7.75 with flow 
rate of 0.5 ml/min. The fractions containing the GGT activity were collected and 
stored at -20°C until use. 
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3.12.5 Mass spectrometry 
The protein bands of interest were excised and in-gel digestion was carried out based 
on slight modification to the method as described by Gharahdaghi et al. (1999). 
 
These bands were cut as close to the protein as possible and rinsed with distilled water. 
The gel bands were incubated in 100 mM ammonium bicarbonate (Merck) until the 
gel spots become transparent. The gel bands were then cut into smaller pieces to 
increase the surface area for incubation in 50 mM ammonium bicarbonate and 50% 
acetonitrile (Merck) at room temperature for 30 minutes with gentle shaking. The gel 
pieces were then shrunk in 3 - 4 volumes of 100% acetonitrile during which the 
fragments became cloudy and adhered together. The gel pieces were vacuum dried. 
 
The dried gel pieces were incubated with 12.5 ng/µl of trypsin (Promega) in 50mM 
ammonium bicarbonate (30 - 50 µl, depending on the size of gel) for 30 minutes at 
4°C. Following which, 50 mM ammonium bicarbonate was added to a volume just 
enough to cover the gel pieces and incubated overnight at 37°C. The supernatant was 
transferred to a fresh tube after incubation overnight. The gel pieces were washed 
with 20 mM ammonium bicarbonate followed by centrifugation at 5,000 × g for 5 
minutes. The supernatant was then transfered into a fresh tube. The gel pieces were 
finally treated with 5% formic acid (Merck) in 50% acetonitrile for 5 minutes at room 
temperature and supernatant was again removed into a fresh tube. The solutions 
containing the tryptic-digested peptides were pooled together and dried in a vacuum 
centrifuge. The peptides were then subjected to identification by mass spectrometry. 
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Peptide mass fingerprints were obtained using a MALDI-TOF mass spectrometer 
(API 300 MS/MS, Micromass). The matrix used was α-cyano-4-hydroxycinnamic 
acid. The process of mass spectrometry was performed at the Protein and Proteomic 
Center, NUS, Singapore, and the data was sent to NCBI database search 
(www.matrixscience.com) to determine the identity of the protein. 
 
3.13 Cell culture 
Two human gastric adenocarcinoma cell lines, AGS (ATCC CRL 1739) and KATO 
III (ATCC HTB 103), were used in this study. These two cell lines were grown in 
RPMI 1640 tissue culture medium (NUMI), supplemented with 1% antibiotics 
(10,000 units penicillin, 10mg streptomycin (Sigma)) and 10% (vol/vol) fetal calf 
serum (Gibco). AGS and KATO III cells were seeded in 75 cm2 polystyrene tissue 
culture flasks (Nunc) and incubated at 37oC in the presence of 5% CO2 in a 
humidified CO2 incubator (Forma Scientific). The cells were incubated for 3 - 4 days 
to reach a monolayer of ~ 80% confluency. 
 
3.14 Assessment of apoptosis  
3.14.1 Adhesion of H. pylori to AGS cells  
AGS cells were incubated with H. pylori at 1:100 ratio in RPMI medium for 2 hours. 
The cell-bacteria mixture was harvested and washed with PBS buffer. To avoid 
nonspecific adsorption, AGS cells were incubated with 1% BSA-PBS for 2 hours and 
then washed three times with PBS. Following which, AGS cells were incubated for 
further 60 minutes in the presence of specific anti-rGGT antibody diluted 1:200 in 
0.1% BSA-PBS before washing three times with PBS. Goat serum anti-rabbit gamma 
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globulin-fluorescein isothiocyanate (FITC) conjugate (BD Biosciences) diluted 1:400 
in 0.1% BSA-PBS was then added and incubated for 90 minutes at room temperature 
in the dark. The interacting cells were then observed under confocal microscope 
(Olympus FluoViewTM FV300). H. pylori alone served as a positive control, while 
AGS cells without H. pylori were employed as the negative control.                   
 
3.14.2 Morphological characterization of apoptotic AGS cells 
For morphological characterization of the cell death process, two fluorescent dyes 
with limited toxicity were used. Movement of phosphatidylserine from the inner to 
the outer layer of the plasma membrane (typical of apoptosis) was monitored in the 
green channel (excitation at 450 - 490 nm, emission above 520 nm) by co-incubation 
with 2.5 µg/ml fluorescein isothiocyanate (FITC)-conjugated Annexin V (BD 
Biosciences), which specifically binds to phospholipid (van Engeland et al., 1996). 
Permeabilization of the plasma membrane, which occurs during necrosis or later 
phases of apoptosis, was indicated by the use of 0.1 µg/ml of the DNA stain 
propidium-iodide (PI), using the red channel (excitation at 530 - 560 nm, emission 
above 580 nm).  
 
3.14.3 Cell apoptosis analysis using flow cytometry 
Cell apoptosis was detected by Annexin V-FITC kit (BD Pharmingen). The human 
gastric carcinoma cell line AGS (ATCC, CRL1739) maintained in RPMI1640 
medium supplied with 10% fetal bovine serum (Gibco) was applied for apoptosis 
analysis. The cells were grown to confluency in 25 cm2 tissue culture flasks before the 
addition of 2×108 H. pylori SS1 cells (MOI, 100:1) or 50 mU purified native H. pylori 
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GGT. Cells incubated in the absence of H. pylori or GGT served as control. After 24-
hour incubation, trypsinized cells were collected and washed twice with cold PBS and 
the cells were resuspended in 1×binding buffer. Following which, 100 µl of the 
resuspended cell solution (1 × 105 cells) were transferred into a 5 ml culture tube 
where 5 µl of Annexin V-FITC and 5 µl of PI were added into the cell solution 
consecutively. Subsequently, the cells were gently vortexed and incubated for 15 
minutes at 37oC in the dark before the addition of 400 µl of 1×binding buffer into 
each tube. The cell samples were then analyzed by flow cytometry within one hour. 
 
The apoptotic index was expressed as the percentage of apoptotic cells (Annexin V-
FITC positive, PI negative) per 105 cells enumerated. Stimulation of GGT was 
performed by adding its acceptor, dipeptide glycyl-glycine (1 mM), and the substrate 
GSH (100 µM). Where indicated, GGT inhibition was obtained by incubating cells 
with anti-rGGT antibody (poly-clonal rabbit antibody raised by Nickel chelating 
column purified rGGT) or a competitive GGT inhibitor SBC (10 mM) in the same 
medium.  
 
In addition, 6 strains each with high GGT activity (> 1 U/mg protein) and low GGT 
activity (< 0.4 U/mg protein) were used to examine their apoptosis-inducing activity. 
The induction of apoptosis for each strain was examined in triplicates. 
 
3.14.4 Dose-dependent effect of GGT on apoptosis induction in AGS cells 
AGS cells (2 × 106) were treated with different concentrations of purified GGT at a 
range of 10 - 100 mU. Rate of apoptosis in AGS cells was then measured using the 
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Annexin V-FITC kit. The effect of different amount of GGT on cell apoptosis 
induction was recorded accordingly. 
 
3.14.5 Caspase activity analysis 
AGS cells (2 × 107) were treated for 24 hours with H. pylori (SS1) or purified native 
GGT in the presence or absence of 10mM SBC or 0.1 mM GSH. The treated cells 
were harvested and lysed for 30 minutes on ice in 50 µl of buffer containing 10 mM 
HEPES, 10 mM KCl, 0.1mM EDTA, 1.5 mM MgCl2 , 1 mM  dithiothreitol, and 0.5 
mM PMSF. The samples were centrifuged at 10,000 × g for 20 min at 4°C, the 
supernatant was collected and 200 µg cytosolic protein was incubated with 10 µM of 
the appropriate caspase substrate (caspase-3, Ac-DEVD-pNA; caspase-8, Ac-IETD-
pNA; caspase-9, Ac-LEHD-pNA; all from Alexis, Carlsbad, CA) in reaction buffer 
(100 mM HEPES, pH7.4, 150 mM NaCl, 5mM DTT and 0.2% CHAPS) for 2 hour at 
37oC. The samples were transferred to a 96-well microtiter plate and the optical 
density was determined at 405 nm using an ELISA plate reader. The caspases activity 
of each sample was carried out in triplicate. 
 
In addition, a total of 4 H. pylori strains with different GGT activity (> 1.0 U/mg 
protein vs. < 0.4 U/mg protein) and different vacA status (vacA+ vs. vacA-) were 
randomly selected to examine the caspases activity in the infected AGS cells. The 
caspases activity analysis of each sample was carried out in triplicate. 
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3.14.6 Detection of mitochondrial transmembrane potential changes 
The mitochondrial transmembrane potential changes of AGS cells were detected by 
Mitochondrial Membrane Sensor kit (BD Clontech). The AGS cells were incubated 
with purified GGT protein for 24 hours. Following which, the treated AGS cells (1 × 
106) were trypsinized, collected and washed twice with ice cold PBS buffer and then 
resuspended in 1 ml of diluted BD MitoSensor Reagent (BD Clontech). After 
incubating the mixture at 37 oC for 20 minutes, 1 ml of incubation buffer was added 
into the mixture and centrifuged at 350 × g for 5 minutes to pellet the cells. 
Subsequently, the cells were resuspended in 500 µl incubation buffer and examined 
under confocal microscope. The MitoSensor Reagent can be taken up and 
accumulated in the mitochondria of viable cells to form red fluorescent aggregates. 
However, in apoptotic cells, increased mitochondrial-membrane permeability 
prevents the MitoSensor Reagent from accumulating inside mitochondria. Hence, the 
MitoSensor Reagent remains in monomeric form in the cytosol, where it fluoresces 
green (Contreras et al., 2002). 
 
3.14.7 Detection of cytochrome c  
Mitochondrial and cytosolic fractions of AGS cells were prepared using a Cell 
fractionation kit (BD, Clontech). Samples of 2×107 AGS cells with or without 
different treatments were harvested by centrifugation at 600 × g for 5 minutes and 
washed with ice-cold wash buffer. The washed cells were then resuspended in 0.8 ml 
of ice-cold fractionation buffer mix. After incubation on ice for 10 minutes, the cells 
were homogenized in an ice-cold Dounce tissue grinder (Fisher). Homogenized 
products were centrifuged at 700 × g for 10 minutes at 4°C. The supernatant collected 
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was centrifuged again at 10,000 × g for 30 minutes at 4°C. The resulting supernatants 
were harvested and designated as cytosolic fractions, and the pellets were resuspended 
in 0.1 ml fractionation buffer mix and designated as mitochondrial fractions. Protein 
concentration was determined using the modified BioRad protein assay (section 
3.10.5). For all experiments, fresh mitochondria were prepared and analyzed within 4 
hours. The cytochrome c distributed in either fraction, the cytosolic or the 
mitochondria, was analyzed using western blot with anti-cytochrome c monoclonal 
antibody (1:100). Signals were detected using the horseradish peroxidase-conjugated 
anti-mouse secondary antibody (1:1,000) and enhanced chemiluminescence substrate 
kit (Amersham Biosciences).  
 
3.15 Cellular viability analysis 
The cellular viability of AGS and KATO III cells were analyzed by MTT assay. The 
cells were cultured for a period of 6 hours in the presence of various inhibitors. The 
medium was then changed and 100 µl diluted 3-(4, 5- dimethylthiazolyl-2)-2, 5-
diphenyltetrazolium bromide (MTT) solution (100 µl MTT stock solution per 1ml 
medium) was added to each well for a 2-hour period. After the formation of formazan 
crystals, the culture medium supernatant was removed from the wells without the 
disruption of the formazan precipitate. The formazan crystals were then dissolved in 
100 µl lysis solution/well (Appendix 11). The absorbance was measured at 570 nm 
using a microplate spectrophotometer (SunRise). 
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3.16 H. pylori adherence assay 
The adherence assay was carried out as previously reported by Nishihara et al. (1999). 
Briefly, AGS and KATO III cells grown on 96-well plates were stimulated for 6 hours 
with H. pylori in the presence of various inhibitors at 37oC in serum-free RPMI 1640. 
Following incubation, the medium and unbound H. pylori were discarded. The cells 
with bound H. pylori were washed with PBS and then fixed with 10% formaldehyde. 
The cells-H. pylori mixture was incubated overnight at 4oC with a 1:200 dilution of 
rabbit anti-rGGT antibody before washing with PBS. The washed mixture was 
incubated further with a 1:400 dilution of FITC conjugated goat anti-rabbit IgG (BD 
Biosciences) antibody at room temperature for 20 minutes. Fluorescence intensity was 
determined in Perkin-Elmer Luminescence Spectrometer (excitation / emission 
wavelengths: 490/525 nm). 
 
3.17 Hydrogen peroxide analysis 
H2O2 production was measured according to the method of Mohanty et al. (1997) 
using the Amplex fed hydrogen peroxide/peroxidase assay kit (Molecular Probes). 
AGS or KATO III cells suspended in RPMI 1640 medium were seeded in 96-well 
plates (5×104 cells/well) and allowed to adhere for at least 12 hours prior to the 
experiments. After treating with H. pylori SS1 cells (MOI, 100:1) or purified native 
GGT protein (1.5 mU), the cells were washed 3 times with PBS. The RPMI 1640 
medium was then replaced by Krebs-Ringer phosphate buffer, pH 7.4, containing 145 
mM NaCl, 5.7mM sodium phosphate, 4.9mM KCl, 0.5mM CaCl2, 1.2mM MgSO4 and 
1g/L glucose. Cells incubated in the absence of H. pylori or GGT served as control. 
Stimulation of GGT was performed by adding the acceptor dipeptide glycyl-glycine 
(1 mM) and the substrate GSH (0.1 mM). To inhibit the GGT activity, the competitive 
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GGT inhibitor SBC (10 mM) was added to cell samples just prior to the assay for 
H2O2 release. In all samples, A6550 and HRP (Molecular Probes) were present at final 
concentration of 50µm and 1U/ml, respectively. After 60 minutes of incubation at 
37oC, aliquots of the incubation medium were withdrawn and fluorescence was 
measured in a Perkin-Elmer Luminescence Spectrometer (excitation / emission 
wavelengths: 530 / 590 nm). Calibration curve obtained by adding H2O2 in the 
concentration range 0.5 - 5 µM to the Krebs-Ringer phosphate buffer containing 
A6550 and HRP, which shows a linear fluorimetric response. This standard curve was 
used to calculate H2O2 released from the cells with different treatments.  
 
In addition, a total of 4 H. pylori strains with different GGT activity (> 1.0 U/mg 
protein vs. < 0.4 U/mg protein) were randomly selected to examine their ability in 
inducing H2O2 production from the infected AGS or KATO III cells. The H2O2 level 
in each sample was carried out in triplicate. 
 
3.18 Detection of NF-κB, I-κBα and β-actin 
3.18.1 Extraction of cytosolic protein and nuclei 
The AGS or KATO III cells were grown to confluency in 75 cm2 tissue culture flasks 
before the addition of 2 × 109 H. pylori SS1 cells (MOI, 100:1) or 500 mU purified H. 
pylori GGT protein. Cells incubated in the absence of H. pylori or GGT were used as 
control. The inhibition and stimulation of GGT were carried out by the addition of 
SBC, GSH and glycyl-glycine, respectively. After aspirating the culture medium, the 
cells were harvested and washed with PBS, and then pelleted by centrifugation at 
1500 × g for 5 minutes.  
                                                                                                     Materials and Methods 
87 
For cytoplasmic protein extraction, cells were homogenized in Tris - HCl buffer (pH 
7.4) containing 0.5% Triton X-100 and protease inhibitor cocktail. Protein 
concentration of soluble supernatant from each sample was measured by the method 
of Modified BioRad protein assay (section 3.10.5). Following which, the samples 
were aliquoted and stored at -80oC until use. 
 
To extract the nuclei, cells were lysed in 2 pellet volume of buffer A (appendix 12) 
and incubated on ice for 10 - 15 minutes with occasional tapping. After centrifugation, 
100 µl nuclear extraction buffer C (appendix 12) was added into the nuclear pellet and 
incubated on ice for 45 minutes with periodic tapping. The supernatant of each sample 
was removed and the nuclear protein concentration was determined by Modified 
BioRad protein assay before quickly frozen at -80oC. 
 
3.18.2 Western blot analysis for NF-κB subunit p65, I-κBα and β-actin 
Protein prepared from the AGS or KATO III cells treated with or without various 
reagents in the absence or the presence of H. pylori for 4 hours were used for western 
blot analysis. Aliquot of 60 µg of protein was loaded per lane, separated by SDS-
polyacrylamide gel electrophoresis under reducing conditions, and then transferred 
onto Hybond-PVDF membranes (Millipore) by eletroblotting [using semi-dry 
transblot (BioRad)]. Membranes were blocked using 5% skim milk overnight at 4oC. 
NF-κB subunit p65, I-κBα, and β-actin proteins were detected by incubating the blots 
with specific monoclonal antibodies accordingly at a dilution of 1:1000 for 2 hours at 
room temperature (anti-NF-κB p65 subunit antibody from BD Biosciences, anti-I-κBα 
antibody from IMGENEX, and anti-β-actin antibody from CHEMICON). This was 
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followed by interacting with sheep anti-mouse secondary antibody conjugated to 
horseradish peroxidase (1:2000) for 1 hour at room temperature. Signals were 
detected using enhanced chemiluminescence substrate kit (Amersham Biosciences). β-
actin protein was used as a loading control. 
 
3.19 Determination of cytokine generation 
AGS or KATO III cells were seeded in 6-well plates (5 × 105 cells/well) and allowed 
to adhere for at least 12 hours. The culture medium was replaced by fresh RPMI 1640 
medium prior to the experiments. Cells incubated in the absence of H. pylori or GGT 
were used as control. The supernatant of the cells incubated with 5 × 107 H. pylori 
SS1 cells (MOI, 100:1) or 15 mU purified H. pylori GGT protein was collected at 
different time points (2 - 24 hour). The aliquot supernatant was stored at -20oC until 
use. Stimulation and inhibition of H. pylori GGT activity were carried out by adding  
glycyl-glycine (1 mM), GSH (0.1 mM) and 10 mM SBC, respectively. 
 
The concentrations of cytokines (IL-4, IL-8, IFN-γ and TNF-α) in cell culture 
supernatants were determined by commercially available ELISA (Enzyme-Linked 
Immunosorbent Assay) kits [BD OptEIATM (BD Biosciences)] according to the 
manufacturer’s instructions.  
 
The protocol is the same for all the different cytokines examined in the study. Briefly, 
a monoclonal antibody was coated on a 96-well plate (Nunc). Cytokine standards and 
supernatant samples after various treatments were added to the wells, and any of the 
specific cytokines present will bind to the immobilized antibody. The wells were 
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washed with wash buffer and avidin-horseradish peroxidase conjugate mixed with 
biotinylated anti-human specific antibody was then added. The wells were again 
washed with wash buffer and TMB (3,3’,5,5’-tetramethylbenzidine) substrate solution 
was added. A blue colour was generated in direct proportion to the amount of specific 
cytokine present in the initial sample. The stop solution changes the colour from blue 
to yellow. The level of cytokine presence was read at 450 nm in Multiskan Ascent 
ELISA reader (Labsystems). 
 
In addition, a total of 4 H. pylori strains with different GGT activity (> 1.0 U/mg 
protein vs. < 0.4 U/mg protein) were randomly selected to examine their ability in 
inducing IL-8 generation from the infected AGS or KATO III cells. The IL-8 level in 
each sample was carried out in triplicate. 
 
3.20 RNA study on IL-8 expression 
3.20.1 Total RNA extraction 
Total RNA of AGS cells with or without treatment was extracted using the RNeasy 
Mini kit (Qiagen). The total RNA extract was treated with 10U of RNase-free DNase 
(Sigma) at 37 oC for 20 minutes to remove any contaminating DNA. The reaction was 
heat inactivated at 95 oC for 5 minutes. The extracted total RNA was rapidly frozen 
and kept in aliquots at -80 oC until use. 
 
3.20.2 Reverse transcription PCR (RT-PCR) 
Reverse transcription polymerase chain reaction was carried out in two steps. The first 
step involved the reverse transcription of the total RNA extract to form the full-length 
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first strand cDNA, using the random hexamers and 1 unit AMV reverse transcriptase 
(Promega), in the presence of 40 units of RNasin (Promega). The reaction was 
incubated at 42oC for 1 hour and then heat inactivated at 70oC for 10 minutes. The 
RNA-cDNA hybrid obtained was kept at -20oC until the subsequent DNA 
amplification was performed using the gene-specific primers and conditions (Table 5) 
 
 
Table 5. Primers for IL-8 and β-actin in RT-PCR 
Target 
genes 
Primer Nucleotide sequence (5’ 3’) 






















3.21 Statistical analysis 
Data were analyzed with the SPSS statistical software package (version 10.0; SPSS 
Inc., Chicago, IL, USA). Values were expressed as means ± standard deviations. 
Frequencies were compared using Fisher’s exact test. Statistical difference between 
two defined sub-groups or more than two groups was determined with the student’s t-
test and one-way ANOVA test, respectively. Values of p < 0.05 were considered to be 
statistically significant.  
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4.1 H. pylori virulence factors and clinical disease status 
4.1.1 Relationship between prevalence of virulence genes and disease status  
In view of earlier reports that many virulence factors re-disposed to gastric ulceration 
or duodenal ulceration rather than both (Shirasaka et al., 2002; Olfat et al., 2005), we 
began analyzing the patient groups under NUD, DU and DU. In this study, we found 
that the cagA is present in 72.7% of the DU patients (n = 33) whereas 76.2% of the 
GU patients (n = 21) are cagA positive (p = 0.69). Similarly, the presence of other 
virulence genes in H. pylori isolates was neither associated with DU nor GU, such as 
84.8% vs. 76.2% (p = 0.32) for vacA; 54.5% vs. 66.7% (p = 0.14) for iceA1; 51.5% vs. 
61.9% (p = 0.19) for iceA2 and 42.4% vs. 38.1% (p = 0.49).  However, the relatively 
low sample number in the present study could not clearly represent the evidence of 
the correlation between virulence factors with DU or GU.  It was therefore decided 
that the GU and DU groups were pooled as a single group, PUD, to relay a direct 
comparison between NUD and PUD. 
 
With the use of specific PCR primer (Lage et al., 1995), cagA gene was found in 40 
of 54 (74.1%) PUD isolates as compared to 35 of 44 (79.5%) NUD isolates (Figure 10 
and Table 6). The frequency of cagA genotype in patients with or without PUD was 
not significantly different (p = 0.53). Similarly, no significant difference could be 
observed between PUD and NUD patients for the presence of other virulence genes in 
H. pylori isolates, such as 81.5% vs. 75.0% (p = 0.47) for vacA; 59.3% vs. 59.1% (p = 
0.98) for iceA1; 55.6% vs. 59.1% (p = 0.63) for iceA2 and 40.7% vs. 38.6% (p = 0.74) 
for babA2 (Figures 10 & 11 and Table 6).  
 






Figure 10. Detection of cagA, vacA and iceA1 genes in H. pylori isolates  
 
Lane 1 - 4, cagA gene; Lane 6 - 9, vacA gene; Lane 11 - 14, iceA1 gene;  
Lanes 5 & 10, 1kb DNA ladder Lanes 1, 6, 11 (#973); Lanes 2, 7, 12 (#847);  
Lanes 3, 8, 13 (#627); Lanes 4, 9, 14 (#1248) 
  cagA vacA












Figure 11. Detection of iceA2 and babA2 genes in H. pylori isolates   
 
Lane 1 - 4, iceA2 gene; Lane 6 - 9, babA2 gene; Lane 5, 1kb DNA ladder 




Table 6. Relationship between cagA, vacA, iceA, babA2 genes and clinical 
outcome of patients 
 























Total 98 75 77 58 56 39 
P  0.53 0.47 0.98 0.63 0.74 
 p values are based on PUD vs. NUD calculated using SPSS version 10.0 
babAiceA2
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4.1.2 GGT activity and diversity of vacA in clonal study 
The frequency of vacA s and m-alleles in clonal study is shown in Table 7. The 
dominant vacA genotype in the 75 clones was s1c (66/75; 88%) and m2 (65/75; 
86.7%), whereas s1b, s2, m1, and m1Tm2 were not detected. Three vacA genotypes 
(s1a/m2, s1c/m2, and s1c/m1T) of H. pylori predominated (Table 7), with the 
distribution as follows: 56 s1c/m2, 10 s1c/m1T and 9 s1a/m2. However, there was no 
significant difference between PUD and NUD patients for infection by s1c/m2 




Table 7. Distribution of the vacA allele types in clonal study 
 
 Isolates s1a/m2 s1a/m1T s1c/m2 s1c/m1T s1b s2 m1 m1Tm2
PUD 45a 6 0 34 5 0 0 0 0 
NUD 30b 3 0 22 5 0 0 0 0 
Total 75 9 0 56 10 0 0 0 0 
PUD, peptic ulcer disease; NUD, non-ulcer dyspepsia 






Among those 15 H. pylori isolates chosen for clonal study, 13 strains showed single 
vacA genotype while 2 (#1196 and #397) showed multiple vacA genotypes (Table 8). 
The results indicate multiple H. pylori stains infection in an individual patient. 
However, the GGT activities of the 5 clones isolated from individual patient were 
very similar irrespective of the vacA genotype, the coefficient of variation (CV) 
ranged from 1 to 4% (data of 5 strains listed in Table 9 is representative of that of 15 
strains examined).  
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Table 8.  vacA genotypes of 5 H. pylori isolates in clonal study  
 
vacA 
Genotype #1211 #1208 #1196 #907 #397 
s1a 0 0 1 (20) 0 3 (60) 
s1c 5 (100) 5 (100) 4 (80) 5 (100) 2 (40) 
M2 5 (100) 5 (100) 5 (100) 5 (100) 5 (100) 
M1T 0 0 0 0 0 
 
Values in parentheses are percentages 







Table 9.  GGT activity of 5 H. pylori isolates in clonal study 
 
 GGT activity (U / mg protein) 
Sub clone #1211 #1208 #1196 #907 #397 
#1 0.71 0.74 0.90 0.72 0.67 
#2 0.69 0.74 0.88 0.72 0.65 
#3 0.68 0.73 0.87 0.68 0.7 
#4 0.69 0.75 0.89 0.71 0.67 
#5 0.73 0.75 0.88 0.72 0.65 
Mean 0.7 ± 0.02 0.74 ± 0.01 0.88 ± 0.01 0.71 ± 0.02 0.67 ± 0.02 
 
Values of GGT activity represent means ± SD 
5 clones were randomly selected from each isolate #. 
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4.1.3 The relationship between GGT activity and PUD 
GGT activity was detected in all 98 H. pylori isolates within the range of 0.23 - 1.28 
U/mg protein. PUD patients (n = 54) show a GGT activity of 0.89 ± 0.23 U/mg 
protein (Figure 12). Interestingly, GGT activity of H. pylori isolates from NUD 
patients was substantially lower (p < 0.001) to that of PUD patients. In effect, the 
GGT activity of 44 isolates from NUD patients was 0.51 ± 0.15 U/mg protein. 
However, as shown in Figure 13, no significant difference was apparent between 
GGT activity of strains isolated from the male and female population (0.71 ± 0.23 vs. 





Figure 12. GGT activity of 98 clinical H. pylori isolates  
 
GGT, γ-glutamyl-transpeptidase; PUD, peptic ulcer disease; NUD, non-ulcer 
dyspepsia; Values of GGT activity represent means ± SD 
 
GGT activity of 98 clinical H. pylori isolates from NUD (n = 44) and PUD (n = 54) 
patients were plotted using GraphPadPrism system (GraphPad Software, Inc., USA). 
Horizontal bars indicate mean GGT activity increases. 
 





Figure 13. GGT activity of 98 H. pylori isolates from female and male patients 
 
GGT, γ-glutamyl-transpeptidase; Values of GGT activity represent means ± SD 
 
GGT activity of 98 clinical H. pylori isolates from Male or Female populations (n = 
49 each) were plotted using GraphPadPrism system. Horizontal bars indicate mean 






4.1.4 GGT activity is not related to cagA, vacA, iceA and babA2 status 
The GGT activity of H. pylori isolates is not significantly different between the 
presence and absence of the various virulence factors studied. This is illustrated in 
Table 10 where the GGT activity of cagA+ vs. cagA- (0.74 ± 0.27 vs. 0.71 ± 0.25; p = 
0.47) and vacA+ vs. vacA- (0.69 ± 0.26 vs. 0.66 ± 0.27; p = 0.52). Similarly, the p 
values for iceA1, iceA2 and babA2 are 0.15, 0.56 and 0.52, respectively. 
 







Table 10. Relationship between H. pylori GGT activity and status of cagA, vacA, 






cagA+ 0.74 ± 0.27 
cagA- 0.71 ± 0.25 
0.47 
vacA+ 0.69  ± 0.26 
vacA- 0.66 ± 0.27 
0.52 
iceA1+ 0.69 ± 0.26 
iceA1- 0.72 ±0.26 
0.15 
iceA2+ 0.74 ± 0.27 
iceA2- 0.69 ± 0.25 
0.56 
babA2+ 0.74 ± 0.27 
babA2- 0.72 ± 0.25 
0.52 
                                 Values of GGT activity represent means ± SD  
                                 ‘+’: presence; ‘-’: absence 
                                 p values are ‘+’ vs. ‘-’ (student’s t-test) 
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4.2 Prominent role of GGT on the growth of H. pylori  
4.2.1 Growth of Different H. pylori strains  
Growth of the four H. pylori strains with disparate GGT activities was followed over 
a period of 3 weeks. Figure 14 shows that H. pylori isolates with higher GGT activity 
(strains 1018 and 712 with GGT activity > 1 U/mg protein) grew better and more 
abundantly than those with lower GGT activity (strains 1082 and 888 with GGT 
activity < 0.4 U/mg protein) by 10 - 100 folds depending on the age of culture. 





























Figure 14. Growth of 4 H. pylori strains with different levels of GGT activity 
 
H. pylori strains 1018 and 712 expressed high GGT activity (> 1 U/mg protein) while 
strains 888 and 1082 produced low GGT activity (< 0.4 U/mg protein). H. pylori 
strains 1018 (♦ diamond), 712 (■ square), 888 (∆ triangle), and 1082 (× cross) were 
cultured in BHI medium microaerobically over 3 weeks. Viability was determined 
continuously at time intervals. (CFU: colony-forming units). 
 
                                                                                                     Results 
100 
4.2.2 Effect of GGT on H. pylori growth 
4.2.2.1 SBC inhibits GGT activity of H. pylori 
Figure 15 shows that H. pylori strain SS1 (mouse adapted strain) GGT activity was 
inhibited in a dose dependent manner upon exposure to a range of SBC concentrations 
(2 - 10mM) for 30 minutes at 37oC, where >90% GGT activity was inhibited by ≥ 
6mM SBC. The maximum inhibitory effect of 96% of GGT activity was achieved at 

























Figure 15. Inhibitory effect of SBC on H. pylori GGT activity 
 
Inhibition of 82%, 89%, 91%, 94% and 96% were obtained by incubating H.  pylori 
in 2, 4, 6, 8 and 10 mM SBC, respectively at 37oC for 30 min. 
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4.2.2.2 GSH enhances the GGT activity of H. pylori 
Figure 16 shows that H. pylori strain SS1 GGT activity was stimulated upon exposure 
to a range of GSH concentrations (0.01 - 1mM) for 30 minutes at 37oC. The 
maximum stimulatory effect of approximately 18% of GGT activity was achieved at 
the concentration of 0.1 mM as well as 1 mM. Thus, 0.1 mM GSH was chosen as the 
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Figure 16. Stimulatory effect of GSH on H. pylori GGT activity 
 
Stimulation of 6%, 18% and 17% were obtained by incubating H.  pylori in the 
presence of 0.01, 0.1 and 1 mM GSH, respectively at 37 oC for 30 min. 
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4.2.2.3 Effects of GGT inhibtor and enhancer on the growth of H. pylori 
Since SBC has inhibitory effect on H. pylori GGT activity, H. pylori SS1 was 
cultured in BHI broth supplemented with different concentrations of SBC (2 - 10 
mM). Figure 17 shows that the H. pylori cultured in the presence of various 
concentrations of SBC (2 - 10mM) over 3 weeks displayed marked inhibition on the 
growth of H. pylori in a dose dependent manner (ANOVA, p = 0.034). A > 99% 
decrease in viability of the bacterial population was observed within 72 hours after 
culturing H. pylori in the presence of 10 mM SBC. In contrast, H. pylori proliferated 
at twice the normal growth rate in the presence of 0.1 mM GSH and 1 mM glycyl-
glycine with increased GGT activity as compared to the control (without any 
supplements). And this acceleration in growth lasted over a period of about two weeks.  























































Figure 17. Effect of GGT inhibitor or enhancer on the growth of H. pylori 
 
A: Effect of   2mM (■ square), 4mM (▲ triangle), 6mM (× cross), 8mM (* star) SBC 
and GGT stimulation (0.1 M GSH + 1 M glycyl-glycine, ● circle) on SS1 over 21 
days. Control (♦ diamond).  
B: Effect of 10mM SBC on SS1 over 72 hours. 
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4.3 Sequencing of ggt gene of H. pylori 
4.3.1 DNA sequencing of H. pylori ggt gene 
PCR amplification with specific primers yielded a 1704 bp fragment from the 
genomic DNA of H. pylori type strain SS1 which served as a template (Figure 18, 
Lanes 2 & 3). No amplified fragment was observed for negative control without the 






Figure 18. PCR amplification of ggt gene 
 
Lane 1, 1 kb DNA ladder; Lanes 2 & 3, PCR product of 1704 bp;  
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The PCR product of 1704 bp was successfully cloned into the pGEM-T vector by TA 
cloning strategy. Plasmids from positive clones (pGEM-ggt) were extracted and 
digested with EcoR I or Nde I. Positive clones were shown to possess a vector band of 
approximate 3.0 kb and a correct insert band of 1704 bp as compared to the PCR 




Figure 19.  pGEM-ggt plasmid 
Lane 1, 1kb DNA ladder; Lane 2, pGEM-T vector digested with EcoR I;  Lane 3, 
pGEM-ggt plasmid digested with Nde I giving a fragment of 4.7 kb; Lane 4, pGEM-
ggt plasmid digested with EcoR I giving 2 fragments of 3.0 kb and 1704 bp, 
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The inserted H. pylori strain SS1 ggt gene fragment in the positive pGEM-ggt clone 
was sequenced using Big Dye (Perkin Elmer).The sequencing result showed that the 






5’ATGAGACGGA GTTTTTTGAA AACGATTGGC TTGGGCGTGA TAGCGCTCTC TTTGGGTTTG 
TTAAGCCCTT TGAGCGCGGC GAGTTACCCT CCCATTAAAA ACACTAAAGT AGGGTTAGCC 
CTTTCTAGCC ACCCGCTAGC CACTGAAATT GGGCAAAAGG TTTTAGAAGA GGGAGGTAAT 
GCGATTGATG CGGCGGTAGC GATGGGCTTT GCTCTAGCAG TAGTCCATCC GGCAGCAGGC 
AATATTGGTG GTGGGGGTTT TGCGGTTATC CATTTAGCTA ATGGTGAAAA TGTTGCCTTA 
GATTTTAGAG AAAAAGCTCC TTTAAAAGCC ACTAAAAACA TGTTTTTAGA CAAGCAAGGC 
AATGTAGTCC CTAAACTCAG CGAAGATGGC TATTTGGCGG CTGGGGTTCC TGGAACGGTG 
GCGGGCATGG AAGCGATGTT GAAAAAATAC GGCACCAAAA AACTATCGCA ACTCATTGAT 
CCTGCCATTA AATTGGCTGA AAATGGTTAT GCGATTTCAC AAAGACAAGC AGAAACCCTA 
AAAGAAGCGA GGGAGCGGTT TTTAAAATAC AGTTCTAGCA AAAAGTATTT TTTTAAAAAA 
GGGCATCTTG ATTATCAAGA GGGGGATTTG TTTGTCCAAA AAGATTTAGC CAAGACTTTG 
AGTCAAATCA AAACGCTAGG CGCTAAAGGC TTTTATCAAG GGCAAGTCGC TGATTTGATT 
GAGAAAGACA TGAAAAAAAA TGGAGGGATT ATCACTAAAG AGGATTTAGC CAGTTACAAT 
GAGAAATGGC GCAAACCCGT GGTAGGGAGT TATCGTGGGT ATAAGATCAT TTCTATGTCG 
CCTCCAAGTT CAGGAGGCAC GCATTTGATC CAGATTTTAA ATGTCATGGA GAATGCGGAT 
TTAAGCGCCC TTGGGTATGG GGCTTCTAAG AATATCCATA TCGCTGCAGA AGCGATGCGT 
CAGGCTTATG CGGATAGGTC GGTTTATATG GGAGATTCTG ATTTTGTTTC AGTGCCGGTG 
GATAAATTGA TTAATAAAGC GTATGCCAAA AAGATTTTTG ACACTATCCA GCCAGATACG 
GTTACGCCAA GCTCTCAAAT CAAACCAGGA ATGGGGCAGT TGCATGAGGG GAGCAATACC 
ACGCATTATT CTGTAGCGGA CAGGTGGGGG AATGCAGTCA GCGTTACTTA CACCATTAAC 
GCTTCTTATG GGAGCGCTGC TAGTATTGAT GGGGCAGGAT TTTTATTGAA CAATGAAATG 
GATGATTTTT CCATAAAACC AGGAAATCCT AATCTCTATG GTTTAGTGGG GGGCGATGCG 
AACGCGATTG AAGCCAATAA ACGCCCTTTA AGCTCCATGT CGCCTACGAT TGTGTTGAAA 
AACAATAAGG TTTTTTTGGT GGTGGGGAGC CCTGGAGGGT CTAGGATTAT CACTACGGTG 
TTGCAAGTGA TTTCTAATGT CATTGATTAT AACATGAATA TTTCTGAAGC AGTCTCAGCC 
CCAAGATTTC ACACGCAATG GCTCCCTGAT GAATTAAGGA TTGAAAAGTT TGGCATGCCC 
GCTGATGTGA AAGACAACCT CACTAAAATG GGCTATCAAA TCGTTACCAA GCCGGTTATG 
GGCGATGTGA ATGCGATCCA AGTTTTACCT AAAACTAAGG GGAGCGTTTT CTATGGATCA 
  ACGGATCCAA GGAAAGAATT TTAA3’ 
 
Figure 20. DNA sequence of H. pylori SS1 ggt gene 
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4.3.2 Comparison of SS1 GGT AA sequence with other GGTs 
The nucleotide sequence of H. pylori SS1 ggt gene was translated into amino acid 
sequence using www.expasy.com and compared with that of other bacterial and 
mammals (Figure 21). The multiple alignment of the GGTs illustrates that H. pylori 
GGT has an overall sequence similarity to that of the well-described mammalian 
GGTs. H. pylori GGT exhibits a typical signal sequence at its N-terminal end (26 
amino acids with the cleavage site occurring between Ala-26 and Ala-27). The 
position of the second cleavage site (between amino acid 379 and 380), which results 
in the processing of the pro-GGT into a large and a small subunit, was deduced for H. 
pylori GGT by comparison with other GGTs. H. pylori GGT shares 49%, 38%, 36%, 
31%, 20% and 28% of identity with the amino acid sequences of the E. coli, 
Pseudomonas  aeruginosa, Bacillus subtilus, Neisseria  meningitidis, human and pig 
GGTs, respectively.  
 
 
SS1                 -MRRSFLKTIGLGVIALSLGLLSPLSAASYPPIKN------------------------- 34 
E.coli              MIKPTFLRRVAIAAL-LSGSCFSAAAAPPAPPVSYGVEEDVFHPVR-------------- 45 
P.aeruginosa        -MQPVLFRTLSLGVA------IAAASSSAFAATLDG------------------------ 29 
B.subtilus          -MKRTWNVCLTALLSVLLVAGSVPFHAEAKKPPKSYDEYKQVDVGK-------------- 45 
N.meningitidis      -MAKTY--LLTALIMSMTISGCQVIHANQGKVNTHSAVITGADAHTPEHATGLTEQKQVI 57 
Human               -MARGYGATVSLVLLGLGLALAVIVLAVVLSRHQAPCGP-------------------QA 40 
Pig                 -MKKRY---LLLALAAVALVLLILGLCLWLPSNSKPHN--------------------HV 36 
                     :       :                .                                  
 
SS1                 TKVGLALSSHPLATEIGQKVLEEGGNAIDAAVAMGFALAVVHPAAGNIGGGGFAVIHLAN 94 
E.coli              AKQGMVASVDATATQVGVDILKEGGNAVDAAVAVGYALAVTHPQAGNLGGGGFMLIRSKN 105 
P.aeruginosa        ---GAVAAPDEYGAKVAAQILKAGGNAVDAAVATAFTLAVTYPEAGNIGGGGFMTLYMD- 85 
B.subtilus          --DGMVATAHPLASEIGADVLKKGGNAIDAAVAIQFALNVTEPMMSGIGGGGFMMVYDGK 103 
N.meningitidis      ASDFMVASANPLATQAGYDILKQGGSAADAMVAVQTTLSLVEPQSSGLGGGAFVLYWDNT 117 
Human               FAHAAVAADSKVCSDIGRAILQQQGSPVDATIAALVCTSVVNPQSMGLGGGVIFTIYNVT 100 
Pig                 YPRAAVAADALRCSEIGRDTLRDGGSAVDAAIAALLCVGLMNAHSMGIGGGLFLTIYNST 96 
                         . :     :. .   *.  *.. ** :*      :  .   .:*** :        
 
SS1                 -GENVALDFREKAPLKATKNMFLDKQGNVVPKLS-EDGYLAAGVPGTVAGMEAMLKKYGT 152 
E.coli              -GNTTAIDFREMAPAKATRDMFLDDQGNPDSKKS-LTSHLASGTPGTVAGFSLALDKYGT 163 
P.aeruginosa        -GKPYFLDYREVAPKAASKTMYLDDKGEVIENLS-LVGAKAAGVPGTVMGLWEAHKRFGK 143 
B.subtilus          TKDTTIIDSRERAPAGATPDMFLDENGKAIPFSERVTKGTAVGVPGTLKGLEEALDKWGT 163 
N.meningitidis      AKTLTTFDGRETAPMRATPELFLDKDGQPLKFMEAVVGGRSVGTPAIPKLMETIHQRYGV 177 
Human               TGKVEVINARETVPASHAPSLLD----QCAQALPLGTGAQWIGVPGELRGYAEAHRRHGR 156 
Pig                 TRKAEIINAREVAPRLASASMFN----SSEQSE---EGGLSVAVPGEIRGYELAHQRHGR 149 
                          :: ** .*   :  :      .              ..*.          : *  
 
SS1                 KKLSQLIDPAIKLAENGYAISQRQAETLKEARERFLKYSSSKKYFFKKGHLDYQEGDLFV 212 
E.coli              MPLNKVVQPAFKLARDGFIVNDALADDLKTYGSEVLPNHENSKAIFWKEGEPLKKGDTLV 223 
P.aeruginosa        LPWSELLTPAIGYAQKGFKVADKQFQYRQDAVALFN-----GKTNFGDYFGHMKAGEAFL 198 
B.subtilus          RSMKQLITPSIKLAEKGFPIDSVLAEAISDYQEKLSR--TAAKDVFLPNGEPLKEGDTLI 221 
N.meningitidis      LPWGKLFDTPIRLAKQGFEVSPRLAISVEQNQQHLARY-PKTAAYFLPNGVPLQAGSLLK 236 
Human               LPWAQLFQPTIALLRGGHVVAPVLSRFLHNSILRPSLQASTLRQLFFNGTEPLRPQDPLP 216 
Pig                 LPWARLFQPSIELASQGFPVGKGLAAALERSQD-AIKRHPALCEVFCRNGNVLREGDLVT 208 
                        .:. ..:     *. :                         *       :  . .  
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SS1                 QKDLAKTLSQIKTLGAKGFYQGQVADLIEKDMKKNG---GIITKEDLASYNEKWRKPVVG 269 
E.coli              QANLAKSLEMIAENGPDEFYKGTIAEQIAQEMQKNG---GLITKEDLAAYKAVERTPISG 280 
P.aeruginosa        QPDLAKTLERIADKGPDEFYKGHTADLLVAQMQQDK---GLITHQDLADYKVRWREPMRV 255 
B.subtilus          QKDLAKTFKLIRSKGTDAFYKGKFAKTLSDTVQDFG---GSMTEKDLENYDITIDEPIWG 278 
N.meningitidis      NLEFADSVQALAAQGAKALHTGKYAQNIVSVVQNAKDNPGQLSLQDLSDYQVVERPPVCV 296 
Human               WPALATTLETVATEGVEVFYTGRLGQMLVEDIAKEG---SQLTLQDLAKFQPEVVDA-LE 272 
Pig                 MPRLAKTYETLAVEGAQAFYNGSLTAQIVKDIQEAG---GIVTAEDLNNYRAELIEQPLR 265 
                       :* : . :   * . :: *     :   : .     . :: :**  :           
 
SS1                 SYRGYKIISMSPPSSGGTHLIQILNVMEN--ADLSALGYGASKNIHIAAEAMRQAYADRS 327 
E.coli              DYRGYQVYSMPPPSSGGIHIVQILNILEN--FDMKKYGFGSADAMQIMAEAEKYAYADRS 338 
P.aeruginosa        DWQGNTLYTAPLPSSGGIALAQLLGIKENRAADFKGVELNSARYIHLLAEIEKRVFADRA 315 
B.subtilus          DYQGYQIATTPPPSSGGIFLLQMLKILDH--FNLSQYDVRSWEKYQLLAETMHLSYADRA 336 
N.meningitidis      TYRIYEVCGMGAPSSGGIAVGQILGILNE--FSPNQVGY-DAEGLRLLGDASRLAFADRD 353 
Human               VPLGDYTLYSPPPPAGGAILSFILNVLRGFNFSTESMARPEGRVNVYHHLVETLKFARGQ 332 
Pig                 ISLGDAQLYAPNAPLSGPVLALILNILKGYNFSRASVETPEQKGLTYHRIVEAFRFAYAK 325 
                                .. .*  :  :* :      .                      :*    
 
SS1                 VYMGDSDFVSVPVDKLINKAYAKKIFDTIQPDTVTPSSQIKPGMGQLHEGSN-------- 379 
E.coli              EYLGDPDFVKVPWQALTNKAYAKSIADQIDINKAKPSSEIRPGKLAPYESNQ-------- 390 
P.aeruginosa        DYLGDPDFSKVPVARLTDPAYLKQRAAEVNPTAISPTEKVRPG----LEPHQ-------- 363 
B.subtilus          SYAGDPEFVNVPLKGLLHPDYIKERQQLINLDQVNKKPKAGDPWKYQEGSANYKQVEQPK 396 
N.meningitidis      VYLGDPDFVPVPIRQLISKDYLKHRSQLL--EQSDKALPSVSAGDFIHEWVSSQAIELP- 410 
Human               RWRLGDPRSHPKLQNASRDLLGETLAQLIRQQIDGRGDHQLSHYSLAEAWGHGTG----- 387 
Pig                 RTLLGDPK-FVNVTEVVRNMSSEFFADQLRARISDTTTHPDSYYEPEFYTPDDAG----- 379 
                        .                 :     :                                
 
SS1                 ------TTHYSVADRWGNAVSVTYTINASYGSAASIDGAGFLLNNEMDDFSIK------- 426 
E.coli              ------TTHYSVVDKDGNAVAVTYTLNTTFGTGIVAGESGILLNNQMDDFSAK------- 437 
P.aeruginosa        ------TTHFSIVDADGNAVSNTYTLNWDFGSGVVVKGAGFLLNDEMDDFSAK------- 410 
B.subtilus          DKVEGQTTHFTVADRWGNVVSYTTTIEQLFGTGIMVPDYGVILNNELTDFDAI------- 449 
N.meningitidis      -----STSHISIVDKAGNVLSMTTSIENAFGSTLMANGY--LLNNELTDFSFE------- 456 
Human               ------TSHVSVLGEDGSAVAATSTINTPFGAMVYSPRTGIILNNELLDLCERCPWGSGT 441 
Pig                 ------TAHLSVVSDDGSAVSATSTINLYFGSKVRSRISGILFNDEMDDFSS-------- 425 
                          *:* :: .  *..:: * :::  :*:         ::*::: *:           
 
SS1                 ---PGNPNLYGLVGGDANAIEANKRPLSSMSPTIVLK-NNKVFLVVGSPGGSRIITTVLQ 482 
E.coli              ---PGVPNVYGLVGGDANAVGPNKRPLSSMSPTIVVK-DGKTWLVTGSPGGSRIITTVLQ 493 
P.aeruginosa        ---PGVANAFGVVGSDANAIEPGKRMLSSMSPSIVTR-DGKVSLVVGTPGGSRIFTSIFQ 466 
B.subtilus          ---PGG----------ANEVQPNKRPLSSMTPTILFK-DDKPVLTVGSPGGATIISSVLQ 495 
N.meningitidis      ---PIKQGKQ-----VANRVEPGKRPRSSMAPTIVFK-AGKPYMAIGSPGGSRIIGYVAK 507 
Human               TPSPVSGDRVGGAPGRCWPPVPGERSPSSMVPSILINKAQGSKLVIGGAGGELIISAVAQ 501 
Pig                 ---PNITNQFGVRPSPANFITPGKQPLSSMCPVIIVGEDGQVRMVVGASGGTQITTSTAL 482 
                       *            .    ..::  *** * *:        :. * .**  *       
 
SS1                 VISNVIDYNMNISEAVSAPRFHTQWLP-DELRIEKF-GMPADVKDNLTKMGYQIVTK-PV 539 
E.coli              MVVNSIDYGLNVAEATNAPRFHHQWLP-DELRVEK--GFSPDTLKLLEAKGQKVALK-EA 549 
P.aeruginosa        VLNNIYDFHLPLEKAVAAQRVHHQLLPKDTIYYDAYAPLAGKVAEELKAMGYTLEDQGWN 526 
B.subtilus          TILYHIEYGMELKAAVEEPRIYTNSMSSYRYEDG----VPKDVLSKLNGMGHKFGTSPVD 551 
N.meningitidis      TIVAHSDWNMDIQDAISAPNLLN-RFGSYELETGT---TALQWQQALNDLGYKTDVRELN 563 
Human               AIMSKLWLGFDLRAAIAAPILHVNSK-GCVEYEPN---FSQEVQRGLQDRGQNQTQRPFF 557 
Pig                 AIIHSLWFGYDVKRAVEEPRLHNQLLPNTTTLEKG---IDQAVAAALKTRHHYIQDASTF 539 
                     :         :  *     .                         *              
 
SS1                 MGDVNAIQVLPKTKGSVFYGSTDPR--KEF-------- 567 
E.coli              MGSTQSIMVGPDGE---LYGASDPRSVDDLTAGY---- 580 
P.aeruginosa        MGDIQAIRVDGKAL----ETASDPRGRGVGLVVKP--- 557 
B.subtilus          IGNVQSISIDHENG--TFKGVADSSRNGAAIGINLKRK 587 
N.meningitidis      SG-VQAIIIEPSR----LVGGADPRREGRVMGD----- 591 
Human               LNVVQAVSQEGACV----YAVSDLRKSGEAAGY----- 586 
Pig                 IGVVQAIVRTPSGW----AAASDSRKGGEPAGY----- 568 
                     .  :::              :*                
 
 
Figure 21. Comparison of H. pylori SS1 GGT AA sequence with other GGTs 
Multiple sequence alignment has been performed using the CLUSTAL W program. 
Designations on the left refer to the origin of the sequence. Numbers on the right 
indicate nucleotide or amino acid positions. The asterisks represent nucleotides or 
amino acids that are identical to the one present at the same position.  
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4.3.3 Comparison of amino acid sequences of GGT from different H. pylori 
strains  
As shown in Figure 22, very high degree of conservation of GGT within H. pylori 
species was observed. Of these, only 21 of the 567 amino acid residues of the whole 
GGT protein are different; 16 of these are located within the large subunit of the GGT, 
and 5 such amino acid residues are within the small subunit of the GGT (as 
highlighted in Bold). There were also no consistent changes in the amino acid 
sequences in all the strains tested. 




825             MRRSFLKTIGLGVIALSLGLLSPLSAASYPPIKNTKVGLALSSHPLASEIGQKVLEDGGN 60 
840             MRRSFLKTIGLGVIALSLGLLSPLSAASYPPIKNTKVGLALSSHPLASEIGQKVLEDGGN 60 
998             MRRSFLKTIGLGVIALSLGLLSPLSAASYPPIKNTKVGLALSSHPLASEIGQKVLEDGGN 60 
712             MRRSFLKTIGLGVIALSLGLLSPLSAASYPPIKNTKVGLALSSHPLASEIGQKVLEDGGN 60 
NCTC            MRRSFLKTIGLGVIAFSLGLLSPLSAASYPPIKNTKVGLALSSHPLATEIGQKVLEEGGN 60 
SS1             MRRSFLKTIGLGVIALSLGLLSPLSAASYPPIKNTKVGLALSSHPLATEIGQKVLEEGGN 60 
                ***************:*******************************:********:*** 
 
825             AIDAAVAIGFALAVVHPAAGNIGGGGFAVIHLANGENVALDFREKAPLKATKNMFLDKQG 120 
840             AIDAAVAIGFALAVVHPAAGNIGGGGFAVIHLANGENVALDFREKAPLKATKNMFLDKQG 120 
998             AIDAAVAIGFALAVVHPAAGNIGGGGFAVIHLANGENVALDFREKAPLKATKNMFLDKQG 120 
712             AIDAAVAIGFALAVVHPAAGNIGGGGFAVIHLANGENVALDFREKAPLKATKNMFLDKQG 120 
NCTC            AIDAAVAIGFALAVVHPAAGNIGGGGFAVIHLANGENVALDFREKAPLKATKNMFLDKQG 120 
SS1             AIDAAVAMGFALAVVHPAAGNIGGGGFAVIHLANGENVALDFREKAPLKATKNMFLDKQG 120 
                *******:****************************************************   
 
825             NVVPKLSEDGYLAAGVPGTVAGMEAMLKKYGTKKLSQLIDPAIKLAENGYAISQRQAETL 180 
840             NVVPKLSEDGYLAAGVPGTVAGMEAMLKKYGTKKLSQLIDPAIKLAENGYAISQRQAETL 180 
998             NVVPKLSEDGYLAAGVPGTVAGMEAMLKKYGTKKLSQLIDPAIKLAENGYAISQRQAETL 180 
712             NVVPKLSEDGYLAAGVPGTVAGMEAMLKKYGTKKLSQLIDPAIKLAENGYAISQRQAETL 180 
NCTC            NVVPKLSEDGYLAAGVPGTVAGMEAMLKKYGTKKLSQLIDPAIKLAENGYAISQRQAETL 180 
SS1             NVVPKLSEDGYLAAGVPGTVAGMEAMLKKYGTKKLSQLIDPAIKLAENGYAISQRQAETL 180 
                ************************************************************ 
 
825             KEARERFLKYSSSKKYFFKKGHLDYQEGDLFVQKDLAKTLNQIKTLGAKGFYQGQVADLI 240 
840             KEARERFSKYASSKKYFFKKGHLDYQEGDLFVQKDLAKTLNQIKTLGAKGFYQGQVADLI 240 
998             KEARERFLKYSSSKKYFFKKGHLDYQEGDLFVQKDLAKTLNQIKTLGAKGFYQGQVAELI 240 
712             KEARERFLKYSSSKKYFFKKGHLDYQEGDLFVQKDLAETLNQIKTLGAKGFYQGQVADLI 240 
NCTC            KEARERFLKYSSSKKYFFKKGHLDYQEGDLFVQKDLAKTLNQIKTLGAKGFYQGQVAELI 240 
SS1             KEARERFLKYSSSKKYFFKKGHLDYQEGDLFVQKDLAKTLSQIKTLGAKGFYQGQVADLI 240 
                ******* **:**************************:**.****************:** 
 
825             EKDMKKNGGIITKEDLASYNVKWRKPVVGSYRGYKIISMSPPSSGGTHLIQIINVMENAD 300 
840             EKDMKKNGGIITKEDLASYNVKWRKPVVGSYRGYKIISMSPPSSGGTHLIQILNVMENVD 300 
998             EKDMKKNGGIITKEDLASYNVKWRKPVVGSYRGYKIISMSPPSSGGTHLIQILNVMENAD 300 
712             EKDMKKNGGIITKEDLASYNVKWRKPVVGSYRGYKIISMSPPSSGGTHLIQILNVMENAD 300 
NCTC            EKDMKKNGGIITKEDLASYNVKWRKPVMGSYRGYKIISMSPPSSGGTHLIQILNVMENAD 300 
SS1             EKDMKKNGGIITKEDLASYNEKWRKPVVGSYRGYKIISMSPPSSGGTHLIQILNVMENAD 300 
                ******************** ******:************************:*****.* 
 
825             LSALGYGASKNIHIAAEAMRQAYADRSVYMGDADFVSVPVDKLINKAYAKKIFDTIQPDT 360 
840             LSALGYGASKNIHIAAEAMRQAYADRSVYMGDADFVSVPVDKLINKAYAKKIFDTIQPDT 360 
998             LSALGYGASKNIHIAAEAMRQAYADRSVYMGDADFVSVPVDKLINKAYAKKIFDTIQPDM 360 
712             LSTLGYGASKNIHIAAEAMRQAYADRSVYMGDADFVSVPVDKLINKAYAKKIFDTIQPDT 360 
NCTC            LSALGYGASKNIHIAAEAMRQAYADRSVYMGDADFVSVPVDKLINKAYAKKIFDTIQPDT 360 
SS1             LSALGYGASKNIHIAAEAMRQAYADRSVYMGDSDFVSVPVDKLINKAYAKKIFDTIQPDT 360 
                **:*****************************:**************************  
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825             VTPSSQIKPGMGQLHEGSNTTHYSVADRWGNAVSVTYTINASYGSAASIDGAGFLLNNEM 420 
840             VTPSSQIKPGMGQLHEGSNTTHYSVADRWGNAVSVTYTINASYGSAASIDGAGFLLNNEM 420 
998             VTPSSQIKPGMGQLHEGSNTTHYSVADRWGNAVSVTYTINASYGSAASIDGAGFLLNNEM 420 
712             VTPSSQIKPGMGQLHEGSNTTHYSVADRWGNAVSVTYTINASYGSAASIDGAGFLLNNEM 420 
NCTC            VTPSSQIKPGMGQLHEGSNTTHYSVADRWGNAVSVTYTINASYGSAASIDGAGFLLNNEM 420 
SS1             VTPSSQIKPGMGQLHEGSNTTHYSVADRWGNAVSVTYTINASYGSAASIDGAGFLLNNEM 420 
                ************************************************************ 
 
825             DDFSIKPGNPNLYGLVGGDANAIEANKRPLSSMSPTIVLKNNKVFMVVGSPGGSRIITTV 480 
840             DDFSIKPGNPNLYGLVGGDANAIEANKRPLSSMSPTIVLKNNKVFMVVGSPGGSRIITTV 480 
998             DDFSIKPGNPNLYGLVGGDANAIEANKRPLSSMSPTIVLKNNKVFMVVGSPGGSRIITTV 480 
712             DDFSIKPGNPNLYGLVGGDANAIEANKRPLSSMSPTIVLKNNKVFMVVGSPGGPRIITTV 480 
NCTC            DDFSIKPGNPNLYGLVGGDANAIEANKRPLSSMSPTIVLKNNKVFLVVGSPGGSRIITTV 480 
SS1             DDFSIKPGNPNLYGLVGGDANAIEANKRPLSSMSPTIVLKNNKVFLVVGSPGGSRIITTV 480 
                *********************************************:*******.****** 
 
825             LQVISNVIDYNMNISEAVSAPRFHMQWLPDELRIEKFGMPADVKDNLTKMGYQIVTKPVM 540 
840             LQVISNVIDYNMNISEAVSAPRFHMQWLPDELRIEKFGMPADVKDNLTKMGYQIVTKPVM 540 
998             LQVISNVIDYNMNISEAVSAPRFHMQWLPDELRIEKFGMPADVKDNLTKMGYQIVTKPVM 540 
712             LQVISNVIDYNMNISEAVSAPRFHMQWLPDELRIEKFGMPADVKNNLTKMGYQIVTKPVM 540 
NCTC            LQVISNVIDYNMNISEAVSAPRFHMQWLPDELRIEKFGMPADVKDNLTKMGYQIVTKPVM 540 
SS1             LQVISNVIDYNMNISEAVSAPRFHTQWLPDELRIEKFGMPADVKDNLTKMGYQIVTKPVM 540 
                ************************ *******************:*************** 
 
825             GDVNAIQVLPKTKGSVFYGSTDPRKEF 567 
840             GDVNAIQVLPKTKGSVFYGSTDPRKEF 567 
998             GDVNAIQVLPKTKGSVFYGSTDPRKEF 567 
712             GDVNAIQVLPKTKGSVFYGATDPRKEF 567 
NCTC            GDVNAIQVLPKTKGSVFYGATDPRKEF 567 
SS1             GDVNAIQVLPKTKGSVFYGSTDPRKEF 567 




Figure 22. Amino acid sequence alignment of the predicted GGT protein in 
different H. pylori strains 
 
Multiple sequence alignment has been performed using the CLUSTAL W program. 
Designations on the left refer to the H. pylori strains. Numbers on the right indicate 
amino acid positions. The asterisks represent nucleotides or amino acids that are 
identical to the one present at the same position. , predicted cleavage sites. 
 
Dissimilarities in large subunit of GGT: No. 16, 48, 57, 68, 188, 191, 218, 221, 238, 
261, 268, 293, 299, 303, 333 and 360th AA. 
Dissimilarities in small subunit of GGT: No. 466, 474, 505, 525 and 560th AA. 
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4.4 Cloning and expression of recombinant GGT (rGGT)  
4.4.1 Construction of pRSET-GGT    
PCR amplification with specific primers yielded an 831 bp (255 - 1086th) fragment (as 
shown by the arrow) from the full length ggt gene in pGEM-ggt, which served as a 
template (Figure23, Lane 2). No amplified fragment was observed for the negative 





Figure 23. PCR amplification of rggt 
Lane 1, 1kb DNA ladder; Lane 2, PCR product of rggt fragment (255th -1086th bp); 
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Figure 24 Lane 4 shows two linear fragments of 3.0 kb and 0.83 kb. The former 
fragment represents the vector while the smaller fragment (as indicated by the arrow) 







Figure 24. pRSET-GGT plasmid 
 
 
Lane1, 1 kb DNA ladder; Lane 2, pRSET-A digested with BamH I; Lane3, pRSET-
GGT digested with BamH I; Lane 4, pRSET-GGT digested with BamH I and Hind III; 
Lane 5, PCR product of rggt fragment 
3.0 kb  
1.0 kb 
1 2 3 4 5
831 bp 
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4.4.2 Optimization of IPTG induction in the expression of rGGT protein 
In order to acquire maximum amount of recombinant protein expression, different 
concentration of IPTG in the range from 0.2 mM to 1 mM and at different time 
intervals with induction using 0.2 mM IPTG was carried out. As shown in Figure 25, 
the percentage of expressed recombinant GGT (rGGT) protein (as indicated by the 
arrow) in total cell extracts ranged from 28% - 35%. In addition, Figure 26 revealed 
that the expression of rGGT remained at around 30% of the total cell extract 
regardless of the IPTG induction time of 3 - 6 hours. It was therefore chosen to induce 





Figure 25. SDS-PAGE protein profiles of the cell lysates collected at 4 hours after 
IPTG induction 
 
M, Low MW protein marker; Lane 1, Negative control (pRSET-A transformed E. coli 
BL21(DE3) lysate); Expression of rGGT in the presence of: Lane 2, 0.2 mM IPTG; 
Lane 3, 0.4 mM IPTG; Lane 4, 0.6 mM IPTG; Lane 5, 0.8 mM IPTG; Lane 6, 1 mM 






    M       1       2       3       4       5       6 
30 kDa 










Figure 26. Time course of the expression of recombinant GGT (rGGT) protein 
M, Low MW protein marker; Lane 1, Negative control (pRSET-A transformed E. coli 
BL21(DE3) lysate); Expression of rGGT following 0.2 mM IPTG induction for: Lane 







    M         1          2          3           4         5        
30 kDa 
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4.4.3 Analysis of soluble and insoluble cell fractions 
In determining the solubility of the recombinant protein, rGGT was detected in the 
insoluble fraction, that is, the inclusion bodies contained most of the recombinant 









Figure 27. SDS-PAGE protein profile of soluble and insoluble protein fractions 
M, Low MW protein marker; Lane 1, Negative control (pRSET-A transformed E. coli 
BL21(DE3) lysate); rGGT expressed following 0.2 mM IPTG induction for 4 hours: 
Lane S1 & I1, Soluble and insoluble fractions at 30oC, respectively; Lane S2 & I2, 






M       1         S1       I1        S2         I2          
30 kDa 
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4.4.4 Purification of rGGT using His-tag affinity chromatography  
Since the recombinant proteins were mainly present as inclusion bodies, 
resolublization of the inclusion body was carried out using 6M urea. The solublized 
rGGT was purified using the His-tag affinity column. The efficiency of the 
purification is indicated the removal of the unbound fractions consisting of other E. 
coli proteins in the flow through while the purified rGGT protein corresponding to a 
molecular weight of approximately 30 kDa was obtained in the eluted fraction as 
indicated by the arrow in Figure 28. Recovery efficiency of recombinant GGT is 





Figure 28. His-Tag Affinity purification of rGGT 
M, Low MW protein marker; Lane 1, Negative control (pRSET-A transformed E. coli 
BL21(DE3) lysate); Lane 2, rGGT protein after IPTG induction; Lane 3, The unbound 
fractions; Lane 4, The fractions eluted by wash buffer; Lane 5, The His-Tag purified 
rGGT 
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4.5 Subcellular localization of H. pylori GGT    
4.5.1 GGT specific antibody 
The purified rGGT protein was diluted to the concentration of 0.05 mg/ml, and then 
refolded by step-wise dialysis as described in section 3.7.8.3. The refolded rGGT 
protein was then injected into New Zealand white rabbits. The sera obtained 
following initial injection and 3 boosters were separated from the whole blood, 
respectively. The antibody titer raised in rabbits against rGGT was shown to be over 1: 
400 as assayed by indirect ELISA method using 10 ng H. pylori total cell lysate as 
antigen. 
 
4.5.2 Subcellular localization of GGT in H. pylori 
Western blot was employed for the different strains where one protein band of 38 kDa 
was observed in H. pylori strain NCTC 11637 and SS1 (Figure 29). The results show 
that the protein bands of 38 kDa (large subunit of GGT as identified by mass 
spectrometry) appeared to be conserved in both the 2 strains tested.  
 
Figure 30 shows the western blot of various subcellular fractions of H. pylori strain 
SS1 using rabbit anti-rGGT serum as a probe. One protein band of GGT large subunit 
was observed for outer membrane protein fraction and cytoplasmic protein fraction 
(Lanes 2 & 3). A very faint protein band of similar molecular weight was detected in 
acid glycine extract (Lane 4). And the GGT activity analysis results also showed that 
OMP and CP fractions appeared to contain the most active GGT component as 
compared to AGE extract (Table 11).  
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Figure 29. Western blot of GGT in whole cell lysate of different H. pylori strains 
 
M, Low MW protein marker; Lane 1, Purified rGGT protein (a protein fragment on 
GGT large subunit of 30 kDa served as  positive control); Lane 2, H. pylori NCTC 





Figure 30. Western blot of various subcellular fractions of H. pylori strain SS1 
 
M, Low MW protein marker; Lane 1, Purified rGGT protein (used as positive control); 
Lane 2, H. pylori OMP fraction; Lane 3, H. pylori CP fraction; Lane 4, H. pylori AGE 
fraction 
 





M 1 2 3 4
38 kDa 
38 kDa 
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Data in Table 11 indicate that GGT mainly existed in membrane fractions (OMP and 
CP) of H. pylori as compared to the whole cell lysate (0.89 ± 0.06, 0.84 ± 0.06 vs. 
0.23 ± 0.02; p < 0.05). In addition, OMP and CP fractions appeared to contain the 
most active GGT component as compared to AGE extract. And these results are 











   AGE extract CP OMP 
*GGT activity 
(U/mg protein) 
0.69 ±0.06 0.23±0.02 0.08±0.01 0.84±0.06 0.89±0.06
 
* GGT activity as measured by GGT assay (section 3.5.1) 
AGE, Acid-glycine extraction; CP, Cytoplasmic protein; OMP, Outer membrane 
protein 
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4.6 Purification of native H. pylori GGT 
4.6.1 Three-step purification of GGT protein  
It was found that H. pylori native GGT mainly existed in cytoplasmic protein (CP) 
fraction. Therefore, CP protein fraction of H. pylori SS1 cells was applied to the 1st 
ion exchange column (SP Sepharose).  
 
Different pH conditions (range 6.0 - 8.5) were examined in order to determine the 
choice of pH for use in purification starting buffer (method described in section 3.12). 
It is shown that at pH 7.5, almost all native GGT protein in the H. pylori cytoplasmic 
protein fraction was bound to the column while only 30% of the native GGT protein 
could bind to the column when the pH of buffer was increased to 8.0 (Table 12). 
Therefore, pH 7.5 was selected as the pH of starting buffer. Native GGT was eluted 
by 200 mM NaCl (as indicated by red circles in Figure 31).  
 
The 200 mM NaCl-eluted protein fraction was loaded onto gel filtration Sephadex 
G200 column. The protein fraction containing GGT activity was eluted at 1/3 vol of 
the total bed volume (Figure 32, Lane 3).  
 
Upon altering the pH and salt concentration, the fraction obtained from gel filtration 
was loaded onto RESOURCE S column. The purified H. pylori native GGT protein 
contained two protein bands with molecular masses of about 38 and 22 kDa (Figure 
33, Lane 4) were obtained. The purity of the purified GGT protein was > 95%.  
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Purified H. pylori GGT protein ran on native PAGE showed a single band (Figure 
34A). This protein band was separated into two protein bands after running on a SDS-
PAGE gel (Figure 34B). The data in Figure 34 indicate that the two subunits of H. 




Table 12. Determination of the pH of the first IEX starting buffer 
 
pH of the start buffer GGT loaded Unbound GGT 
6.0 100% 0% 
6.5 100% 0% 
7.0 100% 0% 
7.5 100% 0% 
8.0 100% ~ 70% 
8.5 100% > 90% 
 









Figure 31. SDS-PAGE protein profile of first ion exchange chromatography 
purification 
 
M, Low MW protein marker; Lane 1, Protein fraction before purification; Lane 2, 100 
mM NaCl-eluted fraction; Lane 3, 200 mM NaCl-eluted fraction; Lane 4, 350 mM 



































Figure 32. SDS-PAGE protein profile of gel filtration purification 
M, Low MW protein marker; Lane 1, Protein fraction after the first IEX purification; 
Lane 2, Protein fraction eluted from Sephadex G 200 without GGT activity; Lane 3, 
Protein fraction eluted from Sephadex G 200 with GGT activity 
37 kDa 
20 kDa 
     M       1          2         3  
38 kDa 
22 kDa 




Figure 33. SDS-PAGE protein profile of H. pylori GGT protein purification 
M, Low MW protein marker; Lane 1, Protein fraction before purification; Lane 2,    
Protein fraction after the first IEX purification; Lane 3, Protein fraction after the gel 







              
 
Figure 34. Native and SDS-PAGE of purified GGT protein 
A. The purified H. pylori GGT protein was run on 12% native PAGE. The arrow 
indicates the direction of electrophoresis. The arrowhead indicates the GGT 
protein.  
B. The protein on the native PAGE gel was subsequently separated by SDS-
PAGE. Arrowheads indicate the large and small subunit fragments of GGT 
protein.   
37 kDa 
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4.6.2 Protein identification by Mass Spectrometry 
MS combine MS/MS (automation) analysis indicated both of the protein bands as 
separated in the SDS-PAGE gel belonged to γ-glutamyl transpeptidase of H. pylori. 
As shown in Figure 35, peptides identified from the larger protein band were 
highlighted in yellow, while those peptides highlighted in green were identified from 
the smaller protein band. The results indicate these two protein bands are the large 
and small subunits of H. pylori gamma-glutamyl transpeptidase, respectively. The 




M R R S F L K T I G L G V I A L S L G L L S P L S A A S Y P P I K N T K V G L A L S S H P L A 
T E I G Q K V L E E G G N A I D A A V A M G F A L A V V H P A A G N I G G G G F A V I H L 
A N G E N V A L D F R E K A P L K A T K N M F L D K Q G N V V P K L S E D G Y L A A G V 
P G T V A G M E A M L K K Y G T K K L S Q L I D P A I K L A E N G Y A I S Q R Q A E T L K 
E A R E R F L K Y S S S K K Y F F K K G H L D Y Q E G D L F V Q K D L A K T L S Q I K T L G 
A K G F Y Q G Q V A D L I E K D M K K N G G I I T K E D L A S Y N E K W R K P V V G S Y R 
G Y K I I S M S P P S S G G X H L I Q I L N V M E N A D L S A L G Y G A S K N I H I A A E A 
M R Q A Y A D R S V Y M G D S D F V S V P V D K L I N K A Y A K K I F D T I Q P D T V T P 
S S Q I K P G M G Q L H E G S N T T H Y S V A D R W G N A V S V T Y T I N A S Y G S A A S I 
D G A G F L L N N E M D D F S I K P G N P N L Y G L V G G D A N A I E A N K R P L S S M S P 
T I V L K N N K V F L V V G S P G G S R I I T T V L Q V I S N V I D Y N M N I S E A V S A P R 
F H T Q W L P D E L R I E K F G M P A D V K D N L T K M G Y Q I V T K P V M G D V N A I Q 
V L P K T K G S V F Y G S T D P R K E F 
 
Figure 35. Identification of the protein bands after 3-step purification 
AA peptides highlighted in yellow were matched with large subunit of GGT protein; 
AA peptides highlighted in green were matched with small subunit of GGT protein. 
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4.6.3 Specific GGT activity, yield and total recovery  
Table 13 shows that the specific GGT activity after 3-step purification was increased 
by about 240 times as compared to that of the crude sample (from 0.8 U/mg protein to 
192 U/mg protein). The total GGT activity recovery was around 35 %. 
 
Table 13. Purification of native GGT 
 
Purification steps 




Total GGT activity 
recovery (%) 
Crude sample 0.8 31.5 100 
1st IEX 40 0.41 65 
GF 96 0.13 50 




4.7 Effects of reagents on the cytotoxicity and H. pylori adhesion to cells 
MTT assay was carried out as described in section 3.15 to analyze cell viability and 
thereby confirming if inhibitors or GSH used in this study were not toxic to gastric 
epithelial cells. The results show that N-benzoyloxycarbonyl (Z)-Leu-Leu-leucinal 
(MG132, 30 µM), N-acetylcysteine (NAC, 10 mM), a-Cyano-(3-ethoxy-4-hydroxy-5-
henylthiomethyl) cinnamide (ST638, 30 µ M), SBC (10 mM), and GSH (0.1 mM) had 
no effect on cell viability as indicated by the equivalent mitochondrial activities in 
control and reagent-treated cells under the conditions used for all the experiments 
described in this study (Figure 36A). In addition, treatment of these reagents did not 
change the adhesion of H. pylori (107 CFU/ml) to AGS cells (Figure 36B).  
 























































Figure 36. Effects of reagents on cytotoxicity and H. pylori adhesion to  
AGS cells 
 
A: Effects of reagents used on cytotoxicity to AGS cells (as measured by MTT cell 
     viability analysis) 
B: Effects of reagents used on H. pylori adhesion to AGS cells (as measured by  
     H. pylori adherence analysis) 
A
B 
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4.8 H. pylori GGT and cell apoptosis  
4.8.1 Examination of adhesion of H. pylori to AGS cells using confocal 
microscopy 
Adherence of H. pylori to the gastric epithelial cells is the initial step for H. pylori-
mediated cell apoptosis. Figures 37 A & B demonstrate H. pylori cells displaying 
green  fluorescence while uninfected AGS cells do not show any fluorescence. As 
shown in Figures 37 C & D, green fluorescence was detected in H. pylori infected 













Figure 37. Confocal microscopy examination of the adhesion of H. pylori to AGS 
cells 
 
A: H. pylori cells labeled with FITC, served as positive control. B: AGS cells in the 
absence of H. pylori, served as negative control. C: AGS cells incubated with H. 





                                                                                                     Results 
130 
4.8.2 Confocal microscopy and flow cytometry analysis of apoptotic AGS cells   
Phosphatidylserine translocated from the inner to the outer leaflet of the plasma 
membrane which binds annexin V of early apoptotic AGS cells are effectively 
demonstrated using confocal microscopy (Figures 38 A & B as indicated by arrows). 
The late apoptotic or dead AGS cell shows that PI was bound to the DNA of the cell 
(indicated by the arrow) as shown in Figures 38 C & D. The percentage of early 
apoptotic cells was calculated by the number of cells stained by annexin V alone as PI 
is an indicator for late apoptotic or necrosis cells. 
 
H. pylori-induced apoptosis of AGS cells was further confirmed by flow cytometry 
analysis. A flow cytometry analysis representative of three individual experiments is 
depicted in Figure 39. As shown in the upper panel of Figure 39, only 5% of 
uninfected AGS cells were apoptotic (Annexin-V+ PI-). However, 16% of the H. 
pylori-infected AGS cells underwent apoptosis (lower panel of Figure 39). 
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Figure 38. Confocal microscopy examination of apoptotic AGS cells 
 
Confocal images of apoptotic AGS cells which bind annexin (green) on the surface. 
Arrows show the apoptotic cells. A: Transmition image of early apoptotic AGS cells 
as indicated by the arrow. B: Green and red fluorescence image of early apoptotic 
AGS cells. Annexin is labeled with fluorescein. C: Transmition image of late 
apoptotic or dead AGS cell as indicated by the arrow. D: Green and red fluorescence 
















Figure 39. H. pylori induces apoptosis by flow cytometry analysis 
 
AGS cells were infected with H. pylori at an MOI of 100:1 for 24 hours. Viable cells 
(annexin-V-PI-); nonviable, including late apoptotic or necrotic cells (annexin-V+ PI+ 
or annexin-V-PI+); and early apoptotic cells (annexin-V+PI-) were detected by the 
binding of Ann-V to externalized phospatidylserine in conjunction with PI, a dye 
excluded from viable cells. The upper panel, uninfected AGS cells (5% are early 
apoptotic). The lower panel, H. pylori infected AGS cells (16% are early apoptotic). 
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4.8.3 Induction of cell apoptosis by different H. pylori isolates 
A total of 12 randomly selected clinical H. pylori strains with disparate GGT activities 
were used for apoptosis induction of gastric epithelial AGS cells. Figure 40 shows 
that H. pylori isolates (n = 6)  with higher GGT activity of > 1 U/mg protein induced a 
significant increase in apoptosis as compared to the apoptosis induced by those H. 
pylori (n = 6) with lower GGT activity of < 0.4 U/mg protein (18.09 ± 1.15% vs. 





Figure 40. Induction of cell apoptosis by different H. pylori strains with different 
GGT activity 
 
The apoptosis induction of 6 strains each from lower or higher GGT activity H. pylori 
group has been plotted using GraphPadPrism system. Horizontal bar indicates the 
mean of apoptosis induction in each group.  
Cell apoptosis was measured according to the method described in section 3.14. 
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4.8.4 Involvement of GGT in the induction of cell apoptosis 
The presence of purified H. pylori GGT induced apoptosis in AGS cells displayed in a 
dose-dependent manner is as shown in Figure 41. In comparison, data in Figure 42 
demonstrate that the purified GGT and H. pylori cells induced a significant increase in 
apoptosis as compared to the apoptosis of AGS cells alone (12.17 ± 1.01% and 16.53 
± 1.61% vs. 4.94 ± 0.74%; p < 0.05). However, the induction of apoptosis was 
reverted to the control level when GGT activity was completely suppressed by anti-
rGGT antibody or SBC, a GGT inhibitor (with a residual GGT activity in H. pylori of 
~ 5%). On the contrary, in the presence of GSH and glycyl-glycine, the GGT activity 
in H. pylori was increased by about 18%; significant increase in apoptosis was 
observed as compared to the value as induced in the presence of H. pylori (19.13 ± 
1.45% vs. 16.53 ± 1.61%; p < 0.05).  
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Figure 41. Dose-dependent apoptosis inductions in AGS cells by purified native 
 H. pylori GGT 
GGT was added to the medium at the indicated concentrations. The experiment was 































































Figure 42. Involvement of GGT in the induction of cell apoptosis  
(*) Significantly different from uninfected AGS cells value (p < 0.05) as assessed by 
student t test. 
(**) Significantly different from H. pylori infected AGS cells value (p < 0.05) as 
assessed by student t test. 
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4.8.5 GGT and caspase activity 
The activity of selected caspases in the AGS cells after incubating with H. pylori cells 
or purified GGT fraction was examined. Figure 43 shows H. pylori induced the 
activation of caspase-3, caspase-8 and caspase-9 in AGS cells (287.5 ± 8%, 170.6 ± 
10% and 212.4 ± 6% of control, p < 0.05), while significantly elevated caspase-3 and 
caspase-9 activities (232 ± 4% and 221 ± 11% of control, respectively) with p value 






























Figure 43. Activation of caspases by H. pylori GGT 
 
AGS cells were co-incubated with H. pylori cells or purified H. pylori GGT fraction 
for 24 hours. Caspase activities were determined spectrophotometrically. The 
experiment was performed in triplicate and values shown are means ± SD.  
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Caspase activities were assayed, both in basal conditions, and in conditions of 
modulated GGT activity (Figure 44). It is interesting to note that in the presence of 
SBC, the inhibitor of GGT, only the activities of caspase-3 and caspase-9 were 
significantly blocked as compared to the ‘H. pylori’ value (caspase activities in H. 
pylori infected AGS cells). Similarly, only elevated caspase-3 and caspase-9 activities 
were detected in the presence of GSH and glycyl-glycine, the enhancer of GGT, as 
compared to the ‘H. pylori’ value. The data indicate that GGT affects H. pylori-




























AGS + H. pylori
AGS + H. pylori + SBC
AGS + H. pylori + GSH + glycyl-glycine
 
Figure 44. Caspase activities induced by modulated GGT 
 
AGS cells were coincubated with H. pylori cells in the presence of GGT inhibitor or 
enhancer for 24 hours. Caspase activities were determined spectrophotometrically. 
The experiment was performed in triplicate and values shown are means ± SD. 
(*) Significantly different from H. pylori infected AGS cells value (p < 0.05) as 
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Figure 45 shows the caspase activities in AGS cells after incubating with different H. 
pylori strains displaying different GGT activity as well as different vacA status. It was 
found that the high GGT activity strains showed higher caspase-9 activity as 
compared to the low GGT activity producing strain (#825 & #1018 vs. #998 & #1090). 
However, higher caspase-8 activity rather than caspase-9 activity was detected in the 
vacA+ H. pylori strains as compared to vacA- strain (#825 & #998 vs. #1018 & #1090). 
It is interesting to note that higher caspase-3 activity was also detected in AGS cells 
reacted with high GGT producing H. pylori strains as compared to that of low GGT 
producing H. pylori infected AGS cells regardless of the vacA status (#825 & # 1018 































Figure 45. VacA and GGT in H. pylori induced caspase activities 
 
AGS cells were coincubated with different H. pylori cells for 24 hours. Caspase 
activities were determined spectrophotometrically. The experiment was performed in 
triplicate and values shown are means ± SD. #825: vacA+ and high GGT activity; 
#1018: vacA- and high GGT activity; #998: vacA+ and low GGT activity. # 1090: 
vacA- and low GGT activity.  
vacA+, vacA positive; vacA-, vacA negative. 
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4.8.6 GGT induces mitochondrial dysfunction and cytochrome c release 
4.8.6.1 GGT and mitochondrial transmembrane potential changes  
Confocal microscopy examination of mitochondrial transmembrane potential changes 
of the apoptotic AGS cells is shown in Figure 46. All of the untreated AGS cells were 
nonapoptotic which showed red fluorescence (Figure 46A). On the other hand, the 
majority of the cells in Figure 46B exhibited green fluorescence, indicating the 
mitochondrial membrane permeability increased in GGT incubated AGS cells. 





Figure 46. AGS cells stained with BD MitoSensor™ Dye 
A: AGS cells without purified H. pylori GGT incubation. Non-apoptotic cells exhibit 
an intense red fluorescence. B: Cells were treated with purified GGT. Apoptotic cells 
exhibit a bright green fluorescence. 
A B
A B 
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4.8.6.2 GGT and cytochrome c release  
Cytochrome c oxidase subunit IV (COX4), a protein that is localized to the inner 
mitochondrial membrane and remains in the mitochondria during apoptosis, was 
detected by COX4 antibody (Figure 47). The results indicate that the cytosolic and 
mitochondrion-enriched fractions have been well separated.      
 
As shown in Figure 48, AGS cells when incubated in the presence of H. pylori or 
purified native H. pylori GGT led to an increase in cytosolic and a decrease in 
mitochondrial cytochrome c protein levels as compared to the uninfected AGS cells.  
 
The effect of GGT inhibitor and enhancer on AGS shows that more cytochrome c was 
released from mitochondria under GGT stimulation condition (Figure 49). In contrast, 
most of the cytochrome c stayed in mitochondria when GGT activity was inhibited by 







Figure 47. Western blot detection of cytochrome c oxidase subunit IV  
Mitochondrial and cytosolic fractions from H. pylori infected AGS cells probed with 
anti-COX4 Antibody. Cyt, cytosolic protein faction. Mito, mitochondrial protein 
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Figure 48. H. pylori GGT induced cytochrome c release 
Uninfected, most of the cytochrome c stayed in mitochondria of uninfected AGS cells; 
H. pylori, cytochrome c released from H. pylori-infected AGS cells; GGT, 














Figure 49. Modulated H. pylori GGT induced cytochrome c release  
 
Uninfected, most of the cytochrome c stayed in mitochondria of uninfected AGS cells; 
H. pylori, cytochrome c released from H. pylori-infected AGS cells; 
H. pylori + GSH, cytochrome c released from H. pylori-infected AGS cells in the 
presence of 0.1 mM GSH and 1 mM glycyl-glycine; 
H. pylori + SBC, cytochrome c released from H. pylori-infected AGS cells in the 





Uninfected H. pylori GGT 
Cytosolic 
Mitochondrial 
Uninfected     H. pylori      H. pylori        H. pylori  
                                            + GSH           + SBC                  
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4.9 H. pylori GGT and hydrogen peroxide production 
4.9.1 H2O2 production in the presence of different cell – bacteria ratio 
Figure 50 shows that the generation of hydrogen peroxide from AGS cells (upper 
panel) and KATO III cells (lower panel) after H. pylori infection was increased in a 
dose dependent manner upon exposure to different cell-bacteria ratio (1:1 to 1:100). 
The highest amount of H2O2 released from AGS and KATO III cells was detected at 
1:100 ratio. In view of the similar pattern on the effect of cell:bacteria ratio in relation 
to  H2O2 production in both cell lines, AGS was chosen to elaborate the effect of GGT 
on gastric epithelial cells. 
 








Conrtrol  1:1  1:5 1:10 1:50  1:100















Control  1:1  1:5 1:10 1:50  1:100









Figure 50. H2O2 production in AGS (upper panel) and KATO III (lower panel) 
cells treated with H. pylori at different cell - bacteria ratio 
 
Control, H2O2 released from uninfected cells; 1:1 to 1:100, H2O2 released from cells 
treated with H. pylori at different cell - bacteria ratio. Each point represents means ± 
SD of 4 experiments. 
H2O2 production was examined based on the method described in section 3.17.
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4.9.2 Effects of GGT inhibitor and enhancer on H2O2 production 
 
H. pylori SS1 was co-cultured with AGS cells in RPMI 1640 medium supplemented 
with different concentrations of GGT inhibitor, SBC, at concentration of 2 - 10 mM. 
Figure 51 shows that the H2O2 generation decreased dramatically when GGT activity 
of H. pylori was inhibited by SBC. The inhibitory effect was in a dose dependent 
manner, which was parallel to the inhibitory effect of SBC on the H. pylori GGT 
activity. In contrast to the effect of SBC on H2O2 generation, significantly (p < 0.05) 
higher amount of H2O2 was released from AGS cells when H. pylori GGT activity 




















Figure 51. Inhibitory effect of SBC on H2O2 production                                           
(*) Significantly different from H. pylori infected AGS cells value (p < 0.05) as 
assessed by student t test. 
Basal, hydrogen peroxide released from untreated AGS cells 




























Figure 52. Stimulatory effect of GSH on the H2O2 generation 
(*) The significant difference from H. pylori infected AGS cells value (p < 0.05) was 
assessed by student t test. 
Basal, hydrogen peroxide released from untreated AGS cells 
Each point represents means ± SD of 3 experiments.  
*
*
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4.9.3 H2O2 production in cells treated with different strains of H. pylori  
Four H. pylori strains with disparate GGT activities were tested for measuring the 
hydrogen peroxide generation from gastric epithelial AGS cells. Figure 53 shows that 
H. pylori isolates with higher GGT activity of > 1 U/mg protein (strains 1018 and 712) 
induced a significantly higher hydrogen peroxide production as compared to the H2O2 
released from the cells infected with those H. pylori (strains 1082 and 888) possessing 



















Figure 53. Generation of H2O2 after infection with H. pylori strains presenting 
with different GGT activity 
 
Control, H2O2 released from uninfected AGS cells; #1082 & 888, low GGT activity 
producing H. pylori strains; #1018 & 712, high GGT activity producing H. pylori 
strains. Each point represents means ± SD of 3 experiments. 
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4.9.4 Purified native H. pylori GGT on H2O2 production in cells 
Hydrogen peroxide production by AGS cells was assayed, in basal conditions 
(uninfected cells), in the presence of purified H. pylori GGT protein, and under 
conditions of modulated GGT activity (Figure 54). It was interesting to note that basal 
H2O2 production was increased significantly in the presence of purified H. pylori 
GGT protein (p < 0.05). In addition, under the condition of stimulated GGT activity 
(i.e. in the presence of substrates, GSH and glycyl-glycine), significantly elevated 
H2O2 was generated from AGS cells as compared to the GGT treated cells. 
Interestingly, the GGT-dependence of H2O2 production by AGS cells was further 
confirmed by the fact that the production of H2O2 was reverted to the basal level when 
GGT activity was almost completely suppressed with an independently acting 
inhibitor (SBC: 96% inhibition).  



















Figure 54. H2O2 generation by purified H. pylori GGT 
 
H2O2 released from: Control, uninfected AGS cells; GGT, purified GGT protein 
treated AGS cells; GGT + SBC, purified GGT protein treated AGS cells in the 
presence of 10 mM SBC; GGT + GSH, purified GGT protein treated AGS cells in the 
presence of 0.1 mM GSH and 1mM glycine-glycine. 
The significant different from uninfected AGS cells value (*) and GGT treated AGS 
cells value (**) (p < 0.05) as assessed by student t test. 
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4.10 I-κB degradation and NF-κB activation by GGT 
4.10.1 Time course of NF-κB activation  
Figure 55 shows the intensity of NF-κB p65 protein band was similar irrespective of 
the infected period (2 - 6 hours) by H. pylori. Thus, the time point of 4 hour 








Figure 55. Time course of NF-κB activation 
 
Lane 1, AGS; AGS + H. pylori for: Lane 2, 2 hours;  




1 2 3 4
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4.10.2 GGT in the I-κB degradation and NF-κB activation  
Data in Figure 56 show that H. pylori induced a decrease in cellular level of I-κBα 
and an increase of nuclear level of NF-κB at 4 hour of infection. However, in the 
presence of SBC, H. pylori-induced activation of NF-κB and the degradation of I-κBα 
in the cells were inhibited. In contrast, in the presence of GGT enhancer, GSH, 
significantly more NF-κB was activated. In addition, it is interesting to note that 
purified H. pylori GGT increased the NF-κB level in nuclear extract dramatically as 
compared to the basal level (AGS cells without any treatment). The intensity of β-
actin protein band was similar for all the samples examined, indicating the same 
amount of sample was loaded in each condition. Similar results were observed for 






Figure 56. H. pylori GGT-mediated I-κBα degradation and NF-κB activation 
 
 
Lane 1, AGS; Lane 2, AGS + H. pylori; Lane 3, AGS + H. pylori + SBC (10 mM);  
Lane 4, AGS + H. pylori + GSH (0.1 mM) + glycyl-glycine (1mM); 







1                2                3               4              5 
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4.10.3 Effects of different inhibitors in GGT-mediated I-κB degradation and NF-
κB activation  
To further characterize the signaling cascade leading to NF- κB activation in response 
to H. pylori GGT, we determined whether hydrogen peroxide as well as tyrosine 
kinase is involved in the process. Pretreatment of AGS cells with NAC (inhibit the 
function of H2O2), ST638 (tyrosine kinase inhibitor) or MG132 (proteasome inhibitor) 
completely blocked both NF-κB activation and I-κBα degradation induced by GGT 
incubation (Figure 57). The results indicate that GGT-induced hydrogen peroxide 







Figure 57. Effects of inhibitors on H. pylori GGT-mediated I-κBα degradation 
and NF-κB activation 
 
Lane 1, AGS; Lane 2, AGS + GGT + NAC (10 mM); Lane 3, AGS + GGT + ST638 
(30 µM); Lane 4, AGS + GGT + MG132 (30 µM); 
Lane 5, AGS + GGT 
I-κB 
     1                   2                   3                   4                   5 
NF-κB  
β-Actin 
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4.11 H. pylori GGT and IL-8 generation  
4.11.1 Cytokine production in cells treated with H. pylori 
Gastric epithelial cells (AGS and KATO III) were initially tested for enhanced 
production of cytokines (IL-4, IL-8, IFN-γ and TNF-α) following treatment with H. 
pylori for 2 - 24 hrs according to the method as described in section 3.19. The results 
indicated that of the 4 cytokines examined, IL-8 production was stimulated by H. 
pylori in AGS and KATO III cells (Table 14). Thus, IL-8 production stimulated by H. 
pylori was chosen for the follow-up experiments. 
 
 
Table 14. Cytokine production in H. pylori treated gastric epithelial cells 
 
AGS  KATO III Cytokine 
(pg/ml) None H. pylori None H. pylori 
IL-4 5.3 ± 0.4 5.6 ± 0.3 4.2 ± 0.3 4.3 ± 0.4 
IL-8 655.2 ± 68.1 2669.7 ± 98.2* 634.6 ± 73.7 2137.9 ± 87.9* 
IFN-γ 3.2 ± 0.2 3.3± 0.3 3.8 ± 0.3 4.2 ± 0.2 
TNF-α 5.6 ± 0.4 6.3 ± 0.6 4.9 ± 0.4 5.1 ± 0.5 
 
Bacterial cells were grown on CBA plates at 37°C under microaerophilic conditions. 
The cells were harvested, resuspended in antibiotic-free cell culture medium before 
adding to the gastric epithelial cells at a cell:bacteria ratio of 1:100 in 2 ml volume. 
Supernatants were collected for cytokine assay [BD OptEIATM (BD Biosciences)] at 
incubation period of 2 - 24hrs. Values represent mean ± SE at 24-hour culture. Each 
value represents means ± SD of 4 experiments.  
*p < 0.05 vs. none. 
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4.11.2 Time course of IL-8 generation in cells treated with H. pylori 
Figure 58 shows that a statistically significant increase in IL-8 production was 
apparent 2 hour after treatment with H. pylori SS1 cells in AGS cells (upper panel) 
and KATO III cells (lower panel). Increased IL-8 production continued during the 
subsequent 24 hours. Data obtained from AGS cells would be representative of the 




































Figure 58. Time course of IL-8 generation  
IL-8 production in AGS (upper panel) and KATO III (lower panel) treated without (-
♦-) or with (-□-, cell:bacteria ratio of 1:100) H. pylori. Each point represents means ± 
SD of 4 experiments.  
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4.11.3 IL-8 generation in cells infected with different H. pylori strains 
Four H. pylori strains with disparate GGT activities were used to examine the IL-8 
generation from AGS cells. As shown in Figure 59, H. pylori isolates with higher 
GGT activity of > 1 U/mg protein (strains 1018 and 712) induced a significant (p < 
0.05) increase in IL-8 production as compared to the IL-8 released from the cells 
infected with those H. pylori (strains 1082 and 888) presenting lower GGT activity of 
< 0.4 U/mg protein. Interestingly, SS1 is a medium-GGT producer (with GGT activity 


























Figure 59. Generation of IL-8 after infection with H. pylori strains with different 
GGT activity 
Each point represents means ± SD of 3 experiments.  
# 1018 & 712 with high GGT activity of > 1 U/mg protein  
# 888 &1082 with low GGT activity of < 0.4 U/mg protein 
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4.12 Effect of native H. pylori GGT on IL-8 generation 
IL-8 generation by AGS cells after incubating with H. pylori cells or purified H. 
pylori GGT fraction for 6 hours is shown in Figure 60. H. pylori infection 
significantly increased the IL-8 generation in AGS cells (608.3 ± 48 vs. 105.3 ± 15.2, 
p < 0.05), while 2 fold more IL-8 was detected after incubating with the purified 
native GGT. However, in the presence of SBC, a specific GGT inhibitor, the IL-8 
level was reverted to the basal level. On the contrary, elevated IL-8 level was detected 




















Figure 60. H. pylori GGT-induced IL-8 generation 
 
AGS cells were co-cultured with purified H. pylori GGT fraction for 6 hours in the 
presence of SBC (10mM) or GSH (0.1 mM). Results are the means ± SD of 4 
experiments. 
(*) Significantly different from uninfected AGS cells value (p < 0.05) as assessed by 
student t test. 
Significantly different from H. pylori (**) or purified native GGT (***) infected AGS 
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4.12.1 Effect of different inhibitors in GGT-induced IL-8 generation 
Specific inhibitors were used to determine whether hydrogen peroxide, tyrosine 
kinase activity and I-κB degradation are required for IL-8 production in response to 
GGT. After preincubating with NAC, ST638 and MG132, AGS cells were 
coincubated with purified native GGT for 6 hours. Following this, the IL-8 released 
from cells were collected and examined by ELISA. As shown in Figure 61, these 


























Figure 61. Effects of inhibitors on H. pylori GGT-induced IL-8 production 
 
AGS cells were pretreated with or without the inhibitors NAC (10 mM), ST638 (30 
µM), and MG132 (30 µM) for 30 minutes, and then were co-cultured with purified H. 
pylori GGT fraction for 6 hours. Results are the means ± SD of 4 experiments. 
Significantly different from uninfected (*) and GGT-incubated AGS cells (**) (p < 
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4.12.2 Detection of IL-8 expression at mRNA level 
The total RNA was extracted from AGS cells under different treatments to study the 
transcription of the IL-8 gene. As shown by RT-PCR, a significant increase (2-3 folds) 
in IL-8 mRNA transcription was detected in AGS cells stimulated with H. pylori GGT 
(Figure 62A, Lane 4). In contrast, no significant increase in IL-8 mRNA production 
was demonstrated when GGT activity was inhibited by SBC (Figure 62A, Lane 6). 
Similarly, the IL-8 mRNA transcription was blocked in the presence of the inhibitors 
tested in this study, including NAC, ST638 and MG132 (Figure 62A, Lanes 7 - 9). 
The β-actin mRNA transcription was analyzed as a control to indicate the amount of 
total mRNA used for each RT-PCR reaction (Figure 62B). 









Figure 62. RT-PCR analysis 
A: RT-PCR of IL-8 gene; B: RT-PCR of β-actin gene 
 
Lane 1, 100 bp DNA ladder; Lane 2, AGS cells; Lane 3, AGS + H. pylori; Lane 4, 
AGS + GGT; Lane 5, AGS + GGT + GSH; Lane 6, AGS + GGT +SBC; Lane 7, AGS 
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5.1 Virulence factors in H. pylori and gastroduodenal disease outcome 
5.1.1 Prevalence of cagA, vacA, iceA, babA2 and disease outcome  
Studies in the Western populations suggested a strong association between infection 
by cagA+ H. pylori and peptic ulcer disease (Crabtree et al., 1991; Weel et al., 1996). 
However, in this study, the cagA is present in 74.1% of the PUD patients (n = 54), 
while 79.5% of the NUD patients (n = 44) are cagA positive (Table 6). The accuracy 
of the PCR product was examined by running with different set of primers as well as 
DNA sequencing (data not shown). The finding shows that the presence of cagA in H. 
pylori is insignificant between PUD and NUD in Singapore population (p = 0.53). 
The results indicate that cagA status is not predictive of gastroduodenal diseases in the 
Singapore population, which is in agreement with earlier findings that cagA gene 
should not be regarded as a universal virulence marker of peptic ulcer disease 
(Mitchell et al., 1996; Park et al., 1998; Zheng et al., 2000). 
 
Similarly, no significant difference was detected for the presence of the other 
virulence genes (vacA, iceA1, iceA2 and babA2) in H. pylori isolates between PUD 
and NUD patients where the p values range from 0.47 - 0.98 (Table 6). Therefore, 
although virulent H. pylori strains with cagA, vacA, iceA and babA2 have been 
reported to be associated with gastrointestinal diseases in Western populations (Cover 
et al., 1995; Atherton et al., 1997; Peek et al., 1998; Gerhard et al., 1999), these 
virulence markers had little or no predictive value in Asian populations (Maeda et al., 
1998; Zheng et al., 2000; Ito et al., 2000). It further exercebates the implication that 




5.1.2 Diversity of vacA genotypes in clinical isolates  
Among the reported virulence factors, VacA has been considered to have an 
important role in the pathogenesis of H. pylori infection which is encoded by vacA 
that has distinct allelic types (Cover et al., 1994; Atherton et al., 1995; van Doorn et 
al., 1999). Genomic differences in vacA are located in both the signal sequences (s 
region) and the mid-region (m region) of the gene. The s-region coexists as s1 or s2 
allelic types. Among type s1 strains, subtypes s1a, s1b and s1c have been identified 
(Atherton et al., 1995). The m-region occurs as the m1, m1T, m1Tm2, and m2 allelic 
types (Wang et al., 1998). The mosaic combination of s- and m-region allelic types 
determines cytotoxin production and is thereby associated with pathogenicity of the 
bacterium. It has been reported that in North American and Western Europe, infection 
with H. pylori strains containing the s1 vacA allele is associated with peptic ulcer 
disease (Atherton et al., 1997; van Doorn et al., 1998). However, although H. pylori 
has a worldwide distribution, the variation in vacA genotypes exists among 
geographic regions. As reported by van Door et al. (1999), subtype s1a is 
predominant in Northern Europe and Australia, whereas subtype s1b is prevalent in 
South America.  
 
The results from clonal study comprised 5 clones from each of a subset of 15 primary 
H. pylori isolates showed that the predominant vacA genotype in Singapore is s1c/m2 
(56/75, 74.7%). This is in agreement with earlier findings that vacA s1c genotype is 
present in 95.8% of the population harboring H. pylori in Hong Kong (Wong et al., 
2001) and 80% in Japan (Zhou et al., 2004). In addition, s1c/m2 is prevalent in East 
China with 61.1% (Zhou et al., 2004). These findings further support that subtype s1c 
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is the major subtype in East Asia, but is extremely rare in Western Europe (Van 
Doorn et al., 1999). 
 
Unlike the association of severe gastric diseases with H. pylori vacA s1 genotype 
(Atherton et al., 1997; van Doorn et al., 1998), the study shows that there was no 
significant difference between PUD and NUD patients for infection by s1c/m2 
genotype H. pylori isolates (75.6 vs. 73.3%; p = 0.794). The result agrees well with 
the finding reported by Pan et al. and Shimoyama et al. (1998) that in Japan and 
China, where s1 alleles predominate, vacA genotypes have not been shown to be 
associated with more severe clinical outcome. Thus, it indicates that vacA s1 genotype 
is not closely related to the severe gastroduodenal diseases outcome in Singapore. 
 
Some studies show an association between vacA m1 strains and gastric cancer or pre-
cancer (Miehlke et al., 2000; Zagari and Bazzoli, 2004). In the present study, no vacA 
m1 genotype was detected in the 75 clonal strains demonstrating the circulation of H. 
pylori genotypes in different geographic regions around the world. However, 
investigation of vacA genotype in more H. pylori isolates from gastric ulcer or gastric 
cancer patients is desirable.  
 
It was noted that among the 15 H. pylori isolates chosen for clonal study, 2 strains 
(#1196 and #397) showed more than one allelic variant in vacA s- region (Table 8). 
This agrees with earlier studies that multiple H. pylori strain infection is present in 




5.1.3 GGT activity and peptic ulcer disease 
Unlike the GGTs of E. coli (Suzuki et al., 1986) and B. subtilis (Xu and Strauch, 
1996), temperature does not affect the gene expression of GGT in H. pylori 
(Chevalier et al., 1999). The present study demonstrates that GGT being a membrane 
bound enzyme (Figure 30 and Table 11) is present in all 98 H. pylori isolates. 
Furthermore, we also found that GGT is constantly expressed in different growth 
phases (spiral or coccoid) of H. pylori. It is therefore suggested that the constitutively 
expressed GGT could be used as an identification marker for H. pylori isolates.  
 
H. pylori GGT has been reported as a virulence factor and plays an essential role in 
the H. pylori colonization to gastric mucosa of mice (Chevalier et al., 1999; 
McGovern et al., 2001). The strong association of GGT and H. pylori-induced cell 
apoptosis has also been documented by Shibayama et al. (2003). In addition, it was 
shown that GGT upregulates COX-2 and EGF-related peptide expression in human 
gastric cells suggesting it may play an important role in H. pylori-associated gastric 
carcinogenesis (Busiello et al., 2004). In the current study, we report for the first time 
that H. pylori strains isolated from PUD patients showed significantly higher GGT 
activity as compared to those isolated from NUD patients (0.89 ± 0.23 vs. 0.51 ± 0.15 
U/mg protein, p < 0.001). The results suggest a close association between H. pylori 
GGT activity and the development of peptic ulcer disease. 
 
5.1.4 GGT activity and the status of cagA, vacA, iceA, and babA2 
The relationship between GGT activity and other virulence factors (like cagA, vacA, 
iceA and babA) in H. pylori has not been reported. This study shows there was no 
significance in GGT activity between cagA+ and cagA- H. pylori isolates (p = 0.47). 
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Similar results were also observed for vacA, iceA1, iceA2 and babA2 with p values 
ranging from 0.15 to 0.56 (Table 10). In addition, it was noted that GGT activities of 
the clones isolated from individual patient were very similar irrespective of the vacA 
genotypes, the coefficient of variation (CV) ranged from 1 to 4% (Table 9) indicating 
that the vacA genotype has no influence on the GGT activity of H. pylori. The results 
suggested that GGT activity is independent of the presence of those virulence factors 
examined in the present study.   
 
Combining the data on GGT activity, presence of virulence genes and clinical 
outcome of patients together (Figure 12 and Tables 6 & 10), it is interesting to note 
that H. pylori strains presenting with higher GGT activity are closely associated with 
peptic ulcer diseases while there was no correlation between the presence of other 
virulence factors studied and PUD. These findings strongly indicate that GGT being a 
virulence factor of H. pylori (McGovern et al., 2001) may play an essential role in the 
development of peptic ulcer disease in Singapore. 
 
5.2 Prominent role of GGT on the growth of H. pylori  
H. pylori strains displaying various GGT activities grow differently. The 10 - 100 
folds faster growth rate by higer GGT producing strains as compared to that of the 
strains with lower GGT activities depending on the age of culture (Figure 14) can be 
attributed to the importance of GGT in the GSH metabolism where breaking down of 
GSH into glutamate and cysteinyl-glycine which will be further degraded into glycine 




Tokunaga et al. (1998) reported that the severity of gastroduodenal diseases is 
associated with higher number of H. pylori. We may therefore question if high GGT 
producers will proliferate faster and help in the colonization under in vivo condition. It 
was therefore postulated that H. pylori strains presenting with high GGT activity may 
favour the development of severe gastroduodenal diseases as they may grow faster, 
which in turn injure the gastric mucosa. 
 
It was observed that a maximum of 96% of H. pylori GGT activity was suppressed by 
10 mM serine borate complex (SBC) (Figure 15). In the presence of SBC,   the 
growth of H. pylori was retarded in a dose dependent manner (Figure 17). Inhibition 
of GGT activity by SBC could be caused by the competition with respect to γ-
glutamyl substrate and that SBC was formed that might bind to the active site of the 
enzyme by interacting with a carbohydrate residue of the enzyme (Tate and Meister, 
1978). In this study, SBC was used as a specific inhibitor of GGT in place of acivicin, 
a more effective GGT inhibitor (Vina et al., 1983) because acivicin is a non-specific 
GGT inhibitor (Anderson and Meister, 1986) which also inhibits many other 
glutamine-dependent enzymes involved in purine and pyrimidine biosynthesis (Lyons 
et al., 1990). 
 
In contrast, higher growth rate was observed when GGT activity was enhanced in the 
presence of 0.1 mM glutathione and 1mM glycyl-glycine (Figure 17). The GSH level 
chosen was based on the reported Km values (Huseby and Stromme, 1974) and 
physiological concentration in human (Paroni et al., 1995). Thus, the acceleration of 
the growth of H. pylori in the presence of GSH and glycyl-glycine demonstrates the 
possibility of such event in in vivo situation.  
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The results of earlier studies (Chevalier et al., 1999; McGovern et al, 2001; 
Shibayama et al., 2003) indicated that GGT is an important enzyme for the growth 
and survival of H. pylori in vivo while our findings that growth of H. pylori is relative 
to the level of bacterial GGT activity where higher GGT activity favours its growth in 
vitro. It is therefore proposed that GGT has a vital and prominent role to play on the 
growth of H. pylori.  
 
5.3 Comparison of amino acid sequences of GGTs 
5.3.1 Between H. pylori and other bacterial and mammalian homologues 
Although the importance of GGT in glutathione metabolism (Meister and Anderson, 
1983) and amino acid transport (Orlowski and Meister, 1970) in mammalian tissues 
has been recognized for many years, few data are currently available on the role of 
this enzyme in bacteria (Suzuki et al., 1989; Ishiye et al., 1993; Xu and Strauch, 
1996). GGT activity is not detected in all species of bacteria, and in many cases it is 
not clear whether the lack of such an activity is due to the absence of the gene or to 
the absence of expression under the experimental conditions used. To date, the 
sequences of only 4 bacterial GGT-encoding genes have been reported, i.e. E. coli 
(Suzuki et al., 1989), P. aeruginosa (Ishiye et al., 1993), B. subtilis (Xu and Strauch, 
1996) and N. meningitidis (Parkhill et al., 2000). However, the virulent effect of GGT 
in these bacteria has not been documented. 
 
H. pylori GGT was found to have an overall sequence similarity to that of mammalian 
and bacterial GGTs (Figure 21). The amino acid sequence of H. pylori GGT shows 
only 20% homology with human GGT but higher homology to bacterial GGTs (49% 
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with E. coli; 38% with P. aeruginosa). The 49% homology with E. coli (Figure 63) 
has casted doubt on H. pylori GGT being used as a diagnostic marker for 
distinguishing the PUD patients from NUD patients as biopsy samples from H. 
pylori+ patients can be affected by the presence of non-H. pylori bacteria, i.e. E. coli 





Figure 63. Immunofluorescence analysis of E. coli GGT 
E. coli GGT was examined using FITC conjugated anti-rGGT antibody  
 
5.3.2 Comparison of GGTs of different H. pylori strains 
This study has shown that GGT is present in all the H. pylori isolates studied but 
different H. pylori strains display different level of GGT activities. It was thus 
necessary to sequence ggt gene of H. pylori isolates with different GGT expression 
level in an attempt to identify the GGT activity-associated amino acid transitions. Of 
the 6 clinical isolates studied, two standard strains (NCTC11637, SS1) expressed 
medium GGT activity (~ 0.7 U/mg protein), two (strain 825 and 712) displayed high 
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GGT activity (>1 U/mg protein), and strains 840 and 998 presented low GGT activity 
(< 0.4 U/mg protein). As shown in Figure 22, the GGT sequences of these 6 H. pylori 
strains showed only 21 of the 567 amino acids of the whole GGT molecule are 
different with no consistent amino acid changes regardless of their GGT activities. On 
separate studies carried out by Ito et al. (1998) and Kersulyte et al. (2000) who 
reported that deletion, insertion and substitution motifs were identified in H. pylori 
vacA and cag pathogenicity island which were correlated with the toxicity of the 
strains. However, DNA sequencing and translated protein sequence alignment of ggt 
gene of 6 individual H. pylori isolates showed a > 97% homology but neither deletion 
/ insertion nor substitution motifs was found. The results indicate that host 
environmental factors may regulate or affect the GGT activity of H. pylori and that 
highly conserved GGT might play crucial roles in the survival and pathogenesis of H. 
pylori.  
 
5.4 Recombinant GGT protein expression and refolding  
Using the computerized prediction of antigenicity of the protein by the method of 
Welling et al. (1985), the antigenic regions of GGT were found to lie in the large 
subunit of GGT within the fragment (85th – 362th AA) (Figure 8). Interestingly, the 
AA sequence of this selected fragment showed that it is highly conserved at > 97% 
homology in the 5 clinical strains examined in this study as well as in the reported H. 
pylori strains (J99, 26695, NCTC 11637). In contrast, this region only shares 19% 
homology with that of human GGT. Furthermore, no protein band of GGT large 
subunit was lighted when rabbit-anti-rGGT was used as a probe against human serum 
(data not shown) indicating that the anti-rGGT antibody rose is H. pylori specific. 
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For more than 20 years (Marino, 1989), E. coli has been proven to be a reliable host 
for the production of heterologous proteins. However, the expression of heterologous 
proteins as a soluble functional protein remains unpredictable (Marston and Hartley, 
1990). It was suggested that over-expression of the heterologous protein may favour 
its aggregation in the inclusion body (Clark, 1998; Tsumoto et al., 2003). Sawyer et al. 
(1994) employed lower temperature of culture as one of the approaches to improve 
the expression of recombinant protein in the soluble faction. However, rGGT was 
expressed as an insoluble pellet with lower culturing and induction temperature 
(Figure 27). Therefore, in order to recover it in biologically active form, it was 
necessary to solubilize and refold rGGT in vitro according to the method as described 
by Mitraki et al. (1987). As rGGT in inclusion body was purified under denaturing 
condition, refolding of the solubilized proteins was initiated by the removal of the 
denaturant through step-wisely dialysis using PBS buffer containing decreasing 
concentration of urea (from 4M to 0M). 
 
In addition, the efficiency of refolding also depends on the competition between 
correct folding and aggregation. Gething and Sambrook (1992) reported that many 
factors have been reported to be involved in the protein refolding process, such as 
protein concentration, temperature, pH, ionic strength, and additives (arginine, PEG, 
etc.). It has been suggested that 0.1 - 1 M L-arginine can facilitate in vitro refolding of 
the recombinant protein (Rudolph et al., 1992; Tsumoto et al., 2003; 2004). Hence, in 
this study, purified rGGT protein was refolded by dialysis at a low protein 
concentration (0.05 mg/ml) in the presence of 0.5 M L-arginine to slow down the 
aggregation process. The recovery of active protein (rGGT) of up to 50% of the initial 
protein (purified under denaturing condition) was achieved during refolding upon 
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reduction of denaturant concentration with the assistance of L-arginine (data not 
shown) indicating that rGGT was efficiently and inexpensively refolded with high 
yield.  
 
5.5 Subcellular localization of GGT 
The cell localization of GGTs varies among different bacterial species. All bacterial 
GGTs are synthesized as pro-GGT with a typical peptide signal, indicating that these 
proteins are secreted into the periplasmic space. The E. coli GGT has been found to 
be localized exclusively in the periplasmic space (Susuki et al., 1986), whereas the 
GGTs from Proteus mirabilis (Nakayama et al., 1984) and Actinobacillus 
actinomycetemcomitans (Mineyama et al., 1995) are localized predominantly in the 
outer membrane fraction. This suggests that the enzymes in the latter two bacteria are 
membrane-bound proteins, as is the case with mammalian GGTs. On the other hand, 
Bacillus subtilis GGT was found to be secreted mainly into the medium (Xu and 
Strauch, 1996).  
 
In 2002, Bumann et al. reported that two GGT fragments of 38 kDa (large subunit) 
and 21 kDa (small subunit) are two major components of the proteins secreted by H. 
pylori. In this study, rggt encodes the 85th - 362th on the large subunit was used to 
raise anti-rGGT antibody for use in western blot analysis which shows that H. pylori 
GGT is localized on the cell membrane. This was confirmed by the presence of the 
large subunit of 38 kDa in outer membrane protein (OMP), cytoplasmic protein (CP) 
and acid-glycine extraction (AGE) protein factions (Figure 30). In addition, when 
examined by GGT activity assay, the OMP and CP fractions showed higher GGT 
activity as compared to that in protein fraction obtained by AGE method (Table 11). 
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Although the acid-glycine extracted protein fraction comprises mainly cell membrane 
and membrane associated proteins, only one dim band was detected (Figure 30, Lane 
4). This implies that AGE extraction method may not be a suitable method for 
extracting the GGT protein from H. pylori cells. A possible reason for the low 
recovery of GGT may be due to AGE extraction which was carried out at low pH (pH 
2.2), while GGT is stable under the condition with pH around 8.0 (Chevalier et al., 
1999). It was also shown by Suzuki et al. (1986) who demonstrated that E. coli GGT 
was inactivated and degraded at lower pH (< pH 6.0). Thus, during the extraction 
process, the GGT protein could have been denatured at pH of 2.2 and therefore could 
not be recovered successfully in AGE fraction. 
 
 
5.6 Purification of native H. pylori GGT  
5.6.1 Three-step purification 
The predicted pI of GGT provides an important clue to setting protein purification 
process. The pI of H. pylori GGT was determined to be 9.22 as shown by analysis 
using Compute pI/MW tool (http://us.expasy.org/tools/pi_tool). In this study, 
purification of GGT involved concentration of proteins from crude sample using ion 
exchange chromatography based on pI, following by gel filtration to separate protein 
based on the molecular weight and again reconcentrated and polished using ion 
exchange chromatography. 
 
Lillehoj and Malik (1989) reported that selectivity during adsorption of protein of 
interest to an ion exchanger is optimized by careful selection of pH and ionic strength 
of the starting buffer. The choice of optimal pH will always be a balance between 
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selectivity and capacity. It has been suggested that the starting pH should be at least 1 
pH unit below the isoelectric point of cation exchangers to facilitate adequate binding 
(Lampson and Tytell, 1965). Using test-tube method, pH 7.5 was selected as the 
starting pH of the buffer (Table 12). The buffer system selected was to give maximum 
buffering power at the least possible ionic strength to ensure high binding capacity of 
the molecule of interest.  
 
In an attempt to achieve dissolution of protein of interest, step gradient elution with 
increasing ionic strength (low to high) was used to select the ionic strength of the 
elution buffer. Partially purified GGT was eluted with 200 mM NaCl (Figure 31). 
From this initial purification step using ion exchange chromatography (SP Sepharose), 
the specific GGT activity was increased by about 50 times (Table 13) as shown by the 
GGT activity analysis. 
 
The partially purified GGT was put through gel filtration column to separate the 
proteins on the basis of their molecular size and shape using the properties of 
molecular sieve of a variety of porous materials. In the present study, G200 Sephadex 
resin (with the fractionation range from 5 to 600 kDa) was chosen based on the 
molecular size of H. pylori GGT protein (~ 61 kDa). As the flow rate can affect the 
resolution of gel filtration purification, a slow speed of flow rate (0.3 - 0.5 ml/min) 
was set to improve the resolution. The activity of GGT obtained was shown to be 2.4 
times higher as compared to the protein obtained from the initial purification step or 




In order to further improve the purity of native GGT, a more refined ion exchanger, 
RESOURCE S was used. The results showed that the protein obtained exhibiting 
GGT activity correspond to the two bands (38 and 22 kDa) with similar molecular 
weight of GGT large and small subunits as predicted according to the sequence of H. 
pylori GGT. This purified GGT showed 240 times in its activity as compared to the 
original sample.  It shows that the 3-step purification procedure has successfully 
purified GGT to a high purity (> 95%). 
 
5.6.2 Native PAGE analysis of H. pylori GGT  
Native PAGE is a technique for separating biologically active proteins. In contrast to 
SDS-PAGE, the mobilities of proteins in a Native PAGE system depend on both size 
and charge. There is no single electrophoresis buffer system that will optimally 
separate all proteins in a native gel. Key parameters for separating proteins in a Native 
PAGE system are pI of the protein of interest and the pH of the electrophoresis buffer 
(Ornstein, 1964). 
 
The pH of the electrophoresis buffer must be within the pH range over which the 
protein of interest is stable and yet retains biological activity. In addition, the pH of 
the buffer must impart sufficient charge to the protein for it to move through the gel. 
Changes in the buffer pH will affect both the charge and size (hydrodynamic volume) 
of the protein of interest and will affect migration rates. Buffers with a pH closer to 
the pI will provide the best resolution, whereas run times may be lengthy (Ornstein, 
1964). Conversely, buffers with a pH further and higher from the pI will allow faster 
migration but resolution may be compromised. Thus, the choice of pH of 
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electrophoresis buffer becomes a tradeoff between separation and speed (Ornstein, 
1964). 
 
It has been identified that the pI of H. pylori GGT protein is about 9.22. As GGT has 
a pH optimum of 8.0 (Chevalier et al., 1999) but is not stable at pH 11 and above 
(unpublished data), the electrophoresis buffer containing 37 mM ammonia and 20 
mM CAPS giving a pH at 10.2 was chosen to balance the separation resolution and 
running speed. 
 
In this study, it was observed that the purified native H. pylori GGT protein run on a 
native PAGE gel showed a single band (Figure 34A), which when extracted from the 
native gel was separated into two bands by subsequent SDS-PAGE (Figure 34B). The 
results indicate that there are two protein subunits of H. pylori GGT which exist in 
combination in their natural form. Our results are consistent with the findings that 
GGT is a heterodimer in which a large and a small subunit associate in a non-covalent 
manner, and it is translated in a single-chain precursor form that is subsequently 
processed into two subunits (Hanigan, 1998; Taniguchi and Ikeda, 1998; Shibayama 
et al., 2003).  
 
In addition, this finding confirms the existence of a post-translational maturation 
process although it is rare in prokaryotic cells. Hashimoto et al. (1995) reported that 
when present, this post-translational maturation process is commonly associated with 
an autoendoproteolytic activity of the protein. They showed that in E. coli K-12, the 
sequence of threonyl-threonyl-histidinyl residues at the N-terminal of the small 
subunit is vital for the processing of GGT and this processing is essential to the 
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expression of its activity. Our study also shows that H. pylori GGT displayed 
threonyl-threonyl-histidinyl (380th - 382th AA) residues similar to that of E. coli K-12 
GGT. It is therefore implied that post-translational process also occurs in H. pylori. 
 
5.6.3 Protein identification 
The purified H. pylori GGT protein that exhibited GGT activity was further identified 
by mass spectrometry (MS). The generation of peptide maps of proteins by in-gel 
approaches is used often in proteomics-type studies (Mortz et al., 1994; Shevchenko 
et al., 1996a; Jungblut and Thiede, 1997). This in-gel approach has been reported to 
be used for the generation of peptide maps of membrane proteins (Buhler et al., 1998; 
Soskic et al., 1999). However, high sequence coverage is difficult to obtain because 
of lack-or limited accessibility-of proteolytic cleavage sites in the membrane-
spanning segments. As shown in Figure 35, the matched peptide masses generated 
after tryptic digestion covered 30.2% of the whole protein. This relatively low 
coverage may be explained as GGT being a membrane protein, therefore in-gel 
digestion by trypsin might have resulted in large fragments that are highly 
hydrophobic (with higher percentage of hydrophobic amino acids, e.g. C, I, F, L, V, 
and W). Thereby limits the coverage of those membrane domains in protein 
identification. This approach combines the high separation capacity of SDS-PAGE 
and sensitivity of MS revealed that the protein bands matched well with both the large 
and small subunits of H. pylori gamma-glutamyl transpeptidase, indicating the native 




5.7 H. pylori GGT and cell apoptosis  
5.7.1 Gastric cell lines for apoptosis analysis 
It has been demonstrated that H. pylori is capable of directly inducing the death of 
gastric epithelial cells in vitro (Kuck et al., 2001; Perfetto et al., 2004). However, the 
mechanism of cell death differed between the two commonly used gastric cell lines 
(KATO III and AGS). KATO III cells underwent necrosis in response to prolonged 
infection with the bacterium, while AGS cells underwent apoptosis (Chen et al., 1997; 
Jones et al., 1999). As reported by Chen et al. (1997), KATO III and many other 
available gastric cell lines have a deletion and rearrangement of p53 that potentially 
affect the apoptotic response to H. pylori infection. In contrast, the response of AGS 
cells to bacterium infection mimics the in vivo setting, indicating that the AGS cell 
line serves as a more suitable model for investigation of H. pylori-mediated apoptosis 
than the KATO III cell line agreeing with the finding of Chen et al. (1997). 
 
This study shows that uninfected AGS and KATO III cells did not contribute any 
GGT activity as examined by the GGT assay. Based on the combination of 
information obtained from literatures and reaction of GGT assay, AGS cell was 
selected for analyzing cell apoptosis, while both of the two gastric epithelial cell lines 
were used for analyzing GGT-mediated hydrogen peroxide and IL-8 generation. 
 
5.7.2 GGT, an apoptosis-inducing protein of H. pylori 
H. pylori GGT upon secretion and maturation is associated to cell membrane 
(Shibayama et al., 2003; present study). The membrane localization of GGT favours 
its direct contact with host cells where this direct contact has been documented to be 
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required for cell apoptosis induction (Chen et al., 1997; Wu et al., 2004). It has been 
documented by Shibayama et al. (2003) that characteristic features of apoptosis, 
including cytoplasmic vacuolation, blebbing of the membrane and apoptotic body 
formation was detected in AGS cells after incubating with H. pylori GGT protein for 
24 hours. Thus, the incubation time of 24 hours was selected for GGT-induced cell 
apoptosis analysis in the present study.  
 
It was interesting to note that H. pylori with higher GGT activity (> 1 U/mg protein) 
showed higher apoptosis-inducing activity than those with lower GGT activity of < 
0.4 U/mg protein (Figure 40). In addition, the purified native GGT-induced apoptosis 
in AGS cells was dose dependent (Figure 41). The induction of cell apoptosis 
decreased to the basal level when GGT activity was completely suppressed by anti-
rGGT antibody or SBC, whereas significantly higher apoptosis occurred in AGS cells 
when H. pylori GGT activity was stimulated with the addition of GSH and glycyl-
glycine. These observations are in agreement with previously published data 
(Shibayama et al., 2003) that GGT being a plasma membrane enzyme of H. pylori 
plays a significant role in H. pylori-mediated apoptosis.  
 
5.7.3 Possible mechanism of native H. pylori GGT-induced cell apoptosis 
5.7.3.1 COX4  
COX4 is a membrane protein in the inner mitochondrial membrane, which remains in 
the mitochondria regardless of apoptosis activation. Thus, COX4 is a convenient 
marker for the mitochondria-enriched fraction. In this study, COX4 protein band was 
only detected in the mitochondrial fraction rather than in cytosolic fraction (Figure 
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47), indicating that enriched mitochondrial fraction has been successfully separated 
from the cytosolic fraction. And these mitochondrial and cytosolic fractions obtained 
could be used as starting material for studying the presence of cytochrome c in the 
cytosolic fraction which indicates that mitochondrial membrane permeability 
increases when the AGS cells undergo apoptosis. 
 
5.7.3.2 GGT on caspase activities in AGS cells  
Members of the caspase family of cysteine proteases have been firmly established to 
play key roles in signal transduction cascades that culminate in apoptosis (Takahashi, 
1999). Caspases are normally expressed as inactive precursor enzymes (zymogens). 
When cells undergo apoptosis, these caspases become activated through one or two 
sequential proteolytic events that cleave the single peptide precursor into the large and 
small fragments that constitute the active enzyme (Thornberry and Lazebnik 1998).  
 
It has been reported by Slee et al. (1999) that the caspases implicated in apoptosis can 
be further divided into two functional subgroups based on their known or hypothetical 
roles in the process. Upstream or apical caspases (caspase-2, -8, -9, and -10) are 
thought to be primarily responsible for initiating caspase-activation cascades. The 
second group, the downstream or effector caspases (caspase-3, -6, and -7), is thought 
to be responsible for the actual demolition/dismantling of the cell during apoptosis. 
Upon activation, apical caspases propagate death signals by activating downstream 
effector caspases in a cascade-like manner. The effector caspases then orchestrate the 
direct dismantling of cellular structures, disruption of cellular metabolism, 
inactivation of cell-death inhibitory proteins, and activation of additional destructive 
enzymes (Adrain and Martin, 2001). 
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Of the two well characterized caspase-activating cascades that regulate apoptosis: 
caspase-8 activation is associated with death receptor apoptotic signaling (Seol et al., 
2001) while caspase-9 activation is mainly associated with mitochondrial mediated 
apoptotic signaling (Krajewski et al., 1999; Costantini et al., 2002). The effector 
caspase-3 can be activated by either caspase-8 or caspase-9 (Slee et al., 1999).  
 
In this study, the presence of purified native GGT has initiated the elevation of 
caspase-3 and caspase-9 but not caspase-8 activities (Figure 43). In addition, it was 
found that H. pylori-induced elevation of caspase-3 and caspase-9 activities were 
significantly blocked in the presence of SBC, the inhibitor of GGT. Conversely, only 
caspase-3 and caspase-9 activities were further elevated as compared to the ‘H. 
pylori’ value (AGS cells treated with H. pylori cells) when GGT activity was 
enhanced in the presence of GSH and glycyl-glycine (Figure 44). These results 
indicate that GGT treatment increased the activity of caspase-9 and caspase-3, 
resulted in inducing cell apoptosis. It was suggested that mitochondria dysfunction 
was strongly associated with caspase-9 activation (Krajewski et al., 1999; Costantini 
et al., 2002). Therefore, the permeability of mitochondrial membrane and the release 
of cytochrome c, a mitochondrial protein, were examined to illustrate the involvement 
of mitochondria in the GGT-induced cell apoptosis. 
 
5.7.3.3 GGT and mitochondrial-mediated apoptosis pathway 
Role of mitochondria in the pathogenesis of apoptosis has been well defined (Petit et 
al., 1996; Desagher and Martinou, 2000; Hengartner, 2000). Many pro-apoptotic 
signals converge at mitochondria and most of these stimuli trigger a change of the 
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mitochondrial transmembrane potential resulting in altered membrane permeability 
(Green and Reed, 1998). 
 
As suggested by He et al. (2002), the mitochondrial membrane permeability changes 
were examined using BD MitoSensor Dye, a cationic dye that fluoresces differently in 
apoptotic and nonapoptotic cells. Using the MitoSensor Dye, it was observed that all 
of the untreated AGS cells exhibited red fluorescence (Figure 46A). On the contrary, 
after incubating with purified GGT for 24 hours, most of the AGS cells showed green 
fluorescence (Figure 46B). It has been suggested that the BD MitoSensor Dye is taken 
up in the mitochondria of non-apoptotic cells, where it forms aggregates that exhibit 
intense red fluorescence. In contrast, in apoptotic cells, dye cannot accumulate in the 
mitochondria because of altered mitochondrial membrane permeability. As a result, 
the dye remains in monomeric form in the cytoplasm where it fluoresces green. Hence, 
the results obtained indicate that the mitochondrial membrane permeability increased 
in AGS cells in the presence of H. pylori GGT. 
 
It has been well documented that a change in mitochondrial membrane permeability 
may result in the release of several mitochondrial proteins into the cytoplasm. This 
constitutes a key event of mitochondrial-mediated apoptosis (Susin et al., 1999a). Pro-
apoptotic proteins released from mitochondria during apoptosis include: (a) 
cytochrome c (Liu et al., 1996), (b) caspase 9 (Susin et al., 1999b), (c) the protein 
named second mitochondrial activator of caspases (Smac)/direct inhibitor of apoptosis 
proteins binding protein with low pI (DIABLO) (Du et al., 2000;  Verhagen et al., 
2000), (d) apoptosis-inducing factor (AIF) (Zamzani et al., 1996). Among these, 
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cytochrome c is the widely reported pro-apoptotic protein that is involved in almost 
all forms of mitochondrial-induced apoptosis (Haga et al., 2003). 
 
Cytochrome c localizes at the mitochondrial intermembrane space and the increase of 
the outer mitochondrial membrane permeability permits the release of cytochrome c 
into the cytoplasm (Liu et al., 1996). Therefore, the findings that AGS cells when 
incubated in the presence of purified native H. pylori GGT had led to an increase in 
cytosolic and a decrease in mitochondrial cytochrome c protein levels as compared to 
the uninfected AGS cells (Figure 48) support the result in this study that 
mitochondrial membrane permeability increased in AGS cells in the presence of H. 
pylori GGT. 
 
Liu et al. (1996) reported that cytosolic cytochrome c initiates the formation of a 
multiprotein complex composed of apoptotic protease-activating factor (Apaf-1), 
dATP and caspase 9. This complex has been termed apoptosome. The autocatalytic 
maturation of caspase 9 in the complex and/or the allosteric activation of caspase 9 by 
Apaf-1 binding finally resulted in the cleavage of caspase 3 and, thus, the activation 
of the execution phase of apoptosis. Therefore, the findings that more cytochrome c 
released from mitochondria under the GGT stimulation condition whereas most of the 
cytochrome c stayed in mitochondria when GGT activity was inhibited by the specific 
GGT inhibitor as compared to the GGT treated AGS cells (Figure 49) further support 
our findings that caspase-3 & 9 were significantly blocked or elevated in the presence 




Results obtained in relation to the increase of mitochondrial membrane permeability, 
cytosolic cytochrome c level and elevated caspases-3 & 9 activities in purified native 
H. pylori GGT treated AGS cells; it is therefore possible to hypothesize that GGT-
mediated cell apoptosis is controlled by mitochondrial-mediated signaling pathway.   
 
5.7.4 GGT and ligand-mediated apoptosis 
Although mitochondrial-mediated apoptotic pathway is essential for  H. pylori 
induced cell apoptosis (Potthoff et al., 2002), Jones et al. (1999) reported that H. 
pylori also induces gastric epithelial cell apoptosis in association with increased Fas L 
receptor expression. It has been documented that caspase-8 activation is associated 
with death receptor apoptotic signaling (Seol et al., 2001). In addition, the effect of 
VacA in H. pylori-induced cell apoptosis has also been examined as VacA is the most 
well identified virulence factor that induces cell apoptosis via death receptor pathway, 
especially through increasing the expression of Fas L receptor (Kuck et al., 2001). 
Therefore, caspase-8 activity in AGS cells in the presence of purified native GGT or 
H. pylori strains with different GGT activities as well as different vacA status has 
been examined in this study.  
 
Our study on caspase-8 activity showed that higher caspase-8 activity was detected in 
the vacA+ H. pylori strains as compared to vacA- strain (Figure 45). This is consistent 
with the earlier study carried out by Kuck et al. (2001) indicating that VacA is 
involved in the H. pylori-induced cell apoptosis by death receptor pathway. However, 
it was observed that H. pylori strains exhibiting high GGT activity regardless of vacA+ 
/ vacA- showed significantly higher caspase-9 activity rather than caspase-8 activity as 
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compared to the low GGT activity producing strain (Figure 45). Thus, GGT-induced 
cell apoptosis may not be mainly controlled through death receptor pathway. 
Interestingly, higher caspase-3 activity was detected in AGS cells treated with high 
GGT producing H. pylori strains as compared to that of low GGT producing H. pylori 
infected AGS cells regardless of the vacA status. The results suggest that GGT might 
be a major factor involved in H. pylori-induced cell apoptosis. 
 
Apoptosis is an essential part of the cycle of cellular turnover in many tissues, 
including the gastrointestinal tract. It has been reported that H. pylori infection is 
associated with increased epithelial cell apoptosis in the gastric mucosa of peptic ulcer 
patients, while apoptosis decreases to the levels found in normal controls after 
eradication of H. pylori (Moss et al., 1996; Houghton et al., 1999; Kohda et al., 1999). 
In addition, Kohda and colleagues showed that the increase in apoptosis in the antral 
mucosa correlated closely with the stage of ulceration (Kohda et al., 1999). These 
findings suggested that apoptosis plays an important role in the development of 
ulceration.  
 
Combining the results obtained that the expression of GGT activity is common to all 
H. pylori strains and that H. pylori GGT mediates cell apoptosis, which may favour 
the bacteria to gain essential nutrients from the apoptotic cells and thereby establish a 
successful colonization in vivo, it is therefore proposed that all H. pylori strains 
possess the capability of inducing cell apoptosis and gastroduodenal diseases. 
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5.8 H. pylori GGT in H2O2 and IL-8 generation  
In the current study, significantly higher amount of H2O2 was released from AGS and 
KATO III cells when incubated with H. pylori cells at 1:100 ratio (p < 0.05, Figure 
50). As reported by Aihara et al. (1997) that higher H. pylori:cell ratio would induce 
the death of gastric cells, the 100:1 H. pylori:cell ratio was thereby chosen for follow-
up studies. In addition, our results agree well with earlier studies that demonstrated H. 
pylori infection increased H2O2 generation in vivo and in vitro (Davies et al., 1992; 
Ding et al., 2004).   
 
As shown in Table 14, production of cytokines (IL-4, IL-8, IFN-γ and TNF-α) were 
examined in AGS and KATO III cells following the treatment with H. pylori cells. 
The results in this study that only IL-8 production was stimulated by H. pylori in AGS 
and KATO III cells support previous finding that IL-8 induction in H. pylori-infected 
gastric epithelial cells is an important factor which is responsible for the 
inflammation-associated mucosal injury (Maeda et al., 2001). Thus, IL-8 production 
stimulated by H. pylori was chosen for the follow-up experiments.  
 
5.8.1 H. pylori GGT associated H2O2 production  
Earlier studies showed that the main function of the GGT-mediated metabolism of 
extracellular GSH appears to lie in the recovery of cysteine, whose adequate supply is 
critical for protein synthesis, especially in rapidly dividing neoplastic cells (Hanigan 
and Ricketts, 1993). On the other hand, a further effect of GGT-mediated GSH 
metabolism appears to lie in the induction of oxidizing processes (Stark et al., 1989; 
1993; Paolicchi et al., 1997). It has been documented in mammalian cells that GGT 
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activity can give rise to redox reactions, leading to the production of reactive oxygen 
species (ROS) and lipid peroxidation (Paolicchi et al., 1997; Drozdz et al., 1998). 
However, the contribution of bacterial GGT in ROS generation has not been well 
established. 
 
Interestingly, in this study, when gastric epithelial cells were incubated with purified 
H. pylori GGT, the production of hydrogen peroxide was significantly increased (p < 
0.05, Figure 54). In contrast, in the presence of 10 mM of SBC as GGT inhibitor, the 
production of H2O2 was blocked completely indicating that GGT plays an important 
role in the H. pylori-induced H2O2 generation. Although the production of ROS 
induced by H. pylori infection has been documented in vitro and in vivo (Zhang et al., 
1997; Hyeyoung et al., 2000), the virulence factor/s involved in ROS generation has 
not been well defined. Here, we demonstrated for the first time that GGT might be a 
possible virulence factor involved in H. pylori-induced H2O2 generation. 
 
The mechanism by which GGT mediates H2O2 generation can be explained by the 
fact that GGT affect the cleavage of the γ-glutamyl moiety from GSH molecule 
generating cysteinyl-glycine (a thiol provided with much higher reactivity as 
compared to GSH). Due to a lower pKa than that of GSH (Stark et al., 1989), at near-
neutral pH, cysteinyl-glycine will be mostly in its dissociated form gly-cys-S2 
(thiolate anion). In principle, gly-cys-S2 thiolate anions would be capable of starting 
redox interactions, for example, with iron ions present in the medium, leading to the 










H. pylori infection has been shown to be strongly related to the level of iron in 
infected patients as demonstrated by population-based studies (Milman et al., 1998; 
Parkinson et al., 2000). It has been reported that iron plays an important role as an 
essential nutrient for the growth of H. pylori and showed critical role in mediating 
oxidant injury in vitro and in vivo. In addition, iron chelation protects gastric cells 
against oxidant stress induced by H. pylori infection (Yajima et al., 1995). In the 
present study, the addition of Fe3+ to the incubation mixture resulted in a further gain 
in H2O2 production in GGT incubated gastric epithelial cells (data not shown). With 
the information from literature and our results, it is therefore proposed that H. pylori 
GGT participates in the hydrogen peroxide generation through interactions with 
redox-reactive iron.   
 
GGT has been shown to play an important role in the degradation of GSH (Meister 
and Tate, 1976; Meister and Anderson, 1983). Therefore, our data suggesting that 
GGT has a pro-oxidant effect during H. pylori infection was further supported by the 
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finding that antral GSH concentration and GSH S-transferase activity are reduced 
during H. pylori infection (Verhulst et al., 2000; Shirin et al., 2001) and that 
incubation of cultured gastric mucosal cells with H. pylori depletes intracellular GSH 
stores (Shirin et al., 2001).  
 
It has been documented by Davies et al. (1992) that ROS induces injury to gastric 
mucosa, thereby potentially predisposing the tissue to ulcer formation. This was 
confirmed by Zhang et al. (1997) who reported that increased production of ROS in 
the antrum and duodenum was found to be related to H. pylori density and associated 
with peptic ulceration suggesting that ROS generated after H. pylori infection may be 
important in the course of peptic ulceration. Therefore, the finding that GGT plays an 
important role in the H. pylori-induced H2O2 generation implies that GGT might be a 
virulence factor of H. pylori participates in the development of peptic ulcer disease. 
 
5.8.2 Relationship of GGT, H2O2, NF-κB activation and IL-8 production  
It has been shown that NF-κB could be activated by hydrogen peroxide (Schmidt et 
al., 1996) and linked to IL-8 production (Roebuck, 1999). In this study, different 
inhibitors were used to examine the possible pathway of GGT-mediated IL-8 
generation in cultured gastric epithelial cells including SBC, N-acetylcysteine (NAC), 
a-Cyano-(3-ethoxy-4-hydroxy-5-phenylthiomethyl) cinnamide (ST638) and N-
benzoyloxycarbonyl (Z)-Leu-Leu-leucinal (MG132).  We confirmed that these 
pharmacological inhibitors did not affect the gastric cell viability and did not change 




NF-κB is well characterized as a transcriptional regulator of IL-8 production (Keates 
et al., 1997; Münzenmaier et al., 1997; Maeda et al., 2000). And its activation is a 
consequence of phosphorylation and subsequent proteolytic degradation of the I-κB 
proteins (Baeuerle and Henkel, 1996). Therefore, NF-κB activation and degradation 
of I-κB protein were analyzed using western blot method. In the present study, the 
nuclear level of NF-κB in AGS and KATO III cells was significantly increased after 
H. pylori infection. In contrast, as shown in Figure 56, H. pylori infection resulted in a 
marked degradation of I-κBα. This finding is consistent with previous observations 
that H. pylori infection activates NF-κB in gastric epithelial cells via phosphorylation 
and degradation of I-κBα (Aihara et al., 1997; Keates et al., 1997). It further 
illustrates that H. pylori GGT initiate I-κBα degradation leading to the activation of 
NF-κB. 
 
Interestingly, it was noted that treatment with SBC, a specific GGT inhibitor, 
inhibited H. pylori-induced activation of NF-κB and degradation of I-κBα in the 
cultured gastric epithelial cells. On the contrary, after stimulating the H. pylori GGT 
activity with GGT enhancer, significantly more NF-κB was activated suggesting that 
GGT may play a significant role in H. pylori-induced NF-κB activation. Similarly, it 
was observed that cells incubated with purified H. pylori GGT protein exhibited a 
marked increase in NF-κB activation and a degradation of I-κBα, resulted in the 
elevation of IL-8 as compared to the basal level (cells without any treatment). The 





Phosphorylation and degradation of I-κBα have also been linked to generation of 
H2O2.  It has been well documented that hydrogen peroxide is one of the most 
important mediators which can regulate the activation of some protein kinases (Serine 
kinase, Tyrosine kinase, etc.). Consequently, those activated protein kinases would 
result in the phosphorylation and degradation of I-κBα (Kang et al., 2003) and then 
lead to IL-8 production (Aihara et al., 1997; Yoshihisa et al., 2002). Therefore, it is 
speculated that GGT-mediated hydrogen peroxide generation is responsible for the 
NF-κB activation and IL-8 production.  
 
In the current study, it was observed that pretreatment of gastric epithelical cells with 
NAC which can inhibit the function of H2O2 completely blocked NF-κB activation,  
I-κBα degradation and IL-8 generation induced by H. pylori GGT. The results 
confirmed that GGT signals the activation of NF-κB and IL-8 generation by 
increasing the hydrogen peroxide level in the cells. It was also found that inhibition of 
tyrosine kinase by ST638 (a specific inhibitor of tyrosine kinase) contributes to the 
inactivation of NF-κB, resulted in blocking the IL-8 generation. The finding is in 
agreement with the observation reported by Aihara et al. (1997) that H. pylori-
induced IL-8 production as well as NF-κB activation through a tyrosine kinase-
sensitive pathway. In addition, the inactivation of NF-κB and abolition of IL-8 
production after incubation with H. pylori GGT may also be due to the inhibition of I-
κB degradation by the treatment of MG132, a specific inhibitor of IκB/NF-κB 
pathway through a mechanism that blocks a proteasome that specifically degrades 
ubiquitinated I-κB. Thus, the results obtained suggest that GGT-mediated downstream 
signaling of hydrogen peroxide generation resulting in NF-κB activation contributes 
to the H. pylori-induced IL-8 generation in gastric epithelial cells. 
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It was found that expression of IL-8 gene was markedly up-regulated at the mRNA 
level in the presence of GGT, which was in parallel with the elevated expression of 
IL-8 in H. pylori infected gastric epithelial cells (Figure 62). In contrast, the GGT-
induced IL-8 mRNA transcription was much reduced in the presence of the various 
inhibitors, including NAC, ST638, and MG132. These results further confirmed our 
finding that GGT-mediated hydrogen peroxide production may be a signaling 







5.9 CONCLUSION and FUTURE WORK 
GGT has hitherto been reported to play a major role in the degradation and 
neosynthesis of glutathione (Meister and Anderson, 1983), but has not been 
implicated in its association with peptic ulcer disease (PUD). This study shows that 
GGT is present in all H. pylori isolates tested with 0.23 - 1.28 U/mg protein. More 
interestingly, H. pylori isolates obtained from PUD patients showed significantly 
higher GGT activity as compared to those isolated from non-ulcer dyspepsia (NUD) 
patients (0.89 ± 0.23 U/mg protein vs. 0.51 ± 0.15 U/mg protein, p < 0.001). 
Furthermore, it was also shown that GGT activity is not related to the presence of 
other virulence factors (vacA, cagA, iceA and babA2) of H. pylori examined in this 
study with the p values ranged from 0.15 to 0.56. These results indicate that GGT 
rather than other virulence factors plays an important role in the development of 
peptic ulcer disease in Singapore. Undoubtedly, this novel finding offers a new focus 
for investigating the cause and course of the peptic ulcer disease. 
 
The exposure of H. pylori to the increasing concentration of SBC (2 - 10 mM), a GGT 
inhibitor, resulted in the reduction of its GGT activity and retardation on its growth. In 
contrast, higher growth rate was observed when GGT activity was enhanced in the 
presence of glutathione and glycyl-glycine. In addition, it was observed that growth 
was more profuse for H. pylori isolates with higher GGT activity than those present 
with lower GGT activity in vitro. Our findings reveal that GGT plays an important 
role on the growth of H.  pylori. Unquestionably, H. pylori strains presenting with 
high GGT activity may favour the development of severe gastroduodenal diseases as 
they may grow faster, promote cell apoptosis, activate host’s inflammatory responses, 
which in turn damage the gastric mucosa.  
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The ggt gene was shown to be constitutively expressed during in vitro growth, which 
is in agreement with the findings of Chevalier et al. (1999). The results suggest that 
GGT could be used as an identification marker for H. pylori isolates. The study on ggt 
gene sequencing shows that the ggt gene sequences of 6 individual isolates did not 
show any consistent amino acid changes regardless of different GGT activities 
displayed. It is possible to speculate that some elements beyond ggt gene may regulate 
the GGT activity of H. pylori. Dissecting the whole ggt gene and characterizing the 
various domains within may provide clue to the existence of such regulation process. 
 
Our results show that the 3-step purification procedure has successfully purified 
native GGT to a high purity (> 95%) with a recovery rate of 35%. In an attempt to 
further increase the purity of purified GGT, hydrophobic interaction chromatography 
(HIC) could be an additional intermediate purification step to seperate protein based 
on its hydrophobicity. In addition, to further improve the protein recovery should not 
be undermined.  
 
This study shows that the native GGT, being a single-chain precursor, is subsequently 
processed into two subunits (38 and 22 kDa) suggests a post-translational maturation 
process exists in the course of maturation of H. pylori GGT. Understanding the 
relationship between the protein structure and its function may provide approaches to 
the investigation of the accessory proteins which are responsible for this maturation 
process.  
 
The enriched presence of GGT in the membrane fraction of H. pylori as examined by 
western blot and GGT assay indicates that GGT is membrane bound. Being localized 
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on the membrane, GGT may provide the bacteria an advantage in bacteria-host 
interaction.  
 
In this study, significantly higher apoptosis induction rate was observed in the native 
GGT incubated AGS cells indicating that GGT plays a significant role in H. pylori-
mediated apoptosis as was also reported by Shibayama et al. (2003). It has been 
documented that H. pylori induces cell apoptosis through both mitochondrial pathway 
and death receptor pathway (Jones et al., 1999; Potthoff et al., 2002; Ledig et al., 
2004; Menaker et al., 2004). As reported by Seol et al. (2001) that death receptor 
mediated cell apoptosis would show increased caspase-8 activity, therefore, based on 
our results that caspase-8 activity was not significantly elevated after GGT incubation, 
death receptor pathway is unlikely to be the major pathway in GGT-mediated cell 
apoptosis. In contrast, elevated caspase-3 and caspase-9 activities, increased 
mitochondrial membrane permeability and protein level of cytosolic cytochrome c in 
purified native GGT treated AGS cells suggest that GGT-mediated cell apoptosis is 
dominated through mitochondrial-mediated signaling pathway. However, the question 
on how GGT interacts with epithelial cells to initiate the apoptosis induction remains 
unknown. Further studies on identifying the receptor/s of gastric epithelial cells that 
interact with GGT will help us to clarify the intracellular signaling machinery that 
controls GGT induced apoptosis. Apoptosis was reported to be responsible for the 
development of peptic ulcer disease (Kohda et al., 1999) and gastric carcinoma 
(Shirin and Moss, 1998; Xia and Talley, 2001).  It is therefore concluded that the 





It is interesting to note that elevated amount of hydrogen peroxide, activated NF-κB 
and IL-8 were detected in gastric epithelial cells in the presence of purified native H. 
pylori GGT suggesting that GGT participates in the H. pylori-induced ROS 
generation and involved in the IL-8 production through activation of NF-κB. In 
addition, NAC (an antioxidant), ST638 (a tyrosine kinase inhibitor) and MG132 (an 
NF-κB pathway inhibitor) blocked the NF-κB activation and IL-8 production. The 
results indicate that the GGT-induced IL-8 production is initiated by hydrogen 
peroxide generation and tyrosine kinase plays a probable role in signal transmission 
for the efficient activation of GGT-induced NF-κB activation, resulting in IL-8 
generation. Undoubtedly, identifying the specific bacterial mediators that contribute 
to oxidative damage on epithelial cells and mucosal inflammation will be important in 
elucidating the role of H. pylori in the pathogenesis of gastroduodenal diseases. Thus, 
our findings reveal a novel aspect of the bacterial γ-glutamyl transpeptidase function 
providing a new focus on H. pylori-mediated hydrogen peroxide and IL-8 generation.  
 
The unique association of GGT with peptic ulcer disease, its role as an apoptotic 
protein and effect on the pro-inflammatory pathway demonstrate the critical and 
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APPENDIX 1: CHOCOLATE BLOOD AGAR (CBA) 
Blood agar base No.2 (Oxoid)                                    20.0 g 
Distilled water                                                             475 ml (qsp) 
Horse blood (5%) (Gibco)                                          25 ml 
 
Procedure: 
1.  Mix the blood agar base No.2 and distilled water was mixed in a 500 ml bottle. 
2.  Autoclave the medium at 121°C for 15 minutes. 
3.  Cool the agar to 80°C before adding 5% horse blood aseptically. 
4.  The blood is lysed by immersing the bottle in the 80 °C water bath for 10 minutes 
with constant swirling. 
5.  Subsequently cool the CBA to 50 °C before pouring into sterile petri dishes. 





APPENDIX 2: BRAIN HEART INFUSION (BHI) BROTH  
Brain heart infusion (BHI) (Oxoid)                             19 g 
Yeast extract (YE) (Oxoid)                                          2 g 
Distilled water                                                              450 ml (qsp) 
Horse serum (10%) (Gibco BRL)                                50 ml (added before use) 
 
Procedure: 
1.  Dissolve appropriate amount of BHI and YE powder in distilled water in a conical 
flask. 
2.  Dispense the BHI broth into 100 ml bottle in aliquots of required amount and    
     autoclave at 121°C for 15 minutes. 
3.  Store the cooled autoclaved medium at room temperature. 





APPENDIX 3: DNA EXTRACTION REAGENTS 
(A) Tris-EDTA (TE) buffer 
Tris-HCl (Sigma)                                                        1.576 g 
EDTA (Sigma)                                                            0.372 g 
Distilled water                                                             1L (qsp) 
Adjust the pH to 8.0 using 5N HCl. 
 
(B) Lysozyme 
Prepare as a stock solution of 10 mg/ml and keep as 500 µl aliquots at -20°C until use. 
 
(C) Proteinase K 
Prepare as a stock solution of 10 mg/ml and keep as 50 µl aliquots at -20 °C until use. 
 
(D) 3M sodium acetate 
Sodium acetate (Merck)                                              40.82 g 
Procedure: 
1.  Dissolve the chemical in 80 ml of distilled water. 
2.  Adjust pH to 5.2 with glacial acetic acid and top up with distilled water to 100 ml. 






APPENDIX 4: AGAROSE GEL ELECTROPHORESIS REAGENTS 
(A) 50 × TAE buffer 
Tris base (Sigma)                                                        242.2 g 
Glacial acetic acid (Merck)                                         57.1 ml 
EDTA (Sigma)                                                            37.2 g 
Distilled water                                                             1L (qsp) 
 
(B) 6 × loading buffer 
Bromophenol blue (Sigma)                                         0.2 g 
Xylene cyanol FF (Sigma)                                          0.2 g 
Glycerol (Merck)                                                        60 ml 
EDTA                                                                         18.76 g 
Distilled water                                                            100 ml (qsp) 
 
(C) Ethidium bromide (10mg/ml stock) 
EtBr (Sigma)      100 mg 
Distilled water      10 ml (qsp) 
Dissolve EtBr in distilled water at room temperature and store the solution in the dark 





APPENDIX 5: MOLECULAR CLONING MEDIA AND REAGENTS 
(A) Luria-Bertani medium (LB) 
Bacto-tryptone (Oxoid)                                               10 g 
Yeast extract (Oxoid)                                                  5 g 
NaCl (Merck)                                                              10 g 
Distilled water                                                             1L (qsp) 
Adjust the pH to 7 using 5N NaOH before autoclaving at 121°C for 15 minutes. 
 
(B) LB agar 
Bacto-agar (Gibco)                                                      15 g 
LB medium                                                                  1 L (qsp) 
Autoclave at 121°C for 15 minutes. 
 
(C) LB agar (with ampicillin) 
Prepare 500 ml of LB agar as described in Appendix 5B. Cool the agar to 50°C before 
adding ampicillin to a final concentration of 50 µg/ml. 
 
(D) Isopropyl-β-D-thiogalactoside (IPTG) 
Prepare IPTG as a stock of 200 mg/ml and keep as aliquots of 500 µl at -20°C until 
use.  
 
(E) X-galactosidase (X-gal) 






APPENDIX 6: PLASMID DNA EXTRACTION BUFFERS 
(A) Solution I 
Glucose (BDH)                                                           9.01 g 
Tris-base (Sigma)                                                        3.03 g 
EDTA                                                                          3.72 g 
Distilled water                                                             1 L (qsp) 
Prepare the solution in batches of 100 ml and autoclave at 121°C for 15 minutes 
before storing at 4°C until use. 
 
(B) Solution II 
Stock solutions:  
10 N NaOH                                                                 40 g / 100 ml distilled water 
10% SDS                                                                     10 g / 100 ml distilled water 
When using, freshly dilute to 0.2 N NaOH and 1% SDS in distilled water. 
 
(C) Solution III 
5 M potassium acetate                                                  60 ml 
Glacial acetic acid                                                        11.5 ml 
Distilled water                                                              100 ml (qsp) 




APPENDIX 7: His-Tag AFFINITY PURIFICATION BUFFERS 
(A) 8 × Charge buffer 
NiSO4-6 H2O (Merck)                                                 52.57 g 
Distilled water                                                             500 ml (qsp) 
 
 (B) 8 × binding buffer 
Imidazole (Sigma)                                                       1.36 g 
NaCl                                                                             116.88 g 
Tris base                                                                       9.69 g 
Distilled water                                                             500 ml (qsp) 
Adjust the pH to 7.9 using 5N HCl. 
 
(C) 8 × Wash buffer 
Imidazole                                                                    16.34 g 
NaCl                                                                            116.88 g 
Tris base                                                                       9.69 g 
Distilled water                                                             500 ml (qsp) 






(D) 4 × Elute buffer 
Imidazole                                                                     27.23 g 
NaCl                                                                             11.69 g 
Tris base                                                                        0.97 g 
Distilled water                                                             100 ml (qsp) 
Adjust the pH to 7.9 using 5N HCl. 
 
(E) 4 × Strip buffer 
EDTA                                                                          14.89 g 
NaCl                                                                            11.69 g 
Tris base                                                                       0.97 g 
Distilled water                                                             100 ml (qsp) 




APPENDIX 8: NATIVE PAGE BUFFERS 
(A) 5 × Electrophoresis buffer 
Ammonia                                                                    12.5 ml 
CAPS                                                                          22.13 g 
Distilled water                                                            1 L (qsp) 
 
(B) Sample buffer 
Electrophoresis buffer                                                 1.0 ml 
Glycerol                                                                       3.0 ml 
0.5% Bromophenol blue                                              0.2 ml 





APPENDIX 9: SDS-PAGE BUFFERS 
(A) Polyacrylamide gel  
The stacking and resolving gels are prepared in accordance to the protocol in the 
BioRad Acrylamide/Bis Solutions Instruction Manual. 
 
(B) Resolving Buffer (1.5 M Tris-HCl, pH 8.8)  
Tris-base                                                                      90.75 g 
Distilled water                                                              500 ml (qsp) 
Adjust the pH to 8.8 with HCl. 
 
(C) Stacking buffer (0.5 M Tris-HCl, pH 6.8) 
Tris-base                                                                      30.17 g 
Distilled water                                                              500 ml (qsp) 
Adjust the pH to 6.8 with HCl. 
 
(D)  10 × Tris-glycine SDS buffer 
Tris-base                                                                      30.17 g 
Glycine                                                                         188 g 
SDS                                                                               10 g 





(E) 2 × loading buffer 
10% SDS                                                                      4 ml 
0.5 M Tris-HCl (pH 6.8)                                              2.5 ml 
β-mecaptoethanol (Merck)                                           1 ml 
Glycerol                                                                        2 ml 
Bromophenol Blue                                                       5 mg 






APPENDIX 10: PROTEIN EXTRACTION BUFFERS 
(A) Acid glycine buffer (pH 2.2) 
Glycine       (Merck)                                                    7.507 g 
Dissolve the glycine crystals in distilled water and adjuste pH to 2.2 with HCl. The 
solution is then made up to 500 ml with distilled water. 
 
(B) Lysis buffer  
Urea (BioRad)                                                              9.8 g 
CHAPS (USB)                                                             0.8 g 
1.5 M Tris HCl (pH 8.8)                                              533 µl 
Protease inhibitor cocktail tablet (Complete, Roche)  ½ tablet 





APPENDIX 11: CELL VIABILITY ANALYSIS SOLUTIONS 
(A) MTT [3-(4, 5- dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide] stock 
solution 
MTT (Sigma)                                                               25 mg 
PBS buffer (pH 7.4)                                                     5 ml 
The solution is filter sterilized and stored at 4°C. 
 
(B) Lysis solution 
SDS                                                                             10 g 
DMSO (Dimethyl sulfoxide ) (Merck)                       99.4 ml 




APPENDIX 12: CYTOSOLIC AND NUCLEI PROTEIN EXTRACTION 
BUFFERS 
(A) Buffer A 
Hepes                                                                           240 mg 
KCl                                                                               70 mg 
EDTA                                                                           3.7 mg 
MgCl2 (Merck)                                                                                           31 mg 
Tween 20 (Merck)                                                        0.2 ml 
DTT                                                                              15.42 mg                  
PMSF (Merck)                                                             8.71 mg 
Distilled water                                                              100 ml (qsp) 
 
(B) Buffer C 
Hepes                                                                           480 mg 
NaCl                                                                             2.3 g 
EDTA                                                                           3.7 mg 
MgCl2                                                                                 31 mg 
Glycerol                                                                        25 ml 
DTT                                                                             15.42 mg 
PMSF                                                                           8.71 mg 
Distilled water                                                              100 ml (qsp) 
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